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Zusammenfassung 
 
Heilpflanzen und endophytische Pilze produzieren Naturstoffe mit einer großen Vielfalt von 
chemischen Strukturen, die für bestimmte medizinische Anwendungen geeignet sein könnten. 
Die meisten dieser Sekundärmetaboliten zeigen biologische Aktivitäten in pharmazeutisch 
relevanten Bioassay-Systemen und stellen daher potentielle Leitstrukturen dar, die optimiert 
werden könnten, um wirksame therapeutische und bioaktive Wirkstoffe zu ergeben. 
 
Das Hitze-Schock-Protein 90 spielt eine entscheidende Rolle bei der Aufrechterhaltung der 
Homöostase onkogener Proteine. Hsp90 Inhibitoren bietet großes Versprechen in der 
Behandlung einer Vielzahl von soliden und hämatologischen Malignomen. Zahlreiche 
natürliche Hsp90-Inhibitoren wurden in den letzten Jahren entwickelt, von denen einige 
ausgezeichnete Antitumor-Aktivitäten zeigen und in klinische Studien eingetreten sind. 
 
Ziel dieser Arbeit war die Isolierung von Sekundärstoffen aus der ausgewählten Pflanze 
Thymelaea lythroides und deren endophytischen Pilz Chaetomium aureum, gefolgt von 
Strukturaufklärung und Untersuchung der Antitumor-Aktivitäten isolierter Substanzen durch 
das Screening ihrer inhibierenden Aktivität gegen der Hsp90 Maschinerie. 
 
Die medizinische Pflanze Thymelaea lythroides wurde aus 55 Heilpflanzen, die als 
traditionelle Medizin von den Patienten des „National Institute of Oncology“ in Marokko 
verwendet werden, ausgewählt. Fünf endophytische Pilzstämme (Alternaria sp., Chaetomium 
sp., Cladosporium sp. und Pleospora sp.) wurden aus Thymelaea lythroides isoliert. Der Pilz 
Chaetomium aureum wurde zur weiteren Untersuchung ausgewählt und in Wickerham-
Flüssigmedium sowie auf 11 festen Medien für einen Zeitraum von drei bis vier Wochen 
angezogen. Die Extrakte wurden anschließend verschiedenen chromatographischen 
Trennverfahren unterzogen, um die Sekundärmetaboliten zu isolieren. Zur Strukturaufklärung 
der isolierten Substanzen wurden moderne Verfahren, einschließlich der Massenspektrometrie 
(MS) und der Kernresonanzspektroskopie (NMR) eingesetzt. Zusätzlich wurden chirale 
Derivatisierungsreaktionen bei optisch aktiven Verbindungen angewendet, um deren absolute 
Konfiguration zu ermitteln. 
 
Schließlich wurden die erhaltenen Verbindungen verschiedenen Biotests unterzogen, um ihre 
Antitumor-Aktivität zu untersuchen, wobei ihre Fähigkeit die Chaperon Hsp90 Maschinerie 
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zu hemmen, geprüft wurde. Außerdem wurden die isolierten Verbindungen auf ihre 
antimikrobiellen, antifungiziden und zytotoxischen Eigenschaften, sowie die Wirkung als 
Inhibitoren verschiedener Proteinkinasen, getestet.  
 
1 . Isolierte Verbindungen aus der Pflanze Thymelaea lythroides 
Acht Sekundärmetabolite wurden aus der Heilpflanze Thymelaea lythroides isoliert, darunter 
ein Depsipeptid (1; Bassiatin), zwei Coumarine (2; Daphneon und 3; Daphneolon), ein 
Dicoumarin (4; Daphnoretin), zwei Lignane (5; Wikstromol und 6; δ-Sesamin), ein 
Flavonoidglukosid (8; trans-Tilirosid) und ein Dicoumaringlukosid (7; Rutarensin). 
 
Bassiatin (1) ist ein ungewöhnlicher pflanzlicher Sekundärmetabolit, der zuvor ausschließlich 
aus endophytischen Pilzen isoliert wurde. Folglich ist dies der erste Bericht dieser 
Verbindung aus Thymelaea lythroides. 
 
Daphneon (2) zeigte eine starke zytotoxische Aktivität gegen der L5178Y Maus-Lymphom-
Zelllinie. Eine Hemmung mehrerer der getesteten Proteinkinasen wurde nur bei trans-
Tilirosid (8) und Rutarensin (7) beobachtet. Alle aus Thymelaea lythroides isolierten 
Verbindungen waren inaktiv gegen die Hsp90 Chaperon-Maschinerie. 
 
2 . Isolierte Verbindungen aus dem endophytischen Pilz Chaetomium aureum 
Sechs neue Verbindungen wurden aus diesem Pilzstamm erhalten, einschließlich des neuen 
Alkylresorcinolderivats (18; Chaetoresorcinol), vier neue Xanthoradonderivate (14; 
Xanthoradon D1, 15; Xanthoradon D2, 16; Xanthoradon E1 und 17; Xanthoradon E2), und ein 
Pyrochromonderivat (13; SB 236050), zusammen mit vier bekannten Azaphilonderivaten (9; 
Sclerotiorin, 10; Isochromophilon VII, 11; Sclerotioramin und 12; Isochromophilon VI). 
 
(+)-Sclerotiorin (9), (+)-Isochromophilon VII (10), (+)-Sclerotioramin (11) und 
Isochromophilon VI (12) waren nicht aktiv im Zytotoxizitätstest gegen der L5178Y Maus-
Lymphom-Zelllinie. Allerdings war (+)-Sclerotiorin (9) gegen alle getesteten Proteinkinasen 
außer MEK1wt aktiv, während seine Derivate, Isochromophilone VI (12) und Sclerotioramin 
(11), nur wenige der getesteten Enzyme hemmen konnten. Darüber hinaus wurden alle 
Verbindungen im Hsp 90 Chaperon-Maschinerie Hemmungs-Assay getestet. Nur (+)-
Sclerotiorin (9) zeigte herausragende Aktivität mit einer dem bekanntenHsp-90-Inhibitor 17-
AAG (Geldanamycinderivat) ähnlichen Wirksamkeit. 
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Chaetoresorcinol (18) zeigte eine mittelmäßige fungizide Wirkung gegen Aspergillus 
fumigatus, während die anderen isolierten Verbindungen in den antibakteriellen und 
fungiziden Tests nicht aktiv waren. 
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General Introduction 
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1. General introduction 
Drug discovery and development has a long history and dates back to the early days of human 
civilization. In those ancient times, drugs were not just used for physical remedies but were 
also associated with religious and spiritual healing. 
 
Even today, after more than 100 years of research in pharmaceutical industries, there is still a 
great need for innovative drugs. Only one third of all diseases can be treated efficiently 
(Müller et al., 2000). The role of natural products in drug discovery is demonstrated by an 
analysis of the number and sources of anticancer and antiinfective agents, reported mainly in 
the Annual Reports of Medicinal Chemistry from 1984 to 1995 (Cragg, 1997). It was 
observed that over 60% of the approved drugs and pre-NDA (New Drug Applications) 
candidates (for the period 1989-1995), excluding biologics (vaccines, monocloneals, etc. 
derived from mammalian sources), developed in these disease areas are of natural origin. 
 
The nature itself, has constantly supplied mankind with a broad and structurally diverse array 
of pharmacologically active compounds that continue to be utilised as highly effective drugs 
to combat a multitude of deadly diseases or as lead structures for the development of novel 
synthetically derived drugs that mirror their models from nature (Proksch et al., 2002). 
 
The ancient medical literature reports that surgery was performed but that physicians also 
recommended the use of some natural, and especially plant products, which represent an 
interesting point of comparison with current knowledge. Natural products play a relevant role 
in cancer therapy today with substantial numbers of anticancer agents used in the clinic being 
either natural or derived from natural products from various sources such as plants, animals 
and microorganisms. Large-scale anticancer drug discovery and screening programs such as 
those promoted by the National Cancer Institute (NCI) have played an important role in the 
development of anticancer natural compounds (Stefania et al., 2009). 
 
The molecular chaperone Hsp90 has been a promising target for cancer therapy. Cancer is a 
disease marked by genetic instability. Thus specific inhibition of individual proteins or 
signaling pathways holds a great potential for subversion of this genetic plasticity of cancers. 
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1.1. Aim and scopes of the study 
The aim of this study is to look for natural lead molecules with anticancer activity specialy the 
inhibitors of Hsp90 machine. For this, the drug discovery process was divided into 4 steps 
namely (Figure 1.1):  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Steps of drug discovery process 
 
1- The selection of the interesting natural sources from an ethnopharmacological study about 
the most usefulness medicinal plant against cancer, then from the selected plant, a screening 
of the most active endophytic fungus; this step is basically of two types of natural sources. 
Firstly, the macro-organism source which are plants, and secondly, the micro-organism source 
which are endophytic fungi. The plant Thymelaea lythroides and the endophytic fungi 
Chaetomium aureum were suspected for this study. 
 
2- The isolation, characterization and structure elucidation of the secondary metabolites. The 
raw extracts of the selected natural sources have to be fractionated and separated using 
various chromatographic techniques and their fractions have to be analyzed by HPLC-DAD 
for their purity and ESI-LC/MS for their molecular weight and fragmentation patterns. The 
pure compounds should then submitted to state-of-the-art one- and two-dimensional NMR 
techniques for structure elucidation.  
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3- The selection of the potential lead compounds. The pure compounds were subjected to 
selected bioassays to determine their pharmaceutical potential. Thus, the application of 
secondary metabolites for the inhibition of the Hsp90 chaperone pathway will be carried out 
by Prof. A. Chadli at the Cancer Research Center, Molecular Chaperones Biology, Georgia 
Regents University in USA. The cytotoxicity will be studied in vitro using mouse lymphoma 
(L5178Y) cell line. Moreover, the pure compounds will also be tested for their protein kinase 
inhibitory activity, whereas, antimicrobial activity will be studied using the agar diffusion 
assay. The latter three assays will be conducted in cooperation with Prof. W. E. G. Müller, 
Mainz, ProQinase, Freiburg and Prof. U. Hentschel, Würzburg, respectively. 
 
4- The clinical study. Sclerotiorin showed similar efficiency to that of 17-AAG, the classical 
inhibitor of Hsp90, which make it the first suspect for the clinical essays. 
 
 
Literature Review 
  4 
2. Literature review 
2.1. Secondary metabolites as natural products 
The compounds known as secondary metabolites were defined in 1891 as materials that were 
relatively unimportant in the overall physiology of plants and not absolutely essential to the 
life and growth of the producing organism (Bentley, 1999). From 1900 to 1950 the term 
secondary metabolites received little use and was restricted to plants. It was not until 1961 
that secondary metabolite was applied to microbial products; soon thereafter a new 
terminology “natural product” was used by organic chemists to refer to materials derived 
from terrestrial plants, bacteria, filamentous fungi, marine creatures, etc. In the strict sense of 
the term, natural products encompass also the primary metabolites. As stated by Davies 
(1992), “a secondary metabolite is a natural product, but a natural product isn’t necessarily a 
secondary metabolite” (Bentley R., 1999). Secondary metabolites are classified depending on 
their structural scaffold. These classes include among others polyketides (PKs), non 
ribosomal peptides (NRPs), terpenoids, alkaloids and hybrid metabolites of the different 
classes. The function of secondary metabolites in their hosts has not yet been exploited to its 
fullest; however, they seem to have several functions including defense, communication, and 
signaling (Calvo et al., 2002; Fox et al., 2008; Kempken and Rohlfs, 2010; Rohlfs and 
Churchill, 2010). 
 
Although there are notable exceptions (e.g., palytoxin, maitotoxin), most secondary 
metabolites have relative molecular masses less than 1500 Da. The range of chemical 
structures is breathtaking from simple aliphatic acids (e.g., itaconic acid, C5H6O4) to complex 
structures such as alkaloids and toxins (e.g., palytoxin, C129H223N3O54). This wide range of 
chemical types has made secondary metabolites a major topic for study by organic chemists 
(Bentley, 1999). 
 
2.2. Medicinal application of natural products 
Medicinal application of natural products has a long history and dates back to the early days 
of human civilization. In traditional medicine, natural products, mainly botanical drugs, were 
and are used on the basis of empirical experiences rather than pharmacological knowledge. 
The World Health Organization has estimated that almost 80% of the world’s inhabitants 
depend mainly on traditional medicines for their primary health care (Arvigo and Balich, 
1993; Farnsworth et al., 1985; Newman, 2008), which Morocco is one of them. Moroccan 
traditional pharmacopoeia is one of the richest and varied in the world (Bellakhdar et al., 
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1978; Bellakhdar et al., 1982; Bellakhdar et al., 1991; Benjelloun, 1997; Bounejmate, 1995). 
Clinical, pharmacological, and chemical studies of these traditional medicines, which were 
derived predominantly from plants, were the basis of most early medicines such as the 
antipyretic and antimalarial active alkaloid quinine (2) (from Cinchona pubescens) or the 
cardiac glycoside digitoxin (3) (from Digitalis purpurea). Even more drugs are derived from 
natural products, like the world-famous aspirin (4) aspirin (acetylsalicylic acid), which is 
derived from the glycoside salicin (5) and is found in many species of the plant genera Salix 
and Populus. Aspirin is only one, albeit the best known example for the prosperous 
interaction of synthetic and natural products chemistry. 
 
 
  
 
 
 
   morphine (1)     quinine (2) 
 
 
 
 
 
 
 
      digitoxin (3) 
 
 
 
 
     
       aspirin (4)               salicin (5) 
 
Figure 2.1. Natural products of medicinal importance 
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With the increase of this knowledge and the better understanding of the mode of action of 
different remedies, more and more distinct drugs were used and chemically modified. 
Additionally, scores of novel active compounds were introduced to medicines that are 
produced by means of traditional or combinatorial synthetic chemistry. In fact, around 60% of 
the new drugs registered during the period 1981-2002 by the FDA as anticancer and anti-
hypertensive agents were either natural products or based on them (Newman et al., 2003). 
Likewise, more recent studies demonstrate that natural products constantly play an important 
role in drug development (Butler, 2008; Newman and Cragg, 2007; Sneader, 1996). 
 
Hence, a large number of examples from medicine reveal the innovative potential of natural 
compounds and their impact on progress in drug discovery and development (Tejesvi et al., 
2007).  
 
2.3. The use of traditional medicine or phytotherapy 
In recent years, there has been growing interest in alternative therapies and the therapeutic use 
of natural products, especially those derived from plants (Goldfrank et al., 1982; Vulto and 
Smet, 1988; Mentz and Schenkel, 1989). This interest in drugs of plant origin is due to several 
reasons, namely, conventional medicine can be inefficient (e.g. side effects and ineffective 
therapy), abusive and/or incorrect use of synthetic drugs results in side effects and other 
problems, a large percentage of the world’s population does not have access to conventional 
pharmacological treatment, and folk medicine and ecological awareness suggest that “natural” 
products are harmless. However, the use of these substances is not always authorised by legal 
authorities dealing with efficacy and safety procedures, and many published papers point to 
the lack of quality in the production, trade and prescription of phytomedicinal products. 
Nevertheless, the phytomedicines are freely marketed and, in underdeveloped or developing 
countries, the use of medicinal plants is widely accepted. This can result in toxic accidents 
resulting from the use of plants as food or for therapy or from accidental ingestion by children 
or animals. Toxicity can result from highly concentrated doses or from the state of 
conservation of plants and the form of use. 
 
The WHO considers phytotherapy in its health programs and suggests basic procedures for 
the validation of drugs from plant origin in developing countries (Rates, 2001). 
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2.4. Plants as sources of bioactive products 
The analysis of data of prescriptions dispensed from community pharmacies in the United 
States from 1959 to 1980 revealed that approximately 25% contained plant extracts or active 
principle from higher plants (Newman et al., 2000). About 25% of the drugs prescribed 
worldwide come from plants, 121 such active compounds being in current use. Of the 252 
drugs considered as basic and essential by the World Health Organisation (WHO), 11% are 
exclusively of plant origin and a significant number are synthetic drugs obtained from natural 
precursors (Rates, 2001). The vast majority of the drugs isolated from plants cannot yet be 
synthesised economically and are still obtained from wild or cultivated plants.  
 
In addition, compounds such as muscarine, physostigmine, cannabinoids, yohimbine, 
forskolin, colchicine and phorbol esters, all obtained from plants, are important tools used in 
pharmacological, physiological and biochemical studies (Williamson et al., 1996). 
 
However, the potential use of higher plants as a source of new drugs is still poorly explored. 
Of the estimated 250,000–500,000 plant species, only a small percentage has been 
investigated phytochemically and even a smaller percentage has been properly studied in 
terms of their pharmacological properties; in most cases, only pharmacological screening or 
preliminary studies have been carried out. It is estimated that 5000 species have been studied 
for medical use (Payne et al., 1991). Between the years 1957 and 1981, the NCI screened 
around 20,000 plant species from Latin America and Asia for anti-tumour activity, but even 
these were not screened for other pharmacological activities (Hamburger and Hostettman, 
1991). 
 
2.5. Endophytic fungi as sources of bioactive products 
The word endophyte means “in the plant” (from gr. Endo = within, phyton = plant). 
‘‘Endophytism’’ is, thus, a unique cost-benefit plant-microbe association defined by 
‘‘location’’ (not ‘‘function’’) that is transiently symptomless, unobtrusive, and established 
entirely inside the living host plant tissues (Kusari et al., 2012). During this association, none 
of the interacting partners is discernibly harmed, and the individual benefits depend on both 
the interacting partners. 
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The existence of fungi inside the organs of asymptomatic plants has been known since the end 
of the 19th century (Guerin, 1898) and the term ‘‘endophyte’’ was first proposed in 1866 (de 
Bary, 1866). 
 
Since endophytes were first described in the Darnel (Lolium temulentum) (Kusari, 2012), they 
have been isolated from various organs of different plant species. 
 
The significance of fungi as unconventional sources of bioactive compounds was first realized 
by the discovery of penicillin from Penicillium notatum, by Alexander Fleming in 1928. 
Since then, natural product discovery from fungi has gained considerable attention and 
momentum, especially after the large-scale production of penicillin during World War II. 
 
For the past 50 years, fungal secondary metabolites have revolutionized medicine yielding 
blockbuster drugs and drug leads of enormous therapeutic and agricultural potential (Amal et 
al., 2011).  
 
Recent development of screening technologies revealed the great potential of endophytes as a 
major source of biologically active compounds with promising medicinal or agricultural 
applications (Zhang et al. 2012; Aly et al., 2010).  
 
In addition, natural products from endophytic fungi represent a huge and largely untapped 
resource of unique chemical structures that have been optimized by (co-)evolution and 
probably play an important role for communication or adaptation as a response to habitat and 
environmental changes (Gunatilaka, 2006). It has been estimated that approximately 1.5 
million fungal species are present on earth of which only about 7% have been described so far 
(Aly et al., 2010). Whereas between 1987 and 2000 approximately 140 new natural products 
were isolated from endophytic fungi, a similar number was subsequently characterised in half 
of this time span, i.e. between 2000 and 2006 (Zhang et al., 2006). Since then, especially 
fungi isolated from soil samples have been identified as a rich source of biologically active 
secondary metabolites. Beside other well known antimicrobial agents like fusidic acid (6) 
(Aly et al., 2010) and griseofulvin (7) (Kjier, 2009), novel semisynthetic antifungal drugs like 
anidulafungin (8) (Eraxis) and caspafungin (Cancidas) are likewise derived from fungal 
metabolites (Kjier, 2009). With the discovery of cyclosporine (9) isolated from 
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Tolypocladium inflatum in 1971, an important step in immunopharmacology was made 
because this substance prevents rejection after organ or tissue transplantations. 
 
 
 
 
 
 
           fusidic acid (6)           griseofulvin (7)  
             
 
 
 
 
 
 
 
 
 
 
anidulafungin (8) 
 
 
 
 
 
     cyclosporine (9) 
 
Figure 2.2. Bioactive fungal metabolites used in medicine  
 
Probably the most economical important fungal metabolites represent antilipidemic drugs 
collectively known as “statins”, with their parent compounds mevastatin and lovastatin (10) 
isolated from Penicillium citrinum and Aspergillus terreus, respectively. Statins reduce blood 
cholesterol levels by inhibiting the rate limiting enzyme HMG-CoA reductase in the 
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mevalonate pathway of cholesterol synthesis, and are used for the treatment of cardiovascular 
diseases (Dewick, 2006). 
 
 
 
 
 
 
              lovastatin (10)         strobilurines (11)  trifloxystrobin (12) 
 
 
 
 
 
 
      phomol (13)    taxol (14) 
 
Figure 2.2. Bioactive fungal metabolites used in medicine  
 
Fungal metabolites are, however, not only indispensable for medicine but are also important 
for plant protection as demonstrated by the discovery of the strobilurines (11), that were first 
isolated from Strobilurus sp. and served as lead compounds for synthetic fungicidals such as 
trifloxystrobin (12) (Flint
®
) (Kjier, 2009). 
 
From the medicinal plant Erythrina crista-galli the endophyte Phomopsis sp. was isolated, 
which produced the anti-inflammatory as well as antifungal and antibacterial active 
polyketide lactone, phomol (13) (Weber et al. 2004). 
 
But it is not only new compounds being isolated from endophytes that are promising. The 
well known plant metabolite taxol (14), the “world’s first billion-dollar anticancer compound” 
(Strobel, 2004), was originally isolated from the bark of the endemic Pacific yew tree, Taxus 
brevifolia. It interferes with the normal function of microtubule breakdown. Specifically, 
taxol binds to the ß-subunit of tubulin and thereby interrupts the dynamic rearrangement of 
this important component of the cytoskeleton. This adversely affects cell function due to the 
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shortening and lengthening of microtubules is necessary for their function as a mechanism to 
transport other cellular components, e.g. during mitosis. Thus taxol affects dividing cells, 
especially fast dividing ones like cancer cells. For the treatment of one patient suffering from 
cancer, 2 g taxol are required, which represents an amount equivalent to twelve trees and 
thereby posing a challenge to the limited natural resources, since the isolation from the inner 
bark implies the destruction of trees. Thus, the demand for taxol greatly exceeds the supply 
that can be sustained by isolation from its natural source and alternative sources of the drug 
have been sought for a long time. Although the highly functionalized, polycyclic diterpene 
has been prepared by total synthesis, the process is too complex and not economically 
feasible. Currently, the supply of the compound is achieved by a successfully implied partial 
synthetic route based on baccatin III or its 10-deacetyl congener, which are isolated from the 
needles of other Taxus species and thus from a renewable resource. However, the extraction 
process of these precursors is tedious and costly. In the ongoing search for alternative sources 
of taxol, the group of Gary Strobel discovered taxol production in a hitherto undescribed 
endophytic fungus associated with Taxus brevifolia, identified as Taxomyces andreanae 
(Stierle et al., 1993). Although initially controversial, these findings prompted further studies, 
and it is nowadays an emerging picture that the ability to produce taxol upon fermentation 
seems to be a rather widespread feature among endophytic fungi. So far, more than 10 
different fungal strains from at least 6 different host plants, most of them only distantly (if at 
all) related to Taxus, have been identified. However, it is worth mentioning that in all cases 
the resulting yields are minuscule, so far preventing any commercial exploitation (Strobel et 
al., 2004). 
 
2.6. The relationship between the endophyte and the host plant 
Any plant-fungal interaction is preceded by a physical encounter between a plant and a 
fungus, followed by several physical and chemical barriers that must be overcome to 
successfully establish an association. The ‘‘balanced antagonism’’ hypothesis (Schulz et al., 
1999; Schulz and Boyle, 2005) was initially proposed to address how an endophyte avoids 
activating the host defenses, ensures self-resistance before being incapacitated by the toxic 
metabolites of the host, and manages to grow within its host without causing visible 
manifestations of infection or disease (Arnold, 2005, 2007, 2008; Schulz and Boyle, 2006) 
(Figure 2.3.A). This hypothesis led to the proposal that the interactions between host plants 
and endophytes in natural populations and communities are described as a balanced symbiotic 
continuum ranging from mutualism through commensalism to parasitism (Tan and Zou, 2001; 
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Kogel et al., 2006). Endophytes and pathogens both possess many virulence factors that are 
countered by plant defense mechanisms. If fungal virulence and plant defense are balanced, 
the association remains apparently asymptomatic and a virulent. Although the genetic basis of 
symbiotic communication is not yet known, studies examining the relation between host 
genotype and symbiotic lifestyle expression revealed that individual isolates of some fungal 
species can express either parasitic or mutualistic lifestyles depending on the host genotype 
colonized (Redman et al., 2001; Unterseher and Schnittler, 2010). Some endophytes are 
generally viewed at as mutualists; by receiving nutrition and protection from their host plants, 
the endophytes enhance resistance of the host plant against insect herbivores or pathogens 
(Clay, 1990). Studies showed that vertically transmitted (systemic) endophytes, growing 
within seeds, are more likely to be mutualistic, while horizontally transmitted (non-systemic) 
endophytes, via spores, tend to be more antagonistic to the host (Schardl et al., 1991; 
Saikkonen et al., 1998). Furthermore, upon leaf aging or senescence, endophytic fungi can 
shift to the pathogenic side of the continuum, thus becoming more widespread and causing 
external infections (Saikkonen et al., 1998). 
 
The environmental factors play a major role to destabilize the delicate balance of 
antagonisms. If the plant defense mechanisms completely counteract the fungal virulence 
factors, the fungus will perish. Conversely, if the plant succumbs to the virulence of the 
fungus, a plant-pathogen relationship would lead to plant disease (Figure 2.3.B). Because 
many endophytes could possibly be latent pathogens, they might be influenced by certain 
intrinsic or environmental factors to express factors that lead to pathogenicity (Arnold, 2008) 
(Figure 2.3.C).  
 
Recently, it was revealed that the plant-endophyte interaction might not be just equilibrium 
between virulence and defense, but a much more complex and precisely controlled interaction 
(Figure 2.3.D). According to the plant-endophyte coevolution hypothesis (Ji et al., 2009), it 
might be possible for endophytes to assist the plant in chemical defense by producing 
bioactive secondary metabolites. Two parallel intriguing propositions have been made. 
Conferring to the ‘‘mosaic effect’’ theory, endophytes might protect host plants by creating a 
heterogeneous chemical composition within and among plant organs that are otherwise 
genetically uniform (Carroll, 1991). Consequently, these organs would vary arbitrarily in 
lusciousness or worth for herbivores, and in terms of infectivity for pathogens. The other 
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theory holds that endophytes might assist their corresponding host plants as ‘‘acquired 
immune systems’’ (Arnold et al., 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Chemical-Ecological Schematic Interpretation of Plant-Fungus Cost-Benefit 
Interactions with Emphasis on Endophytic Fungi (Kusari et al., 2012) 
(A) Balanced antagonism hypothesis is shown. 
(B) Plant disease caused by pathogenic fungi is presented. 
(C) Endophyte-pathogen reciprocity is demonstrated. The question mark (?) indicates that this 
phenomenon might not be universal, and further research is necessary for verification. 
(D) Endophyte survival strategy is illustrated. 
(E) Balanced synergism is shown. 
 
2.7. Pathway to new drug discovery 
New medical discoveries and advancement of associated technology is further widening the 
gap between traditional concepts of diseases, their treatment by healers and the present day 
physicians. A physician interested in ethnopharmacology could fill this gap and offer modern 
explanation of old concepts of healing. However, all this requires a modest and collaborative 
attitude of physicians with healers, botanists and anthropologists which is the key to 
successful acquisition of the information (Lozoya, 1994). 
 
2.7.1. Ethnopharmacological study 
Ethnopharmacology and natural product drug discovery remains a significant hope in the 
current target-rich, lead-poor scenario. Many modern drugs have origin in traditional 
medicine and ethnopharmacology.  
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Enormous ethnopharmacological research was carried out by physicians with expertise or 
interest in chemistry, pharmacology, botany or anthropology during the early period of 
medicinal plant research 250 years ago. The classic example is of Dr. William Withering, 
who in 1775 discovered the use of foxglove in the treatment of ‘dropsy’ (i.e. edema) due to 
cardiac ailment (now known as congestive heart failure). The plant was used for the cure of 
‘dropsy’ in the form of aqueous tea of 20 or more herbs by an old woman in Shropshire. 
Withering combined his medical expertise and knowledge of botany and discovered that 
foxglove was the active ingredient, and that only dropsy related to heart ailment was curable 
(Raza, 2006). 
 
Table 2.1. Selected physicians and their contributions in ethnopharmacological investigations 
(Raza, 2006) 
Willem William Withering (1741–1799)  
Pies (1611–1678)  
Robert Christison (1797–1882)  
John Hutton Balfour (1808–1884)  
Claude Bernard (1813–1878) 
Paolo Mantegazza (1831–1910) 
John Kirk (1832–1922)  
Symphronio Olympio Cezar Coutinho (1832–1887) 
 
Douglas Argyll Robertson (1837–1909) 
Thomas Richard Fraser (1841–1920)  
Nagai Nagayoshi (1844–1929)  
John Raleigh Briggs (1851–1907)  
Arthur Heffter (1860–1925)  
Thomas Moreno Y Maiz (1868)
a 
Medicinal uses of Pilocarpus jaborandi 
Use of Foxglove in “Dropsy” (congestive heart failure) 
Toxicology of Physostigma venenosum 
Description of Physostigma venenosum 
Pharmacological investigation of curare  
Medicinal uses of coca  
Effect of African arrow poison (Strophanthus sp.) on CVS 
Investigation of medicinal uses and introduction of Pilocarpus jaborandi in 
medical practice  
Introduction of Physostigma venenosum in ophthalmic medicine 
Pharmacology of Physostigma venenosum 
Chemistry and pharmacology of ephedrine 
Investigation of peyote 
Chemistry and pharmacology of peyote alkaloids 
Pharmacological investigation of cocaine 
a
 Year of completion of thesis. 
 
Several investigators (Table 2.1) who played leading roles in the discovery and/or use of 
physostigmine, cocaine, ephedrine, emetine, pilocarpine, strychnine, etc. from traditional 
sources were physicians (Raza, 2006). 
 
Moreover, to determine whether the chemical efforts were stimulated by ethnomedical claims 
and to correlate current uses for the compounds with such ethnomedical claims, in 2001 
Fabricant et al., conducted a study on a total of 122 compounds; 80% of these compounds 
were used for the same (or related) ethnomedical purposes (Table 2.2). Further, it was 
discovered that these compounds were derived from only 94 species of plants. 
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Table 2.2. Drugs derived from plants, with their ethnomedical correlations and sources. 
(Fabricant, 2001).  
Drug   Action or clinical use  Plant source Acetyldigoxin 
Acetyldigoxin 
Adoniside 
Aescin 
Aesculetin 
Agrimophol 
Ajmalicine 
Allyl isothiocyanate 
Andrographolide 
Anisodamine 
Anisodine 
Arecoline 
Asiaticoside 
Atropine 
Berberine 
Bergenin 
Bromelain 
Caffeine 
(+)-Catechin 
Chymopapain 
Cocaine  
Codeine  
Colchicine  
Convallotoxin 
Curcumin 
Cynarin 
Danthron  
Deserpidine  
Deslanoside  
Digitalin  
Digitoxin  
Digoxin 
Emetine  
Ephedrine  
Etoposide  
Gitalin 
Glaucaroubin  
Glycyrrhizin 
Gossypol  
Hemsleyadin 
Hydrastine 
Hyoscamine 
Kainic Acid 
Kawain  
Khellin  
Lanatosides A, B, C  
Lobeline 
Monocrotaline  
Morphine  
Neoandrographolide 
Noscapine  
Ouabain 
Papain 
Phyllodulcin  
Physostigmine  
Cardiotonic 
Cardiotonic 
Anti-inflammatory 
Antidysentery 
Anthelmintic 
Circulatory disorders 
Rubefacient 
Bacillary dysentery 
Anticholinergic 
Anticholinergic 
Anthelmintic 
Vulnerary 
Anticholinergic 
Bacillary dysentery 
Antitussive 
Anti-inflammatory; proteolytic agent 
CNS stimulant 
Haemostatic 
Proteolytic; mucolytic 
Local anaesthetic 
Analgesic; antitussive 
Antitumor agent; antigout 
Cardiotonic  
Choleretic 
Choleretic  
Laxative  
Antihypertensive; tranqulizer 
Cardiotonic  
Cardiotonic 
Cardiotonic  
Cardiotonic  
Amoebicide; emetic   
Sympathomimetic 
Antitumour agent 
Cardiotonic  
Amoebicide 
Sweetener 
Male contraceptive 
Bacillary dysentery 
Hemostatic; astringent 
Anticholinergic 
Ascaricide 
Tranquilizer 
Bronchodilator  
Cardiotonic  
Smoking deterrent; respiratory stimulant  
Antitumor agent 
Analgesic 
Bacillary dysentery  
Antitussive 
Cardiotonic  
Proteolytic; mucolytic 
Sweetener  
Cholinesterase inhibitor 
Digitalis lanata Ehrh. 
Adonis vernalis L.  
Aesculus hippocastanum L.  
Fraxinus rhynchophylla Hance 
Agrimonia eupatoria L.  
Rauvolfia serpentina (L.) Benth ex. Kurz  
Brassica nigra (L.) Koch  
Andrographis paniculata Nees  
Anisodus tanguticus (Maxim.) Pascher  
Anisodus tanguticus (Maxim.) Pascher  
Areca catechu L.  
Centella asiatica (L.) Urban 
Atropa belladonna L.  
Berberis vulgaris L. 
Ardisia japonica Bl.  
Ananas comosus (L.) Merrill  
Camellia sinensis (L.) Kuntze  
Potentilla fragaroides L.  
Carica papaya L.  
Erythroxylum coca Lamk 
Papaver somniferum L.  
Colchicum autumnale L.  
Convallaria majalis L.  
Curcuma longa L. 
Cynara scolymus L.  
Cassia spp.  
Rauvolfia canescens L.  
Digitalis lanata Ehrh.  
Digitalis purpurea L.  
Digitalis purpurea L.  
Digitalis lanata Ehrh 
Cephaelis ipecacuanha (Brotero) A. Richard  
Ephedra sinica Stapf. 
Podophyllum peltatum L. 
Digitalis purpurea L. 
Simarouba glauca DC. 
Glycyrrhiza glabra L. 
Gossypium spp.  
Helmsleya amabilis Diels 
Hydrastis canadensis L. 
Hyoscamus niger L.  
Digenea simplex (Wulf.) Agardh 
Piper methysicum Forst. f.  
Ammi visnaga (L.) Lamk. 
Digitalis lanata Ehrh. 
Lobelia inflata L.  
Crotolaria sessiliflora L.  
Papaver somniferum L.  
Andrographis paniculata Nees  
Papaver somniferum L. 
Strophanthus gratus Baill.  
Carica papaya L.  
Hydrangea macrophylla (Thunb.) DC 
Physostigma venenosum Balf.  
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Picrotoxin   
Pilocarpine  
Podophyllotoxin 
Protoveratrines A & B 
Pseudoephedrine 
Pseudoephedrine, nor- 
Quinine  
 Quisqualic 
Rescinnamine  
Reserpine 
Rhomitoxin 
 Rorifone  
Rotenone 
 Rotundine  
Salicin  
Santonin  
Scillarin A 
Scopolamine 
Sennosides A & B 
Silymarin 
Stevioside 
Strychnine 
Teniposide 
Tetrahydropalmatine 
Theobromine 
Theophylline 
Trichosanthin 
Tubocurarine 
Valepotriates 
Vincamine  
Xanthotoxin 
Yohimbine  
Yuanhuacine 
Yuanhuadine  
Analeptic 
Parasympathomimetic 
Condylomata acuminata 
Antihypertensive  
Sympathomimetic  
Sympathomimetic  
Antimalarial  
Acid Anthelmintic 
Antihypertensive; tranqulizer 
Antihypertensive; tranqulizer 
Antihypertensive 
Antitussive 
Piscicide  
Analgesic; sedative 
Analgesic 
Ascaricide 
Cardiotonic 
Sedative 
Laxative 
Antihepatotoxic 
Sweetener 
CNS stimulant 
Antitumor agent  
Analgesic; sedative 
Diuretic; bronchodilator 
Diuretic; bronchodilator 
Abortifacient 
Skeletal muscle relaxant 
Sedative 
Cerebral stimulant 
Leukoderma; vitiligo 
Aphrodisiac 
Abortifacient 
Abortifacient  
Anamirta cocculus (L.) W.&A.  
Pilocarpus jaborandi Holmes 
Podophyllum peltatum L.  
Veratrum album L.  
Ephedra sinica Stapf.  
Ephedra sinica Stapf.  
Cinchona ledgeriana Moens ex. Trimen 
Quisqualis indica L.  
Rauvolfia serpentina (L.) Benth ex. Kurz   
Rauvolfia serpentina (L.) Benth ex. Kurz  
Rhododendron molle G. Don 
Rorippa indica (L.) Hochr.  
Lonchocarpus nicou (Aubl.) DC. 
Stephania sinica Diels 
Salix alba L.    
Artemisia maritima L.  
Urginea maritima (L.) Baker 
Datura metel L. 
Cassia spp.  
Silybum marianum (L.) Gaertn. 
Stevia rebaudiana Bertoni 
Strychnos nux-vomica L. 
Podophyllum peltatum L.  
Corydalis ambigua (Pallas) Cham. & Schltal 
Theobroma cacao L.  
Camellia sinensis (L.) Kuntze 
Thymus vulgaris L 
Chondodendron tomentosum R. & P. 
Valeriana officinalis L. 
Vinca minor L. 
Ammi majus L. 
Pausinystalia yohimbe (K.Schum.) Pierre 
Daphne genkwa Seib. & Zucc 
Daphne genkwa Seib. & Zucc. 
 
The ethnopharmacology knowledge can always serve as an innovative and powerful 
discovery engine for newer, safer and affordable medicines. 
 
2.7.2. Screening of the promising natural sources for drug discovery 
To the discovery of natural products with biologic activity three areas are involved, the 
observation, description, and experimental investigation of indigenous drugs and their 
biologic activities. It is based on botany, chemistry, biochemistry, pharmacology, and many 
other disciplines (anthropology, archaeology, history, and linguistics). Several approaches to 
drug discovery for selecting plants as candidates for drug discovery programs have been 
published (Phillipson, 1989; Kinghorn, 1994; Vlietinck, 1991; Farnsworth, 1966; Farnsworth, 
1977; Harvey, 2000; Farnsworth, 1988); some of these approaches are : 
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- Random selection followed by chemical screening. These so-called phytochemical 
screening approaches [i.e., for the presence of cardenolides/bufadenolides, alkaloids, triter- 
penes, flavonoids, isothiocyanates, iridoids, etc. (Farnsworth et al., 1966; Fabricant et al., 
2001)] have been used in the past and are currently pursued mainly in the developing 
countries. The tests are simple to perform, but it is usually impossible to relate one class of 
phytochemicals to specific biologic targets; for example, the alkaloids or flavonoids produce a 
vast array of biologic effects that are usually not predictable in advance. 
 
- Random selection followed by one or more biologic assays. In the past, plant extracts were 
evaluated mainly in experimental animals, primarily mice and rats. From 1960 to 1981, more 
than 35,000 species were screened in vitro and later in vivo at National Cancer Institute 
(NCI). Taxol and camptothecin were discovered in this program. In 1986 the NCI program 
continued to collect and screen plants using a battery of 60 human tumor cell lines. Calanolide 
A, currently in Phase I clinical trials, was developed from this program (Fabricant et al., 
2001). 
 
- Follow-up of biologic activity reports. These reports showed that the plant extracts had 
interesting biologic activity, but the extracts were not studied for their active principles. The 
literature from the 1930s through the 1970s contains these types of reports.  
 
- Follow-up of ethnomedical (traditional medicine) uses of plants. Several types of 
ethnomedical information are available:  
 
• Plants used in organized traditional medical systems. The individual arrangements all 
emphasize education based on an established, frequently revised body of written 
knowledge and theory. These systems are still in place today because of their 
organizational strengths, and they focus primarily on multicomponent mixtures 
(Bannerman et al., 1983; Fabricant et al., 2001).  
 
• Herbalism, folklore, and shamanism. An apprenticeship system of information passed 
to the next generation through a shaman, curandero, traditional healer, or herbalist. 
The plants that are used are often kept secret by the practitioner, so little information 
about them is recorded; thus there is less dependence on scientific evidence as in 
systems of traditional medicine that can be subject to scrutiny. The shaman or 
  Literature Review 
  18 
 
herbalist combines the roles of pharmacist and medical doctor with the 
cultural/spiritual/religious beliefs of a region or people, which are often regarded as 
magic or mysticism. This approach is widely practiced in Africa and South America 
(Rastogi et al., 1982; Fabricant et al., 2001).  
 
• Use of databases. The NAPRALERT database (Fabricant et al., 2001) currently 
contains information on 43,879 species of higher plants covering ethnomedical, 
chemical, and pharmacologic (including clinical studies) uses. Of these, 13,599 
species contain ethnomedical data, distributed among 3,607 genera and 273 plant 
families. Thus it is possible to correlate ethnomedical use with experimental 
biochemical or pharmacologic activities (in vitro, in vivo, or in humans) to identify 
plants having both types of activity for a given effect-e.g., anticancer, antidiabetic, 
antimalarial. 
 
• Ethnomedical approach. In 1985 an approach based on ethnomedical information to 
experimentally pursue plants as a source of drugs was established. The approach was 
designed primarily for implementation by developing countries, where lack of hard 
currency often prevents sophisticated types of research from being conducted. The 
possibility of drug development in the form of stable, standardized crude extracts and 
eventual development of the active principles from these plants was envisioned 
(Fabricant et al., 2001) (Figure 2.4).  
 
Some examples of drugs from plants that served as models for the next generation of 
drugs are exemplified as follows: Khellin [from Ammi visnaga (L.) Lamk.] was used 
as a bronchodilator in the United States until it was shown to produce nausea and 
vomiting after prolonged use. In 1955 a group of chemists in England set about to 
synthesize khellin analogs as potential bronchodilators with fewer side effects. This 
eventually led to the discovery of chromolyn (used as sodium chromoglycate), which 
stabilized cell membranes in the lungs to prevent the allergen induced release of the 
substance ultimately causing bronchoconstriction in allergic asthma patients 
(Fabricant et al., 2001). 
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Figure 2.4. Flow chart of sequence for the study of plants used in traditional medicine. 
Adapted from Farnsworth et al. (Farnsworth, 1985) 
 
2.8. Anticancer drug discovery 
2.8.1. Cancer statistics  
Worldwide, over ten million new cases of cancer (all sites excluding non-melanoma skin), 
with over six million deaths, were estimated in the year 2000 (Parkin, 2001; Parkin et al., 
2001). Since 1990 there has been a 22% increase in cancer incidence and mortality with the 
four most frequent cancers being lung, breast, colorectal, and stomach and the four most 
deadly cancers being lung, stomach, liver, and colorectal (Parkin et al., 2001). Cancer is the 
second leading cause of death in developed countries, surpassed only by cardio-vascular 
disease (Jemal et al., 2005).  
 
In Morocco, cancer is a major public health problem and is responsible for 56% of morbidity 
related to chronic diseases (Tazi et al., 2013). A total of 2,473 new cases were registered 
among residents in Rabat during the period 2006–2008. The overall world age-standardised 
rate (ASR) for all sites combined was 136.6/100,000 for men and 114.5/100,000 for women 
(Tazi et al., 2013). About 176,620 new cancer cases are expected to be diagnosed among 
African Americans in 2013, including 94,540 cases among men and 82,080 cases among 
women (Figure 2.5). Prostate cancer is expected to be the most commonly diagnosed cancer 
in men and breast cancer the most common in women. Cancers of the lung and colorectum 
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will be the second and third most commonly diagnosed cancers in both African American 
men and women (Desantis et al., 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5. Leading Sites of New Cancer Cases and Deaths Among African Americans, 2013  
Estimates* (Desantis et al., 2013) 
*Estimates are rounded to the nearest 10 and exclude basal cell and squamous cell skin cancers and in situ carcinoma except urinary bladder. 
 
Although these figures are disquieting, some progress has been made in cancer diagnosis and 
treatment as evident through the high incidence of lung, breast and prostate, as compared with 
their relatively lower mortality (Parkin, 2001; Jatoi and Miller, 2003; Jemal et al., 2005). 
From 2000 to 2009, incidence rates decreased by 1.4% per year among African American 
men; however, rates have remained unchanged among African American women during this 
period (Figure 2.6). 
 
Drug discovery from medicinal plants has played an important role in the treatment of cancer 
and, indeed, most new clinical applications of plant secondary metabolites and their 
derivatives over the last half century have been applied towards combating cancer (Newman 
et al., 2000, Newman et al., 2003; Butler, 2004; Balunas et al., 2005).  
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Figure 2.6. Age-Adjusted Cancer Incidence and Mortality Rates Among African Americans 
by Sex, 1975 to 2009 (Desantis et al., 2013) 
 
1.8.2. Secondary metabolites as anticancer agents 
Large-scale anticancer drug discovery and screening programs such as those promoted by the 
National Cancer Institute (NCI) have played an important role in the development of 
anticancer natural compounds. Of all available anticancer drugs between 1940 and 2002, 40% 
were natural products per se or natural product-derived with another and 8% was considered 
natural product mimics (Newman et al., 2003). The most famous anticancer natural product is 
Taxol, which was originally isolated from Taxus brevifolia Nutt. (Taxaceae) and later was 
demonstrated that it was produced by endophytic fungus Taxomyces andreanae from Taxus 
brevifolia (Strobel et al., 1993; Aly, 2007). Paclitaxel (taxol®) was clinically introduced to the 
U.S. market in the early 1990s (Wall and Wani, 1996; Oberlies and Kroll, 2004). The taxanes, 
including paclitaxel and derivatives, act by binding tubulin without allowing 
depolymerization or interfering with tubulin assembly (Balunas, 2005). Taxol is the world’s 
first billion dollar anticancer drug and is used to treat a number of other human tissue 
proliferating diseases as well (Strobel, 2002).  
 
Moreover, the cytotoxic plant alkaloid, camptothecin, originally described from Camptotheca 
acuminate and Nothapodytes foetida, showed unacceptable myelosuppression (Wall and 
Wani, 1996; Balunas, 2005). Interest in camptothecin was revived when it was found to act by 
selective inhibition of topoisomerase I, involved in cleavage and reassembly of DNA (Cragg 
and Newman, 2004). Clinical trials of camptothecin, which was identified in cultures of 
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Entrophospora infrequens endophytic in Nothapodytes foetida, are undergoing since 1992 as 
anticancer drug (Amna et al., 2006).  
 
Together, the taxanes and the camptothecins accounted for approximately one-third of the 
global anticancer market in 2002, over 2.75 billion dollars (Oberlies and Kroll, 2004).  
 
Another anticancer drug, which has been given in chemotherapy treatment for some types of 
cancer including leukemia, lymphoma, breast and lung cancer for many years, is the indole 
derivative vincristine. This drug, available under the trade names Oncovin®, Vincasar®, and 
Vincrex®, was originally obtained from Catharanthus roseus. Very recently, a Chinese group 
reported preliminary evidence that vincristine might be produced by Fusarium oxysporum 
endophytic in the same plant (Zhang et al., 2006). Since then fungal microorganisms became 
a hunting ground for novel drug leads (Strobel and Daisy, 2003; Larsen et al., 2005). This 
stimulated pharmaceutical companies to sample and screen large collections of fungal strains 
(Butler, 2004). Consequently, promising novel natural product leads were isolated. Many of 
these compounds can be produced in large quantities and at a reasonable cost by fermentation 
employing wild type or genetically altered fungi. The search for new drug candidates is still 
pressing to find the adequate cures for not only cancer but also newly emerging diseases, such 
as drug-resistant pathogenic microbes, or parasitic protozoans, are urgently needed. As 
microorganisms occupy almost every niche on earth (Strobel, 2002), scientists speculate that 
many undescribed species exist in unexplored habitats, where the incidence of finding 
microorganisms that produce novel bioactive constituents is high (Hawksworth and Rossman, 
1997). 
 
2.9. Natural products as inhibitors of Hsp 90 chaperon machinery  
2.9.1. Hsp 90 chaperone machinery 
The 90-kDa heat shock protein Hsp90 has an important role in the maintenance of malignant 
transformation and is required to keep the folded and functionally active conformation of 
several aberrantly functioning onco-proteins. In this respect, Hsp90 regulates (in a 
transformation-specific manner) signaling pathways necessary for the growth, survival and 
limitless replicative potential of most tumors. Whereas in normal cells Hsp90 interacts in a 
low-affinity 1-2%, dynamic fashion with a plethora of proteins to help them fold and mature, 
in malignant cells tight association of Hsp90 with onco-client proteins maintains their ability 
to function in the dysregulated state and seems to be essential for their transforming, aberrant 
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activity which increases its affinity to 4-6%. This is most likely because cancer cells must 
cope with numerous external and internal stressors that are not experienced by normal cells, 
such as elevated temperature and oxygen or nutrient deprivation or mutation of important 
regulatory proteins (Figure 2.7) (Rodina et al., 2007; Chadli et al., 2008). 
 
  
 
 
 
 
 
 
 
Figure 2.7. The expression of Hsp90 in normal and multiple myeloma cell 
(@cancer.gov.com) 
 
Hsp90 was originally identified by chance in the early 1960s as one of a group of so-called 
‘heat shock proteins’ (Hsps) that were induced at elevated temperatures in the salivary gland 
of the fruit fly Drosophila melanogaster, providing protection against hyperthermia 
(thermotolerance) and other cellular stresses (Workman et al., 2007). Hsp90 works in concert 
with a number of chaperones and co-chaperones to modulate the conformation of Hsp90 and 
its client proteins. Over 20 co-chaperone proteins, such as p23, Cdc37, HIP, HOP, PP5, 
UNC45A, and immunophilins (FKBP51, FKBP52, and Cyp40), have been shown to regulate 
the function of the Hsp90 protein-folding machine (Chadli et al., 2008). 
 
Hsp90’s clientele is dominated by kinases, hormone receptors and transcription factors, many 
of which are oncogenic and have a key role in the hallmark traits of cancer. In addition to 
cancer, the Hsp90 machine has also been implicated as a target to treat neurodegenerative and 
cardiovascular diseases. 
 
2.9.2. Hsp 90 inhibitors 
Heat shock protein 90 “Hsp90” is a promising therapeutic target. The inactivation of Hsp90 
delivers a combinatorial attack on multiple signaling pathways leading to a more efficient 
killing of cancer cells and reducing resistance to chemotherapy (Workman, 2004). Extensive 
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research efforts in the last two decades have resulted in over 40 clinical trials in phases I-III 
with 13 small molecule inhibitors of Hsp90 ongoing worldwide. Hsp90 inhibitors can be 
classified as those that target the N-terminal domain, the C-terminal domain, Hsp90 co-
chaperones or client-protein/Hsp90 interactions (Neckers et al., 2012). 
  
Hsp90 inhibitors, initially natural products and later synthetic small molecules, have proved 
invaluable as chemical tools to investigate Hsp90 biology; the initial chemical probes have 
now morphed into drugs showing therapeutic activity in cancer patients.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8. Chemical structures of selected Hsp90 inhibitors (Neckers, 2012) 
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The natural products geldanamycin and radicicol as well as semisynthetic derivatives 17-N-
allylamino-17-demethoxygeldanamycin (17AAG) (Figure 2.8) target the ATP-binding site of 
the N-terminal domain to destabilize Hsp90 client complexes, leading to their cellular 
degradation through the proteasome pathway. 
 
Recently, a Chadli team reported that the natural product gedunin inactivates Hsp90 
chaperoning machinery by targeting the co-chaperone p23 in vivo and in vitro. Gedunin is a 
tetranortriterpenoid natural product that is isolated from the Meliacae family of medicinal 
plants and has been used for the treatment of malaria and other infectious diseases in 
traditional Indian medicine (Chadli, 2008).  
 
2.9.3. Example of the inhibition of Hsp 90 in small-cell lung cancer 
 Hsp90 operates with a number of co-chaperones, including Hsp70 and Hop (Hsp90 
organizing protein, also known as p60), to orchestrate the ATP-dependent maturation of many 
oncogenic client proteins (CP). Inhibition of Hsp90 function leads to ubiquitin proteasome–
dependent client protein degradation and inhibition of multiple aspects of the malignant 
phenotype, including evasion of apoptosis in SCLC. During apoptosis, cytochrome c (cyt c) is 
released from the mitochondria to associate with Apaf-1. This triggers the activation of 
proteolytic caspases, which induce apoptosis. Mitochondrial permeabilization is controlled by 
a balance of antiapoptotic (for example, BCL2) and proapoptotic (for example, BAX and 
BAD) members of the BCL2 family.  
 
Activation of the kinase AKT (an Hsp90 client protein) shifts the balance in favor of cell 
survival by phosphorylating BAD, inducing its inactivation by association with 14-3-3 
protein. Hsp90 and Hsp70 are both antiapoptotic, acting at several points in the apoptotic 
cascade. Rodina group have shown Hsp90 to be a critical dual regulator of apoptosis in SCLC 
by supporting AKT activation, which in turn prevents cyt c release, and also by negatively 
regulating the association of Apaf-1 with caspase 9 (Rodina et al., 2007).  
 
Hsp90 inhibition reverses these effects, leading to extensive apoptosis. Several compounds 
that modulate the activity of Hsp90 (17-AAG, radicicol, PU24FCl) and Hsp70 (MAL3-101) 
have been described, along with compounds that can alter the expression of Hsp70 and other 
heat shock proteins in response to stress (for example, KNK437) (Paul Workman et al., 
2007). 
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Figure 2.9. Inhibition of Hsp90 leads to apoptosis in small-cell lung cancer (SCLC). 
 (Paul Workman et al., 2007) 
 
Since then, natural drug discovery has focused on the inhibitors of chaperone Hsp90 (heat 
shock protein 90) because it plays a key role in assisting mutated proteins, making it an 
attractive cancer drug target. 
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3. Materials and Methods 
 
3.1. Biological material  
3.1.1. Plant material 
3.1.1.1. Ethnopharmacological study 
 
Study design 
The work consists of an ethnopharmacological, prospective and randomized investigation. It 
was carried out on a period of seven months (from September 2009 to March 2010) in two 
departments at the National Institute of Oncology in Rabat (Department of Chemotherapy and 
Department of Radiotherapy). The National Institute of Oncology (NIO) is a center where 
patients come from all over Morocco. The patients are taken randomly, to have a 
heterogeneous point of view: origin, sex, age, socio-professional class, type and stage of 
cancer. This study has been carried out with the permission of NIO director. All patients have 
been informed of the study objective and gave their consent. 
Selection of parameters 
An exhaustive questionnaire was established including: 
• Information related to the identification of the patient [registration number, sex, age, 
origin, province region (rural or urban), and socio-professional class];  
• Information on pathology [nature, localization, stage and degree of tumor extension as 
well as protocol and treatment follow-up];  
• Information on the use of traditional medicine [use or non use of TM, its use along with 
modern medicine];  
• Information on the anti-cancer plants used [vernacular name and the part of the plant 
used, the method of preparation, dosage, treatment duration and observance during 
phytotherapy];  
After collecting all the information, a table was prepared to gather different information on 
the plants used with their vernacular name and their scientific name. 
Statistical analysis 
Statistical analysis of data was carried out by Graphpad program (for Windows version 5.01. 
Graphpad, San Diego, CA, USA) and statistical methodology was based on two axes, which 
includes descriptive statistics and statistical analysis. Descriptive statistics reveal the 
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frequencies and characteristics of each parameter (average/mean, minimum, maximum). 
Results are expressed in raw values for qualitative parameters and in mean +/- standard 
deviation for quantitative parameters. The number of valid data (n active) of each variable has 
been mentioned in results section. Statistical analysis was based on associated tests such as 
the Khi 2 test which measures the gap between the observed frequencies and theoretical 
frequencies. We have used this test to compare the two sexes. We have also used one factor 
variance analysis (ANOVA), which estimates intergroup variation (report F). The results are 
considered significant where p is below 0.05, very significant when p < 0.01 and highly 
significant when p < 0.001. 
 
On the other hand, calculation of relative risk (RR) for each age interval as well as sex 
variable concerning the use of TM has allowed us to estimate the degree of association 
between two given parameters. If value 1 is included in the confidence interval (CI) of RR, 
we deduce that there is no association between these two parameters. However, if value 1 is 
excluded of the CI of RR, we deduce the existence of association between them. 
3.1.1.2. Plant worked on during the study 
Thymelaea lythroides was selected according to an ethnopharmacological study of traditional 
plants used in Morocco by cancer patients as herbal therapeutics (Kabbaj et al., 2012). 
Thymelaea lythroides, an ibero-endemic plant in Morocco, is popularly used as medicinal 
plant to treat otitis, diabetes, rheumatism, inflammation of the prostate and uterus cancer 
(Gmira et al., 2007).  
 
 
 
 
 
 
 
 
Figure 3.1. Thymelaea lythroides. (1: Arial part of T. lythroides. 2: Leaf. 3: Flower. 4: Flower 
male. 5: Flower female. 6: Seed) (Dohou, 2003) 
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3.1.1.3. Field trip and sample collection 
Fresh, healthy areal parts of Thymelaea lythroides have been collected from the Maâmora 
forest (NI29-08) in Rabat, Morocco. Small stem, leaf and flower pieces were directly placed 
in paper bags and stored dark and at 4°C until the isolation procedure of the fungi was 
performed two days later. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Collection area of Thymelaea lythroides. 
 
3.1.1.4. Taxonomy of collected plant sample  
 
Phylum: Plantae 
Class: Magnoliopsida 
 Order: Myrtales  
Family: Thymelaeaceae  
Genus: Mentha 
Specie: Thymelaea lythroides 
 
3.1.2. Fungal Material 
3.1.2.1. Pure fungal strain isolated from the selected plant 
Fresh, healthy parts of Thymelaea lythroides (leaf, stem and flower) were rinsed twice with 
sterilized distilled water. Surface sterilization was achieved by immersing the parts of the 
Thymelaea lythroides 
http://www.biodiversia.es 
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plant in 70% ethanol for 2 min (twice) followed by rinsing in sterilized distilled water. Then, 
they were cleaved aseptically into small segments (approx.1 cm in length). The material was 
placed onto a Petri dish with malt agar medium containing chloramphenicol and streptomycin 
to suppress bacterial growth. After one-week incubation at room temperature, when fungal 
mycelium tips were observable, each hyphal tip was transferred onto a fresh malt agar dish. 
For purification of the fungal strains this step was repeated several times until the colony was 
deemed uniform. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Pure fungal strain from Thymelaea lythroides. 
 
3.1.2.2. Taxonomy of isolated fungi 
Table 3.1. Taxonomy of isolated fungi. 
Fungal code Plant part Fungal species Family 
10 MS L-5.2 Leaf Epicoccum nigrum Incertae sedis 
10 MS F-1 Flower Altenaria sp. Pleosporaceae 
10 MS L.5.1 Leaf Cladosporium sp. Davidiellaceae 
10 MS S-2.2 Stem Chaetomium aureum Chaetomiaceae 
10 MS F-2 Flower Pleospora sp. Pleosporaceae 
10 MS F-2 10 MS S-2.2 10 MS L5.1 10 MS F-1 10 MS L5.2 
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3.1.2.3. Endophytic fungi worked on during the study 
After conducting biological activity screening test toward the five fungal strains, derived from 
the plant Thymelaea lythroides, originated from Morocco, one fungal strain was eventually 
selected for further scrutinizing of their secondary metabolite contents, which is Chaetomium 
aureum (Figure 3.4). 
 
 
 
 
 
 
 
Figure 3.4. Chaetomium aureum (A: Thymelaea lythroides; B: pure strain in plate agar; C: 
Culture on solide rice medium) 
 
 
3.2. Isolation and cultivation of endophytic fungi 
3.2.1. Composition of media 
Medium for isolation of fungal strains from the plant or purification and short term storage of 
the pure fungal strain 
Bacto agar (Galke)     15.0 g 
Malt extract (Merck)    15.0 g  
Artificial sea salt (Sera)    10.0 g  
pH      7.4-7.8    (adjusted with NaOH/HCl) 
Dem. Water     ad 1000 mL 
 
 
For the isolation of endophytic fungi from plant tissues chloramphenicol or streptomycin (0.2 
or 0.1 g, respectively) were added to the medium to suppress bacterial growth. 
 
MexA medium for long term storage  
Malt extract (Merck)    20.0 g 
Yeast extract (Sigma)    0.1 g 
Glycerin (Roth)     50.0 g 
Artificial sea salt (Sera)    10.0 g  
Bacto Agar (BD)    13.0 g 
Dem. water     ad 1000 mL 
A  B  C 
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Wickerham medium for liquid cultures 
 
Yeast extract    3.0 g 
Malt extract    3.0 g 
Peptone     5.0 g 
Glucose     10.0 g 
Distilled water     to 1000 mL 
pH     7.2 - 7.4 (adjusted with NaOH/HCl) 
 
Solid rice medium  
Rice      100 g 
Dem. Water     110 mL 
 
Solid red bean medium  
Bean      100 g 
Dem. Water     110 mL 
 
Solid chickpeas medium  
Bean      100 g 
Dem. Water     110 mL 
 
Solid corn medium  
Bean      100 g 
Dem. Water     110 mL 
 
Solid peas medium  
Bean      100 g 
Dem. Water     110 mL 
 
Solid Beans M medium  
Bean      100 g 
Dem. Water     110 mL 
 
Solid black bean medium  
Bean      100 g 
Dem. Water     110 mL 
 
Solid lentils medium  
Bean      100 g 
Dem. Water     110 mL 
 
Solid carrots medium  
Bean      100 g 
Dem. Water     110 mL 
 
Solid potaetos medium  
Bean      100 g 
Dem. Water     110 mL 
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3.2.2. Short term storage of pure strains 
For short storage, pure fungal strains in malt agar plate were stored at 4°C for a maximum 
period of 6 months, and then re-inoculated onto fresh malt agar plate. 
 
3.2.3. Long term storage of pure fungal strains 
For long term storage, pieces of pure fungal strains were transferred to 10 mL BD Falcon® 
tubes containing approx. 5 mL MexA medium. After approx. from three to seven days, the 
growths strain was placed in a deep freezer at -80°C. 
 
3.2.4. Cultivation for screening and isolation 
Pure fungal strain was inoculated in a 1000 mL Erlenmeyer flask containing 100 g of solid 
rice medium and 110 ml of distilled water, which were autoclaved. Small pieces were cut 
from a Petri dish containing the purified fungus, and then transferred under sterile conditions 
to the sterilised rice medium. Cultivation was performed at room temperature under static 
conditions for 4-6 weeks.  
Small scale fermentation was carried out in one Erlenmeyer flask to gain enough extract for 
first bioactivity screening. For mass growth to gain enough fungal extract for isolation of 
secondary metabolites, 20 flasks of rice medium were inoculated. 
3.3. Identification of plant sample and pure fungal strain 
3.3.1. Plant identification 
A voucher specimen of the plant was identified by Prof. FZ. ALAOUI, Department of 
Botany, Faculty of Sciences, Mohamed V University and Prof. Dr. M. IBN TATOU, 
Scientific Institute of Rabat, Morocco. Reference samples are deposited as a herbarium at the 
Scientific Institute of Rabat, in which a collection number (RAB 77777) has been assigned. 
3.3.2. Fungal identification 
Fungal strains were identified based on the analysis of the DNA sequences of the internal 
transcribed spacer regions (ITS) of its ribosomal RNA gene. The identification was performed 
according to a molecular biologic protocol previously described (Kjer et al., 2010). 
 
3.3.2.1. DNA extraction  
The extraction of fungus DNA was carried out with ZR Fungal/Bacterial DNA Kit™ (ZYMO 
RESEARCH, D6005), following the manufacturer protocol: 
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Step 1- Add 50-200 mg of fungal cells to a ZR BashingBead™ Lysis Tube.  Add 750 µl 
Lysis Solution to the tube.  
 
Step 2- Vortex for 5 minutes. Processing times may be as little as 40 seconds when using 
high-speed cell disrupters.  
 
Step 3- Centrifuge the ZR BashingBead™ Lysis Tube in a microcentrifuge at 10,000 x g for 
1 minute.  
 
Step 4- Transfer up to 400 µl supernatant to a Zymo-Spin™ IV Spin Filter (orange top) in a 
Collection Tube and centrifuge at 7,000 rpm (~7,000 x g) for 1 minute. (Snap off the base of 
the Zymo-Spin IV™ Spin Filter prior to use).  
 
Step 5- Add 1,200 µl of Fungal/Bacterial DNA Binding Buffer to the filtrate in the Collection 
Tube from Step 4.  
 
Step 6- Transfer 800 µl of the mixture from Step 5 to a Zymo-Spin™ IIC Column in a 
Collection Tube and centrifuge at 10,000 x g for 1 minute.    
 
Step 7- Discard the flow through from the Collection Tube and repeat Step 6.  
 
Step 8- Add 200 µl DNA Pre-Wash Buffer to the Zymo-Spin™ IIC Column in a new 
collection Tube and centrifuge at 10,000 x g for 1 minute.    
 
Step 9- Add 500 µl Fungal/Bacterial DNA Wash Buffer to the Zymo-Spin™ IIC Column and 
centrifuge at 10,000 x g for 1 minute.  
 
Step 10- Transfer the Zymo-Spin™ IIC Column to a clean 1.5 ml micro-centrifuge tube and 
add 100 µl (25 µl minimum) DNA Elution Buffer directly to the column matrix or sterile 
water.   
 
Step 11- Centrifuge at 10,000 x g for 30 seconds to elute the DNA. 
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After isolation of the genomic DNA, quantification was done after agarose Gel 
Electrophoresis for DNA with the Software GelQuant.NET, where the fluorescent of the 
samples, were compared to that of a known amount of the latter. 
 
3.3.2.2. DNA amplification 
DNA amplification by PCR was performed using Hot StarTaq Master Mix Taq polymerase 
(Qiagen) and the primers (Invitrogen): 
 
ITS1 5’-TCCGTAGGTGAACCTGCGG-3’ White et al. 1990 
ITS4 5’-TCCTCCGCTTATTGATATGC-3’ White et al. 1990 
NS1 5’-GTAGTCATATGCTTGTCTC-3’ White et al. 1990 
Fung 5’-ATTCCCCGTTACCCGTTG-3’ May et al. 2001 
 
PCR program: 
ITS1\ITS4: 
Initial denaturation 95,0 °C 15:00     min.  
Denaturation 95,0 °C 1:00       min. 
35 times Annealing 56,0 °C   0:30       sec. 
Extension 72,0 °C 1:00       min. 
Final extension 72,0 °C 10:00     min.  
   
3.3.2.3. Purification of PCR products 
DNA purification from Agarose Gel was carried out with QiaQuick Gel Extraction Kit 
(Quiagen) following the manufacturer instructions: 
 
Step 1- Excise the DNA fragment from the agarose gel with a clean, sharp scalpel. Minimize 
the size of the gel slice by removing extra agarose. 
 
Step 2- Weigh the gel slice in a colorless tube. Add 3 volumes of Buffer QG to 1 volume of 
gel (100 mg ~ 100 µl). 
 
Step 3- Add 300 µl of Buffer QG to each 100 mg of gel. For >2% agarose gels, add 6 
volumes of Buffer QG. The maximum amount of gel slice per QIAquick column is 400 mg; 
for gel slices >400 mg use more than one QIAquick column. 
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Step 4- Incubate at 50°C for 10 min (or until the gel slice has completely dissolved). To help 
dissolve gel, mix by vortexing the tube every 2–3 min during the incubation.  
IMPORTANT: Solubilize agarose completely. For >2% gels, increase incubation time. 
 
Step 5- After the gel slice has dissolved completely, check that the color of the mixture is 
yellow (similar to Buffer QG without dissolved agarose). If the color of the mixture is orange 
or violet, add 10 µl of 3 M sodium acetate, pH 5.0, and mix. The color of the mixture will turn 
to yellow. The adsorption of DNA to the QIAquick membrane is efficient only at pH ≤7.5. 
Buffer QG contains a pH indicator which is yellow at pH ≤7.5 and orange or violet at higher 
pH, allowing easy determination of the optimal pH for DNA binding. 
 
Step 6- Add 1 gel volume of isopropanol to the sample and mix. For example, if the agarose 
gel slice is 100 mg, add 100 µl isopropanol. This step increases the yield of DNA fragments 
<500 bp and >4 kb. For DNA fragments between 500 bp and 4 kb, addition of isopropanol 
has no effect on yield. Do not centrifuge the sample at this stage. 
 
Step 7- Place a QIAquick spin column in a provided 2 ml collection tube. 
 
Step 8- To bind DNA, apply the sample to the QIAquick column, and centrifuge for 1 min. 
The maximum volume of the column reservoir is 800 µl. For sample volumes of more than 
800 µl, simply load and spin again. 
 
Step 9- Discard flow-through and place QIAquick column back in the same collection tube. 
Collection tubes are re-used to reduce plastic waste. 
 
Step 10- Add 0.5 ml of Buffer QG to QIAquick column and centrifuge for 1 min. This step 
will remove all traces of agarose. It is only required when the DNA will subsequently be used 
for direct sequencing, in vitro transcription or microinjection. 
 
Step 11- To wash, add 0.75 ml of Buffer PE to QIAquick column and centrifuge for 1 min. 
Note: If the DNA will be used for salt sensitive applications, such as blunt-end ligation and 
direct sequencing, let the column stand 2–5 min after addition of Buffer PE, before 
centrifuging. 
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Step 12- Discard the flow-through and centrifuge the QIAquick column for an additional 1 
min at ≥10,000 x g (~13,000 rpm). 
IMPORTANT: Residual ethanol from Buffer PE will not be completely removed unless the 
flow-through is discarded before this additional centrifugation. 
 
Step 13- Place QIAquick column into a clean 1.5 ml micro-centrifuge tube. 
 
Step 14- To elute DNA, add 50 µl of Buffer EB (10 mM Tris•Cl, pH 8.5) or H2O to the 
center of the QIAquick membrane and centrifuge the column for 1 min at maximum speed. 
Alternatively, for increased DNA concentration, add 30 µl elution buffer to the center of the 
QIAquick membrane, let the column stand for 1 min, and then centrifuge for 1 min. The 
purified PCR products can be stored at -20 °C before sequencing. 
 
3.3.2.4. Fungi Identification 
DNA sequencing was performed using primers ITS1 or NS1 and performed by BMBF, 
Heinrich Heine Universität Düsseldorf or GATC Biotech AG. Nucleotide sequences of ITS 
rDNA of each taxon were compared using a Blast search in the nucleotide database in 
GenBank.  
 
3.4. Extraction of plant and fungal cultures 
3.4.1 Extraction and fractionation of Thymelaea lythroides plant material 
The dried aerial part of Thymelaea lythroides was extracted extensively with EtOAc. The 
EtOAc extract was washed with water, taken to dryness, and partitioned between n-hexane 
and 90% MeOH. The 90% MeOH soluble fraction was fractionated over Silica using n-
Hexane:EtOAc and DCM:MeOH gradient elution and the obtained fractions were analysed by 
HPLC and LC/MS. 
 
3.4.2. Extraction and fractionation of fungi grown on solid rice medium 
To each 1L Erlenmeyer about 250 mL EtOAc were added and culture media were then cut 
into small pieces to allow exhaustive extraction with EtOAc. The extraction left 24h under 
agitation. The contents were filtered under vacuum using a Buchner funnel. The extraction 
repeated three times with EtOAc until exhaustion. The combined EtOAc phases were washed 
with 300 mL demineralised water to eliminate remaining sugar and starch. 
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All obtained extracts were taken to dryness under reduced pressure at 40°C and partitioned 
between 90% MeOH and n-hexane to remove the fatty acids. After evaporating the solvent, 
these crude extracts were submitted to TLC, analytical HPLC, LC-MS and also to bioactivity 
screening including cytotoxicity and antimicrobial assays. The extraction scheme is described 
in Figure 3.4.  
 
 
 
 
 
Figure 3.5. Extraction and fractionation of solid rice culture 
 
3.5. Isolation of secondary natural products 
For the isolation of natural products different chromatographic methods depending on the 
nature of the product have been used. A chromatographic system comprises two phases, a 
stationary phase absorbing the compounds according to their physical properties, e. g. polarity 
(silica gel, normal or reversed phase), size (Sephadex LH-20) or charge (Diaion), whereas the 
mobile phase moves through the stationary phase and gradually elutes the compounds 
according to their affinity from it. 
 
3.5.1. Thin layer chromatography (TLC) 
Thin-layer chromatography is, in essence, liquid chromatography performed on a stationary 
phase present as a sheet or layer of solid particles immobilized on a planar support, or a layer 
of polymerized substance (Yrjo ̈nen, 2004). TLC is a mature and very established technique, 
frequently used in many fields of applications ranging from natural product analysis to 
chemistry or pharmaceutical applications. 
 
For rapid characterization and testing of extracts, fractions and isolated compounds the thin 
layer chromatography was used. After development of the TLC plate in a saturated fluid 
chamber, the band separation was observed under a UV lamp at 254 or 366 nm, followed by 
spraying TLC plates with anisaldehyde-sulphuric acid or ninhydrin spraying reagent and 
EtOAc 
Extract 
+ EtOAc 
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heating plates at 110°C for 10 min in an oven heated. 
 
During this work, TLC was performed on pre-coated TLC plates using the following systems: 
 
TLC on silica gel 60 F254, layer thickness 0.2 mm (Merck): 
! n-hexane:EtOAc [90:10, 80:20 and 70:30 (V/V)] and n-hexane:MeOH [95:5 and 90:10 
(V/V)] for non-polar compounds 
! DCM:MeOH [95:5, 90:10, 85:15, 80:20 and 70:30 (V/V)] for semi-polar compounds 
! EtOAc:MeOH:H2O[30:5:4, 30:65 and 30:7:6 (V/V)] for polar compounds TLC on 
Diol F254S, layer thickness 0.25 mm (Merck): 
! n-hexane:EtOAc [90:10, 80:20 and 70:30 (v/v)] EtOAc:acetone [95:5 and 90:10 
(V/V)] 
TLC on reversed phase RP-18, F254 S, layer thickness 0.25 mm (Merck):  
! MeOH:H2O (90:10, 80:20, 70:30 and 60:40 (V/V). 
 
The different compounds could be compared and identified due to their specific retention 
factors in defined chromatographic systems. These so-called Rf-values can be calculated as 
migration distance of compound migration distance of solvent front. 
With ninhydrin spray reagent (0.2 % in MeOH, m/V) amino acids, amines and amino sugars 
can be detected, and the anisaldehyde/sulphuric acid spray reagent was used for the detection 
of phenols, steroids, sugars and terpenes. 
The composition of anisaldehyde/sulphuric acid spray reagent was: 
! Methanol  85 mL 
! Glacial acetic acid 10 mL 
! Conc. sulphuric aci 5 mL 
! Anisaldehyde  0.5 mL 
3.5.2. Vacuum liquid chromatography (VLC) 
Vacuum liquid chromatography (VLC) is a useful method for the initial isolation procedure 
for large amounts of a sample. The apparatus consists of a 500 mL sintered glass Büchner 
filter funnel with an inner diameter of 12 cm. Fractions were collected in Erlenmeyer flasks. 
Silica gel 60 was packed to a hard cake at a height of 5 cm under applied vacuum. The sample 
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used was covered onto a small amount of silica gel using volatile solvents. The resulting 
sample mixture was then packed onto the top of the column. Step gradient elution with a non-
polar solvent (Hexane) and increasing the gradient of a polar solvents (EtOAc, MeOH) gave 
successive fractions. The flow was produced by vacuum and the column was allowed to run 
dry after each fraction collected. 
 
3.5.3. Flash chromatography 
Flash chromatography is a preparative column chromatography based on optimized prepacked 
columns and an air pressure driven eluent at a high flow rate. It is a simple and quick 
technique widely used to separate a variety of organic compounds. Normally, the columns are 
dry Silica Gel 60 GF254 pre-packed, of 18 cm height, vertically clamped and assembled in 
the system. The column is filled and saturated with the desired mobile phase just prior to 
sample loading. Samples are dissolved in a small volume of the initial solvent used and the 
resulting mixture was then packed onto the top of the column using special syringe. The 
mobile phase (isocratic or gradient elution) is then pumped through the column with the help 
of air pressure resulting in sample separation. This technique is considered as a low to 
medium pressure technique and is applied to samples from few milligrams to some gram of 
sample. 
 
3.5.4. Low pressure liquid chromatography (LC) 
Open column chromatography plays a vital role in the separation of compounds from natural 
product extracts. The separation takes place through selective distribution of the components 
between a mobile phase and a stationary phase. Different choice of packing material and 
mobile phase can be applied depending on the class of compounds or fractions. Fractions 
derived from VLC were subjected to repeated separation through column chromatography 
using appropriate stationary and mobile phase solvent systems previously determined by 
TLC.  
 
The following types of separation systems were used in this study: 
 
• Normal phase chromatography using a polar stationary phase, typically silica gel (Silica 
Gel 60, 0.04 – 0.063 mm mesh size, Merck) or Diol (LiChroprep® Diol (40 – 63 µm) for 
liquid chromatography, Merck), in conjunction with a non- polar mobile phase (e.g. n-hexane, 
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DCM) or with a gradually increasing amount of a polar solvent (e.g. EtOAc or MeOH). 
Hydrophobic compounds elute quicker than hydrophilic compounds. 
 
• Reversed phase (RP) chromatography using a non-polar stationary phase and a polar 
mobile phase (e.g. H2O or MeOH). The stationary phase consists of reversed phase silica 
material. For instance, RP-18 stands for an octadecyl ligand in the matrix of the RP-18, 0.04 – 
0.0.63 mm mesh size (Merck) material that was used. The more hydrophobic the matrix, the 
greater the tendency of the column to retain hydrophobic compounds.  
 
Thus, hydrophilic compounds elute more quickly than do hydrophobic compounds. Elution 
was performed using H2O with gradually increasing amounts of MeOH or acetonitrile. 
 
• Size exclusion chromatography involves separations based on molecular sizes of analyzed 
compounds. The stationary phase consists of porous beads (Sephadex LH-20, 0.25 – 0.1 mm 
mesh size, GE Healthcare). Compounds having larger molecular diameter are excluded from 
the interior of the bead and thus elute firstly, while compounds with smaller molecular 
diameters enter the beads and elute according to their ability to exit from the small sized pores 
where they are trapped. Elution was performed using MeOH or MeOH:DCM [1:1 (V/V)] as 
mobile phases. 
 
• Ion exclusion chromatography uses ion exchange resin beds (Diaion HP-20, Supelco) that 
act as a charged solid separation medium. The components of the processed sample have 
different electrical affinities to this medium and consequently are differently retained by the 
resin according to their different affinities. 
 
The eluted fractions were collected by an automate fraction collector and combined according 
to TLC results. 
 
3.5.5. High pressure liquid chromatography (HPLC) 
High pressure liquid chromatography (HPLC) is a high resolution chromatographic technique, 
where the mobile phase is forced through the column containing the stationary phase by a 
pump, resulting in a fast separation. The high resolution is achieved by the use of small 
particle size of the absorbent material, which mostly is RP silica material. Adjacent to the 
HPLC a UV detector is connected for monitoring the separation of the eluted compounds 
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shown in a chromatogram. The method can be used for analytical purposes or semi 
preparative. 
 
3.5.5.1. Analytical HPLC 
Analytical HPLC was used to identify interesting peaks from extracts and fractions as well as 
to evaluate the purity of isolated compounds. The gradient used started with 10:90 [MeOH: 
nanopure H2O (0.1% o-phosphoric acid)] to 100% MeOH in 35 minutes; then 10 minutes 
with 100% MeOH to wash the column and finely 15 min with 10:90 [MeOH: nanopure H2O 
(0.1% o-phosphoric acid)] to stabilize the column for the next injection. Peaks are detected by 
UV-VIS diode array detector.  
 
Parameters: 
Pump     Dionex P580A LPG 
Detector    Dionex Photodiode Array Detector UVD 340S 
Column  Knauer (125 × 4 mm, ID), pre-packed with Eurosphere 100-5 C18, with 
integrated pre-column. (Knauer, Berlin, Germany). 
Column thermostat  STH 585 
Autosampler    ASI-100T 
HPLC Program    Chromeleon (V. 6.3) 
Run time   60 min 
Injection volume   20 µL 
Flow rate   1,0 mL/min 
Detection   235 nm; 254 nm; 280 nm and 340 nm 
 
In case of insufficient separation the gradient was adjusted adequate to the substances to be 
separated. 
 
3.5.5.2. Semi preparative HPLC 
The semipreparative HPLC was used for the isolation of pure compounds from fractions 
previously separated using column chromatography. Each injection consists of 1-3 mg of the 
fraction dissolved in 1 mL of the solvent system. The most appropriate solvent system was 
determined before running the HPLC separation. The solvent system, which is composed of 
MeOH and Nanopure water with or without 0.1% TFA, was pumped through the column at a 
rate of 5 mL/min. The eluted peaks, which were detected by the online UV detector, were 
collected separately in glass tubes. 
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Fr. A1 360 mg  
 
A1.1  
51mg  
 
A1.2  
23mg  
 
Bassiatin  
 1 mg 
 
Daphnelone 
3.4 mg  
 
δ-Sesamin 
2.1 mg  
 
Daphneone + 
Wikstromol   
3 mg  
 
VLC 
n-Hexan:EtOAc; DCM:MeOH  
Sephadex  
DCM:MeOH (1:1) Sephadex  
DCM:MeOH (1:1) 
Sephadex  
100% MeOH 
Semi-preparative  
HPLC 
Semi-preparative  
HPLC 
Semi-preparative  
HPLC 
Semi-preparative  
HPLC 
Semi-preparative  
HPLC 
 
 
 
 
 
Semi-preparative HPLC system specifications are described as follows: 
Pump     Merck Hitachi L-7100 
Detector    Merck Hitachi UV detector L-7400 
Column  Knauer (300 × 8 mm, ID), prepacked with Eurosphere 100-10 C18, with 
integrated pre-column. 
 
3.5.6. Isolation and purification of secondary metabolites 
3.5.6.1. Isolation and purification of plant extract Thymelaea lythroides 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Legend: 
     Fraction 
     Pure compound 
     New compound 
 
 Scheme 3.1. Isolation and purification of plant extract Thymelaea lythroides 
Crude EtOAc 
Extract 4.76 g 
 
90 % MeOH 
1.56 g 
 
n-Hexane      
3,08 g 
 
Fr. A2 160 mg  
 
Fr. A3 22 mg  
 
Fr. A4 270 mg  
 
A2.1  
23mg  
 
Wikstromol   
2.2 mg 
 
Rutarensin 
2.2 mg 
 
A4.1  
23mg  
 
Daphnoretin 
19.6 mg  
 
trans-Tiliroside 
21.6 mg  
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A1.1  
12 mg  
 
Fr. A1 80 mg  
 
A1.2  
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3.5.5.2 Isolation and purification of endophyte extract Chaetomium aureum 
3.5.5.2.1 Isolated secondary metabolites from fermentation of Chaetomium aureum on 
solid rice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: 
     Fraction 
     Pure compound 
     New compound 
 
Scheme 3.2. Isolation and purification of plant extract Chaetomium aureum 
Crude EtOAc 
Extract 12 g 
 
90 % MeOH  
3 g 
 
n-Hexane      
9 g 
 
Fr. A2 250 mg  
 
Fr. A3 370 mg  
 
Fr. A4 270 mg  
 
A2.1  
180 mg  
 
Sclerotiorin 
105 mg 
 
A4.1  
198 mg  
 
A3.1  
38 mg  
 
A3.2  
213 mg  
 
A3.2.1  
60 mg  
 
A3.2.2  
30 mg  
 
Xanthoradone E 
(mix) 1 mg 
 
A4.1.2  
60 mg  
 
Xanthoradone D 
(mix) 3 mg  
 
Isochromophilone 
VII 1 mg 
 
Chetoresorcinol 
5 mg 
 
Sclerotioramin 
 105 mg 
 
Xanthoradone E 
(pure) 3 mg  
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3.6. Structure elucidation of the isolated metabolites 
The structure elucidation of the isolated compounds followed a standard scheme. Firstly, the 
data obtained from analytical HPLC were compared with the in-house substance library 
regarding their retention times at the standard gradient program and their UV spectra. 
Comparable hits indicated the class to which the compound belongs. From LCMS 
measurement the mass of the compound and from 1H-NMR measurement substructures could 
be compiled. With this information, together with the identity of the fungus, a literature 
search using the latest versions of Dictionary of Natural Products (DNP, Chapman and Hall, 
2005-2009), Antibase (2002-2007), Antimarin 0512, 2012 and SciFinder was performed. In 
some cases these data were insufficient and additional measurements, especially one and two-
dimensional NMR experiments were necessary to finally identify the secondary metabolite. 
 
3.6.1. Mass spectrometry (MS) 
Mass spectroscopy (MS) is an analytical technique used to determine the molecular weight, 
the elemental composition of a molecule and for the chemical structures elucidation of the 
molecules. It is a very sensitive technique and even from micro gram amounts good spectra 
can be obtained. Technically, mass spectrometers consist of three parts: ionization source, 
analyzer, and detector, which should be maintained under high vacuum conditions so as to 
maintain the ions flight through the instrument without any hindrance from air molecules. The 
sample is ionized in the ionization source and the rising ions are sorted and separated 
according to their mass (m) charge (z) ratio (m/z) in the mass analyzer. Both negative and 
positive charged ions can be observed. Once the separated ions reach the detector, the signals 
are transmitted to the data system where the mass spectrum is recorded. The molecular ion 
(parent ion) has to be identified giving the molecular weight of the compound. Therefore, 
mass spectrometry is used to determine the molecular weights of pure compounds or 
compounds in a mixture. From the fragmentation patterns of the compound information about 
substructures can be attained.  
 
Many different method of ionization are used in mass spectrometry and the selection of the 
method depends on the type of samples to be analyzed. Some known ionization methods 
include: 
! Electron Impact (EI) 
! Electro-Spray Ionization (ESI) 
! Fast Atom Bombardment (FAB) 
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! Chemical Ionization (CI) 
! Atmospheric Pressure Chemical Ionization (APCI) 
! Matrix Assisted Laser Desorption Ionization (MALDI) 
! Field Desorption / Field Ionization (FD/FI) 
! Thermo-Spray Ionization (TSI) 
 
Low resolution mass spectra were measured by ESI-, EI-, CI- and FAB-MS on a Bruker 
micrOTOF with Liquid chromatography Agilent 1100 Serie mass spectrometer.  
 
3.6.1.1. Electron Impact Mass Spectrometry (EI-MS) 
Analysis involves vaporizing a compound in an evacuated chamber and then bombarding it 
with electrons having 25.80 eV (2.4-7.6 MJ/mol) of energy. The high-energy electron stream 
not only ionizes an organic molecule (requiring about 7-10 eV) but also causes extensive 
fragmentation (the strongest single bonds in organic molecules have strengths of about 4 eV). 
The advantage is that fragmentation is extensive, giving rise to a pattern of fragment ions, 
which can help to characterize the compound. The disadvantage is the frequent absence of a 
molecular ion. 
 
3.6.1.2. Electron spray ionization mass spectrometry (ESIMS) 
ESI-MS is a gentle ionization method where the sample is passed through a high voltage 
metal capillary. At the end of this capillary it is sprayed by a flow of nitrogen gas at 
atmospheric pressure to form an aerosol. Together with heating, the nitrogen evaporates the 
emerging droplets forcing the ions in each droplet together until repulsion causes them to 
eject from the surface. The ions are extracted into the vacuum of the mass analyzer where 
they are detected. Additionally to the molecular ion peaks [M+H]+ or [M-H]- fragments of 
these can detected. 
 
⇒ Liquid chromatography mass spectrometry (LC/MS) 
High pressure liquid chromatography is a powerful method for the separation of complex 
mixtures, especially when many of the components may have similar polarities. If a mass 
spectrum of each component can be recorded as it elutes from the LC column, quick 
characterization of the components is greatly facilitated. Usually, ESI-MS is interfaced with 
LC to make an effective on-line LC/MS. HPLC/ESI-MS was carried out using a Finnigan 
LCQ-DECA mass spectrometer connected to a UV detector. The samples were dissolved in 
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water/MeOH mixtures and injected to HPLC/ESI-MS set-up. For standard MS/MS 
measurements, a solvent gradient that started with acetonitrile:nanopure H2O (10:90), 
adjusted with 0.1 % HCOOH, and reached to 100 % acetonitrile in 35 minutes was used. 
 
LC/UV/MS system specifications are described as follows: 
HPLC system  Agilent 1100 series (pump, detector and autosampler) Finnigan LC Q-
DECA 
MS spectrometer   Knauer, (250 × 2 mm, ID), prepacked with Eurosphere 100-5 
Column    C18, with integrated pre-column 
  
3.6.1.3. Fast atom bombardment mass spectrometry (FAB-MS) 
This was the first widely accepted method that employs energy sudden ionization. FAB is 
useful for compounds, especially polar molecules, unresponsive to either EI or CI mass 
spectrometry. It enables both non-volatile and high molecular weight compounds to be 
analyzed. In this technique, a sample is dissolved or dispersed in a polar and relatively non- 
volatile liquid matrix, introduced into the source on a copper probe tip. Then, this matrix is 
bombarded with a beam of atoms of about 8 Kev. It uses a beam of neutral gas (Ar or Xe 
atoms) and both positive and negative ion FAB spectra can be obtained. 
 
3.6.1.4. High-resolution mass spectrometry (HR-MS) 
High resolution is achieved by passing the ion beam through an electrostatic analyzer before it 
enters the magnetic sector. In such a double focusing mass spectrometer, ion masses can be 
measured with an accuracy of about 1 ppm. With measurement of this accuracy, the atomic 
composition of the molecular ions can be determined. 
 
After the determination of molecular weight, pure compounds are then submitted to the 
measurement of nuclear magnetic resonance (NMR) spectra. 
 
3.6.2. Nuclear magnetic resonance spectroscopy (NMR) 
First observed in 1946, nuclear magnetic resonance leads to the development of a technic, 
called NMR spectroscopy, which is now almost indispensable for structure elucidation. NMR 
spectroscopy allows determining chemical and physical proprieties of those nuclei of atoms 
having magnetic properties. Some nuclei experience this phenomenon, and others do not, 
depending upon whether they possess a property called spin. NMR spectroscopy is nowadays 
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routinely used to study chemical structure by giving not only the constituent of a molecule but 
also its relative stereochemistry. 
 
This technique utilizes the atomic nuclei spinning behavior of atoms with an odd number of 
nucleons, e. g. 
1
H and 
13
C. A NMR spectrum is acquired by varying the magnetic field that is 
applied to the sample dissolved in a deuterated solvent over a small range while observing the 
resonance signal from the sample. Depending on the electron density around each proton they 
obtain different shielding and deshielding effects appearing in different parts of the resulting 
NMR spectrum and thus provide information about the environment of each proton. The 
resulting frequency where the nuclei resonate, the so-called chemical shift, is given in ppm 
and the coupling constants between adjacent nuclei in Hertz (Hz). NMR experiments can be 
conducted in a one (1D) or two (2D) dimensional manner. 2D NMR spectra can be either 
measured between two equal (H, H-COSY, correlated spectroscopy) or two different (H, C-
COSY) frequency axes. For the H-H 2D experiments the connection between two adjacent 
protons (COSY), between two protons through space (NOESY, nuclear Over-hauser 
enhancement spectroscopy; ROESY, rotating- frame enhancement spectroscopy) or between 
all protons in one spin system (TOCSY, total correlation spectroscopy) are given. H-C 2D 
experiments measure the direct correlation between a proton and a carbon (HMQC, 
heteronuclear multiple quantum correlation) or the connection of protons over two, three and 
even four bonds to carbon atoms, so-called long range coupling (HMBC, heteronuclear 
multiple bond correlation). Correlations are shown as cross peaks in the plane between two 
axes containing the 1D NMR shifts. 
 
Most NMR spectra were measured at the University Wuppertal with BRUKER AVANCE III 
600 (1H - Messfrequenz 600.13 MHz) by Andreas Siebert and Ilka Polanz.  
 
3.6.3. Optical activity 
Optical rotation or optical activity is a phenomenon observed in the 1811 in quartz by the 
French physicist Dominique F.J. Arago. Polarized light changes its polarization after passing 
through a chiral molecule; this can be measured with a polarimeter. This equipment consists 
of a light source, two polarizing filters and a cell that contains a solution of the analyzed 
compound. 
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Optical activity is a macroscopic property of a molecule and differs between enantiomers. 
Samples containing two enantiomers in the same ratio are optically inactive. In a solution the 
measured optical rotation depends on concentration (c) and light path length (l) of the sample. 
The specific rotation, [α], expresses the optical rotation degree after correction of 
concentration and path length. Thus the specific rotation is a specific quantity for a chiral 
molecule at certain temperature (T) and at certain wavelength (λ). 
[α]T  λ = 100 α /c.l 
where:  
[α]T  λ is specific rotation at certain temperature T and wavelength λ 
a = the angle of rotation (
o
), 
l = optical path length in (dm) 
λ = wavelength 
T = temperature 
c = concentration (g/100 mL) 
The measurement of optical rotation presented in this study, was recorded on Perkin-Elmer 
241 MC polarimeter and using a 0.5 mL cuvette with 1 dm length. 
 [α] 20
D
is the specific optical rotation of Sodium-D-line at the wavelength, 589 nm and at a 
temperature of 20 °C. 
 
Pure substances were dissolved in appropriate spectroscopic grade solvent. The optical 
rotation of known compounds was compared to literature data. 
 
3.6.4. Circular dichroism (CD) spectroscopy 
Circular dichroism is based on the difference between the absorption of left-handed circularly 
polarized light (L-CPL) and right-handed circularly polarized light (R-CPL). It occurs when a 
molecule contains one or more chiral chromophores (light-absorbing groups). 
 
Circular dichroism = ∆A(λ) = A(λ)LCPL - A(λ)RCPL 
 
where λ is the wavelength. 
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Circular dichroism (CD) spectroscopy is a spectroscopic method. The CD of molecules is 
recorded over a range of wavelengths. CD spectroscopy is widely used to study chirality of 
molecules. 
 
Measurements are carried out in the visible and ultra-violet region of the electro-magnetic 
spectrum to monitor electronic transitions. If the molecule under investigation contains chiral 
chromophores, one CPL state will be absorbed to a greater extent than the other and the CD 
signal over the corresponding wavelengths will be non-zero. A circular dichroism signal can 
be positive or negative, depending on whether L-CPL is absorbed to a greater extent than R-
CPL (CD signal positive) or to a lesser extent (CD signal negative). 
 
Circular dichroism spectra are measured using a circular dichroism spectrometer, which is a 
highly specialized descendant of an ordinary absorption spectrometer. CD spectrometers 
alternately measure the absorption of L- and R-CPL, usually at a frequency of 50 KHz, and 
then calculate the circular dichroism signal. 
 
In this study, the CD spectra were recorded on a J-810 CD spectropolarimeter. 
Conformational searches were carried out by means of the Macromodel 9.7.211 (MacroModel 
et al., 2009) software using Merck Molecular Force Field (MMFF) with implicit solvent 
model for chloroform. Geometry reoptimizations at B3LYP/6-31G(d) level of theory 
followed by TDDFT calculations using various functionals (B3LYP, BH&HLYP, PBE0) and 
TZVP basis set were performed by the Gaussian 03 (Frisch et al., 2004) package. Boltzman 
distributions were estimated from the ZPVE corrected B3LYP/6-31G(d) energies. CD spectra 
were generated as the sum of Gaussians (Stephens and Harada, 2010) with 3000 cm–1 half-
height width (corresponding to ca. 16 nm at 230 nm), using dipole-velocity computed 
rotational strengths for conformers above 5%. The MOLEKEL (Varetto, 2009) software 
package was used for visualization of the results. 
 
3.7. Testing the biological activity 
A bioassay-guided separation can lead to the discovery of compounds with interesting 
activity. Samples from crude extracts and from different fractions, resulting of different 
separation were submitted to biological activity tests. 
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3.7.1. Antimicrobial assay 
Agar diffusion assay 
This method was used to detect the capability of a substance to inhibit the growth of 
microorganisms by measuring the diameter of inhibition zone around a tested compound on 
an agar plate. The agar diffusion assay was performed according to the Bauer-Kirby-Test 
(Bauer et al., 1966). 
 
Culture preparation 
The agar diffusion assay was performed according to the Bauer-Kirby-Test (DIN 58940, 
Bauer et al, 1966). Prior to testing, a few colonies (3 to 10) of the organism to be tested, were 
subcultured in 4 ml of tryptose-soy broth (Sigma, FRG) and incubated for 2 to 5 h to produce 
a bacterial suspension of moderate cloudiness. The suspension was diluted with sterile saline 
solution to a density visually equivalent to that of a BaSO4 standards. The standards were 
prepared by adding 0.5 ml of 1 % BaCL2 to 99.5 ml of 1% H2SO4 (0.36 N). The prepared 
bacterial broth is inoculated onto Müller-Hinton-Agar plates (Difco, USA) and dispersed by 
means of sterile beads. 
 
Microorganisms 
Crude extracts and isolated pure compounds were tested for activity against the following 
standard strains: 
• Gram-positive bacteria Bacillus subtilis 
• Gram-negative bacteria Escherichia coli 
• Yeast Saccharomyces cerevisiae 
• Fungi Cladosporium cucumerinum 
• Fungi Cladosporium herbarum. 
 
3.7.2. Cytotoxicity tests 
3.7.2.1.Microculture tetrazolium (MTT) assay 
Cytotoxicity tests were carried out by Prof. Dr. W. E. G. Müller, Institut für Physiologische 
Chemie und Pathobiochemie, University of Mainz, Mainz. The cytotoxicity was tested against 
L5178Y mouse lymphoma cells using the microculture tetrazolium (MTT) assay, and 
compared to that of untreated controls (Carmichael, 1987). 
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Cell cultures 
L5178Y mouse lymphoma cells were grown in Eagle’s minimal essential medium supplement 
with 10% horse serum in roller tube culture. The medium contained 100 units/mL penicillin 
and 100 µg/mL streptomycin. The cells were maintained in a humified atmosphere at 37° C 
with 5% CO2. 
 
MTT colorimetric assay 
Of the test samples, stock solutions in ethanol 96% (v/v) were prepared. Exponentially 
growing cells were harvested, counted and diluted appropriately. Of the cell suspension, 50 
µL containing 3750 cells were pipetted into 96-well microliter plates. Subsequently, 50 µL of 
a solution of the test samples containing the appropriate concentration was added to each 
well. The concentration range was 3 and 10 µg/mL. The small amount of ethanol present in 
the wells did not affect the experiments. The test plates were incubated at 37° C with 5% CO2 
for 72 h. A solution of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
was prepared at 5 mg/mL in phosphate buffered saline (PBS; 1.5 mM KH2PO4, 6.5 mM 
Na2HPO4, 137 mM NaCl, 2.7 mM KCl; pH 7.4) and from this solution, 20 µL was pipetted 
into each well. 
 
The yellow MTT penetrates the healthy living cells and in the presence of mitochondrial 
dehydrogenases, MTT is transformed to its blue formazan complex. After an incubation 
period of 3h 45 min at 37° C in a humidified incubator with 5% CO2, the medium was 
centrifuged (15 min, 20 °C, 210 x g) with 200 µL DMSO, the cells were lysed to liberate the 
formed formazan product. After thorough mixing, the absorbance was measured at 520 nm 
using a scanning microliter-well spectrophotometer. The color intensity is correlated with the 
number of healthy living cells. Cell survival was calculated using the formula: 
 
    Absorbance of treated cells – absorbance of culture 
 Survival % =  100  
        Absorbance of untreated cells – absorbance of culture 
 
All experiments were carried out in triplicates and repeated three times. As controls, media 
with 0.1% EGMME/DMSO were included in the experiments. 
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3.7.2.2. MTT cell viability assays 
Cytotoxicity tests were carried out by Prof. Dr. M. U. Kassack, Institut für Pharmazeutische 
und Medizinische Chemie, Heinrich-Heine University, Düsseldorf. 
 
Materials, cell lines and cell culture 
The human ovarian carcinoma cell line A2780 (A2780 sens) was obtained from European 
Collection of Cell Cultures (ECACC, Salisbury, UK). A2780 cells were exposed to weekly 
cycles of 2 µmol/L cisplatin over a period of 24 weeks. 
 
Cisplatin-resistant cells were denoted A2780 CisR. The human chronic myelogenous 
leukemia cell line K562 was obtained from the German Collection of Microorganisms and 
Cell Cultures (DSMZ, Germany). All other reagents were supplied by Sigma Chemicals 
unless otherwise stated. All cell lines were grown at 37 °C under humidified air supplemented 
with 5% CO2 in RPMI 1640 (PAN Biotech, Germany) containing 10% fetal calf serum (PAN 
Biotech, Germany), 100 IU/mL penicillin and 100 µg/mL streptomycin. The cells were grown 
to 80% confluency before using them for the MTT cell viability assay. 
 
MTT cell viability assays 
The rate of cell-survival under the action of test substances was evaluated by an improved 
MTT assay (Müller et al., 2004). The assay is based on the ability of viable cells to 
metabolize yellow 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT, 
Applichem, Germany) to violet formazane crystals that can be detected 
spectrophotometrically. In brief, A2780 cells were seeded at a density of 8.000 cells/well and 
K562 at a density of 30,000 cells/well in 96 well plates (Corning, Germany). After 24 h, cells 
were exposed to the test compounds at concentrations of 10
-5
 M and 10
-4
 M. Incubation was 
stopped after 72 h and cell survival was determined by addition of MTT solution (5 mg/mL in 
phosphate buffered saline). The formazan precipitate was dissolved in DMSO. Absorbance 
was measured at 544 nm and 620 nm in a FLUO starmicroplate-reader (BMG LabTech, 
Offenburg, Germany). The absorbance of untreated control cells was taken as 100% viability. 
All tests were performed in triplicate. 
 
3.7.2.3. Protein kinase assay 
Protein kinase assays were carried out by Dr. Michael Kubbutat (ProQinase GmbH, Freiburg, 
Germany). 
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Protein kinase enzymes are integral components of numerous signal transduction pathways 
involved in the regulation of cell growth, differentiation, and response to changes in the 
extracellular environment. Consequently, kinases are major targets for potentially developing 
novel drugs to treat diseases such as cancer and various inflammatory disorders. 
 
The inhibitory potency of the samples was determined using 24 protein kinases (see Table 
3.2). The IC50 profile of compounds/fractions showing an inhibitory potency of ≥ 40% with at 
least one of the 24 kinases at an assay concentration of 1 × 10
-06
 g/mL was determined. IC50 
values were measured by testing 10 concentrations of each sample in singlicate (n=1). 
 
Sample preparation 
The compounds/fractions were provided as 1 × 10
-03
 g/mL stock solutions in 100% DMSO 
(1000 or 500 µL) in micronic boxes. The boxes were stored at -20
o 
C. Prior to the assays, 100 
µL of the stock solutions were transferred into separate microtiter plates. Subsequently, they 
were subjected to serial, semi-logarithmic dilution using 100% DMSO as a solvent resulting 
in 10 different concentrations. 100% DMSO was used as control. Subsequently, 7 × 5 µL of 
each concentration were aliquoted and diluted with 45 µL H2O only a few minutes before the 
transfer into the assay plate to minimize precipitation. The plates were shaken thoroughly and 
then used for the transfer of 5 µL compound solution into the assay plates. 
 
Recombinant protein kinases 
All protein kinases were expressed in Sf9 insect cells as human recombinant GST-fusion 
proteins or His-tagged proteins by means of the baculovirus expression system. Kinases were 
purified by affinity chromatography using either GSH-agarose (Sigma) or NiNTH-agarose 
(Qiagen). Purity was checked by SDS-PAGE/silver staining and the identity of each kinase 
was verified by western blot analysis with kinase specific antibodies or by mass spectrometry. 
 
Protein kinase assay 
A proprietary protein kinase assay (33PanQinase
®
 Activity Assay) was used for measuring 
the kinase activity of the protein kinases. All kinase assays were performed in 96-well Flash 
PlatesTM from Perkin Elmer/NEN (Boston, MA, USA) in a 50 µL reaction volume. The 
reaction mixture was pipetted in the following order: 20 µL assay buffer, 5 µL ATP solution 
in H2O, 5 µL test compound in 10% DMSO and 10 µL substrate/10 µL enzyme solution 
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(premixed). The assay for all enzymes contained 60 mM HEPES-NaOH (pH 7.5), 3 mM 
MgCl2, 3mM MnCl2, 3 pM Na-orthovanadate, 1.2 mM DTT, 50 pg/mL PEG20000, 1 pM [y-
33P]-ATP. The reaction mixtures were incubated at 30°C for 80 minutes and stopped with 50 
µL 2% (v/v) H3PO4. The plates were aspirated and washed two times with 200 µL of 0.9% 
(w/v) NaCl or 200 pL H2O. Incorporation of 33Pi was determined with a microplate 
scintillation counter (Microbeta Trilux, Wallac). All assays were performed with a Beckman 
Coulter/Sagian robotic system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group Names AGC Containing PKA, PKG, PKC families; CAMK Calcium/calmodulin-
dependent protein kinase; CK1 Casein kinase 1; CMGC Containing CDK, MAPK, GSK3, 
CLK families; STE Homologs of yeast Sterile 7, Sterile 11, Sterile 20 kinases; TK Tyrosine 
kinase; TKL Tyrosine kinase-like (@ cellsignal.com). 
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Table 3.2: List of Protein kinases and their substrates 
Family  Kinase  Substrate  Oncologically 
relevant 
mechanism 
Disease 
Serine/threonine 
kinases 
AKT1/PKB 
Alpha 
GSC3 (14‐27)  Apoptosis  Gastric cancer 
(Staal, 1987) 
ARK5  Autophos.  Apoptosis  Colorectal 
cancer 
(Kusakai et al., 
2004) 
Aurora B  Tetra(LRRWSLG)  Proliferation  Breast cancer 
(Keen and Tylor 
2004) 
  PLK‐1  Casein  Proliferation  Prostate cancer 
(Weichert et al., 
2004) 
  MEK1 wt  ERK2‐KR  Apoptosis  Multiple cancers 
(Ryan et al., 
2000) 
  NEK2  RB‐CTF  Apoptosis  Ewing’s tumors 
& B cell 
lymphoma 
(Schultz et al., 
1994) 
  NEK6  GSK3(14‐27)  Apoptosis  Multiple  cancers 
(Li et al., 2003) 
  PIM1  GSK3(14‐27)  Apoptosis  prostate cancer 
(Dhanasekaran 
et al., 2001) 
  PRK1  RBER‐CHKtide  Proliferation  Prostate cancer 
(Manser et al., 
1994) 
 
Receptor tyrosine 
kinase 
IGF1‐R  Poly(glu,Tyr)4:1  Apoptosis  Braest cancer 
(Zhang and Yee 
2000) 
  MET wt  Poly(Ala,glu,Lys,Tyr)6:2:4:1  Metastasis  Lung cancer 
(Qiao et al., 
2002) 
  VEGF‐R2  Poly(glu,Tyr)4:1  Angiogenesis  Pancreatic 
cancer 
(Li et al., 2003) 
  ALK  poly(Glu,Tyr)4:1  Apoptosis  anaplastic large‐
cell lymphoma 
(Morris et al., 
1994) 
  AXL  poly(Glu,Tyr)4:1  Proliferation  Ovarian, gastric 
and breast 
cancer (Liu et al., 
1988) 
 
Soluble tyrosine 
kinase 
FAK  Poly(glu,Tyr)4:1  Metastasis  Breast cancer 
(Schmitz et al., 
2005) 
  SRC  Poly(glu,Tyr)4:1  Metastasis  Colon cancer 
(Dehm et al., 
2001) 
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3.8. Inhibiting the hsp90 chaperone pathway 
3.8.1. Heat shock protein Hsp 90 
Heat shock proteins (HSPs) are chaperone proteins that become up-regulated in response to 
cellular environmental stresses, such as elevated temperature and oxygen or nutrient 
deprivation. Hsps are chaperones that facilitate the proper folding and repair of other cellular 
proteins, referred to as “client proteins”, and also aid the refolding of misfolded proteins. Of 
the several families of Hsps, the Hsp90 family is one of the most abundant, representing 
approximately 1-2% of the total protein content in non-stressed cells and 4-6% of the protein 
content of cells that are stressed.  
 
The N-terminal domain of Hsp90 comprises an ATP-binding site that is central to the 
chaperone function. The C-terminal domain of Hsp90 mediates constitutive Hsp90 
dimerization. Conformational changes of Hsp90 are orchestrated with the hydrolysis of ATP.  
Hsp90 is highly conserved and facilitates the folding and maturation of over 200 client 
proteins, which are involved in a broad range of critical cellular pathways and processes. In 
non-stressed cells Hsp90 participates in low affinity interactions to facilitate protein folding 
and maturation. In stressed cells Hsp90 can assist the folding of dysregulated proteins, and is 
known to be involved in the development and maintenance of multiple diseases. 
 
Hsp90 maintains the conformation and stability of many oncogenic proteins, transcription 
factors, steroid receptors, metalloproteases and nitric oxide synthases that are essential for 
survival and proliferation of cancer cells (Whitesell et al., 2005). Thus, Hsp90 client proteins 
have been associated with the development and progression of cancer. Furthermore, Hsp90 is 
thought to contribute to maintenance of multiple neurodegenerative diseases that are 
associated with protein degradation and misfolding (proteinopathy), such as Alzheimer’s 
disease, Huntingdon’s disease and Parkinson’s disease, through the mis-folding or 
stabilization of aberrant (neurotoxic) client- proteins. 
 
Inhibition of Hsp90 function results in the misfolding of client proteins, which are 
subsequently ubiquitinated and degraded through proteasome-dependent pathways. Hence, 
inactivation of the Hsp90 pathway represents a combinatorial attack on multiple signaling 
pathways and Hsp90 inhibitors have been developed as therapeutics with efficacy in a broad 
variety of human diseases. 
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3.8.2. Progesterone receptor PR reconstitution assay 
An in vitro progesterone receptor PR reconstitution assay as a model system was used to 
identify novel compounds that may inhibit the Hsp90 chaperoning machine. This assay uses 
RRL as a source of molecular chaperones and it has been fundamental in further 
understanding of how geldanamycin and related compounds such as 17-AAG inhibit Hsp90-
dependent chaperoning (Pratt et al., 2003). The assay directly measures the ability of 
molecular chaperones to refold the heat denatured PR to its hormone binding state. Hormone 
binding activity of the PR therefore reflects the functional integrity of molecular chaperones. 
Whether compounds isolated from endophyte affected the recovery of hormone binding 
activity of PR after mild heat denaturation was tested. Compounds with diverse chemical 
structures from Moroccan medicinal plants and microorganisms living in these plants were 
screened.  
 
For the progesterone receptor (PR) reconstitution assay, purified PR was adsorbed onto PR22 
antibody-protein A-sepharose resin beads and was assembled into complexes as described 
previously (Kosano et al., 1998). Briefly, about 0.05 µM PR was incubated with RRL diluted 
twice in reaction buffer (20 mM Tris/HCl, pH 7.5, 10 mM MgCl2, 4 mM DTT, 0.02% NP-40, 
100 mM KCl and 10 mM ATP). After incubation for 30 min at 30°C, 0.1 µM [3H]-
progesterone (American Radiolabeled Chemicals, Inc #ART 0063) was added. Samples were 
incubated on ice for 3 h at 4°C. Complexes were then washed three times with 1ml of reaction 
buffer and assessed for bound progesterone by liquid scintillation using PerkinElmer 
Microbeta plate reader. 
 
3.8.3. Cytotoxicity of Sclerotiorin to breast cancer Hs578T cells 
Cell Culture  
Cell lines were purchased from American type culture collection (ATCC). Cell culture 
medium (MEM) and fetal bovine serum (FBS) were obtained from Gibco. 
Penicillin/streptomycin, and tissue culture grade trypsin were bought from Sigma Chemical 
Co. 3.103.  
 
Cytotoxicity Assay 
Cells of breast cancer triple negative cell lines Hs578T and MDA-MB-231 and prostate 
cancer cell line LNCaP were seeded in 6-well plates (Corning #3516). The next day, cells 
were treated with various concentrations of sclerotiorin and deacetyl-sclerotiorin for 48h. 
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Every 24h, the old media was substituted with new media containing new drug at the same 
concentration. Cells were harvested at 48 h and cell lysate were made.  
 
3.8.4. Comparison of deacetylsclerotiorin and sclerotiorin by inhibiting the Hsp90 
chaperoning of progesterone receptor (PR) in vitro  
Production of deacetylsclerotiorin 
Sclerotiorin was chemically modified by deacetylation. Deacetylsclerotiorin was obtained by 
deacetylation of sclerotiorin, according to the procedure described previously by Isaka et al., 
2001.  
 
Isaka describes a method for deacetylation, including adding concentrated H2SO4 (0.2 mL) to 
a compound (9.0 mg) suspended in dry MeOH (2.0 mL) and stirring the mixture for 45 h. The 
resulting homogeneous solution is partially concentrated under reduced pressure, and the 
residue is diluted with EtOAc (30 mL). The EtOAc solution was washed with H2O (3 x 10 
mL) and concentrated in vacuo to yield the deacetylated compound as a powder that is 
subsequently purified by preparative HPLC (MeCN/H2O) 
 
3.9. General laboratory equipments 
Autoclave     Varioklav, H&P 
Balances     Mettler 200, Mettler AT 250, 
Mettler PE 1600, Sartorious MC1 AC210S 
Centrifuge     Biofuge pico, Heraeus 
Cleanbench     HERAsafe, Heraeus 
Digital pH meter     420Aplus, Orion 
Drying Ovens      Kelvitron t, Heraeus 
Fraction collector     Cygnet, ISCO 
Freeze dryer      Lyovac GT2, Steris 
- 80 °C Freezer     Forma Scientific, 86-Freezer 
Hot plate      Camag  
Magnetic stirrer     Combi Mag, IKA 
Rotary evaporator    Vacuubrand, IKA 
Sonicator      Sonorex RK 102, Bandelin 
Syringes      Hamilton 
Ultra Turrax      T18 basic, IKA 
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UV Lamp      Camag (254 and 366) 
Vacuum centrifuge     SpeedVac SPD 111V, Savant 
 
3.10. Solvents 
3.10.1. General solvents 
Acetone, acetonitrile, dichloromethane, ethanol, ethyl acetate, n-hexane and methanol were 
used. They were distilled before using and special grades were used for spectroscopic 
measurements. 
 
3.10.2. Solvents for HPLC 
Acetonitrile   LiChroSolv HPLC grade (Merck) 
Methanol   LiChroSolv HPLC grade (Merck) 
Nanopure water  distilled and heavy metals free water obtained by passing distilled water 
through nano- and ionexchange filter cells (Barnstead, France) 
 
3.10.3. Solvents for optical rotation 
Chloroform   Spectral grade (Sigma) 
Methanol   Spectral grade (Sigma) 
Water    Spectral grade (Fluka) 
 
3.10.4. Solvents for NMR 
Acetone-d6   Uvasol, Merck 
Chloroform-d   Uvasol, Merck 
DMF-d7   Uvasol, Merck 
DMSO-d6   Uvasol, Merck 
Methanol-d4   Uvasol, Merck 
Pyridine-d5   Uvasol, Merck 
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3. Results 
4.1. Ethnopharmacological study 
4.1.1. Frequency of Cancer according to gender 
During our investigation, we found that the incidence of cancer in the patients attending the 
National Institute of Oncology in Rabat is higher among women than men. Of 691 patients, 
422 were women (61.1 %), and 301 were men (43.5%). This data coincides with that of NIO 
register during the period of our investigation. Out of a total of 2693 patients hospitalized or 
treated, 1677 were women (62.2%) and 1016 were men (37.7%). 
 
This may be explained by the high frequencies of gyneco-mammary cancers that present 57% 
of all cancers affecting women in Morocco (RCRC, 2007). According to cancers register of 
Casablanca of 2004, the incidence of global standardized cancers in Morocco is of 10.171 
new cases per 100.000 inhabitants per year. Cancer affects more frequently women (raw 
incidence = 100.1) than man (raw incidence = 84.3), while in other developed countries, 
cancer is more frequent in man than women (RCRC, 2007).  
 
4.1.2. Frequency of cancer according to the localization  
Breast cancer in women is the most frequent cause of mortality and represents 16% of death 
in adult women (The World Health Statistics, 2008). In our study it was found that the 
incidence of breast cancer comes in the first place with a percentage of 34%, and according to 
the register of Rabat region in 2005, one cancer out of three is breast cancer with a risk 
cumulated 0-74 years of 3.8%. The number of new cases expected yearly would be 4660. 
However, the incidence of breast cancer in Morocco (396 for 100000) remains clearly inferior 
to incidences found in western countries (more than 80 for 100000) (RCR, 2009). In men 
broncho-pulmonary cancer comes in first place with percentage of 11%. 
 
RECRAB (2005) estimates that the number of new cases expected yearly in Morocco is 3000 
with a risk cumulated 0-74 years, that is 3.0% (RCR, 2009). In developed countries, smoking 
causes over 80% of such cancers and generally, heavy smoking increases the risk by around 
30-fold making lung cancer a major problem in developing countries where the consumption 
of tobacco is flourishing (Boutayeb A and Boutayeb S, 2005) Non Hodgkin Lymphoma is 
ranked third, 7%, and it is the most frequent of malignant homeopathies. The incidence of 
cancers of the lung, colon and rectum, breast and prostate generally increases in parallel with 
economic development, while the incidence of stomach cancer usually declines with 
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development (The World Health Statistics, 2008). In developing countries, around 60% of 
such cancers are thought to be a result of micronutrient deficiencies related to a restricted diet 
that is low in fruit and vegetables and animal products. There is also consistent evidence that 
consuming drinks and foods at a very high temperature increases the risk for these cancers 
(The World Health Statistics, 2008) (Table 4.1). 
 
Table 4.1. The incidence of cancer according to its localization (RECRAB, 2009) 
 
Localization Number of 
patients 
Frequency 
(%) 
Frequencies 
of 2005 in 
Rabat (%) 
W M W M W M 
Tonsil 3 2 0,43 0,28 0,26 0,26 
Oral cavity 5 1 0,72 0,14 0 0,26 
Pharynx 11 26 1,60 3,76 0 0 
Colon 11 14 1,60 2,02 1,58 2,60 
Cervical 7 - 1,01 0 13,46 - 
Stomach 17 17 2,46 2,46 3,17 4,69 
Liver 2 2 0,28 0,28 1,06 2,34 
Intestine 9 4 1,30 0,57 0,26 0 
Tongue 0 1 0 0,14 1,32 0,26 
Larynx 0 3 0 0,43 0 3,65 
Naso-pharynx 1 2 0,14 0,28 1,58 2,60 
Oro-pharynx 0 1 0 0,14 0 0 
Lips 0 2 0 0,28 0 0 
Mediastinal 0 1 0 0,14 0,26 0,52 
Esophagus 1 3 0,14 0,43 0,53 0,78 
Bone 6 12 0,86 1,73 1,06 0,78 
Orbit 0 2 0 0,28 0 0 
Pancreas 0 4 0 0,57 1,85 2,86 
Ovaries 27 - 4,00 0 4,49 - 
Skin 3 7 0,43 1,01 0,26 0,26 
Peritoneum 4 0 0,57 0 0,26 0 
Pleura 1 0 0,14 0 0,26 0,52 
Lung 8 64 1,15 9,26 2,9 19,89 
Prostate - 3 0 0,43 - 16,67 
Rectum 12 13 1,73 1,88 2,64 3,13 
Breast 229 2 33,14 0,28 33,51 0,78 
Central nervous system 2 3 0,28 0,43 2,37 2,60 
Testicle - 8 0 1,15 - 0,52 
Gallbladder 3 1 0,43 0,14 1,58 1,04 
Uterus 5 - 0,72 0 3,43 - 
Bladder 1 5 0,14 0,72 0,79 8,07 
Vulva 1 0 0,14 0 0,53 - 
Hodgkin lymphoma 22 21 3,18 3,03 1,06 1,04 
Non Hodgkin Lymphoma 28 27 4,05 3,90 2,64 5,73 
Leukemia 0 2 0 0,28 0,26 1,04 
 
 
Globally, many of the risk factors are due to lifestyle and can be prevented. Physical 
inactivity, western diet and smoking are prominent causes (Alberti, 2001). It should be 
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remembered that the patients surveyed were under treatment with either chemotherapy or 
radiotherapy. 
 
4.1.3. Frequency of cancer according to the age 
According to cancer register of NIO, the age interval mostly affected by cancer in the course 
of our investigation is that between 41 and 60 years. This data is similar to that found during 
our study (Table 4.2) 
 
Table 4.2. The incidence of cancer according to age 
 
 
Ages 
Frequency data of study  Overall frequency between 
September 2009 and March 2010  
Between 1 and 20 years  25 patients  (3,6%) 116 patients (4,3%) 
Between 21 and 40 
years 
180 patients (26%) 499 patients (18,5%) 
Between 41 and 60 
years 
363 patients (52,5%) 1342 patients (50%) 
More than 61 years old 117 patients  (17%) 742 patients (27,5%) 
 
This shows that the incidence of cancer increases with age, while its decrease from 61 years 
on may be explained only by the high rate of deaths. 
 
4.1.4. Frequency of using traditional medicine by NIO patients 
Among the total 691 questioned patients, 272 patients (39%) were identified to regularly use 
medicinal plants along with medical treatment, while 159 patients have used traditional 
medicine before using medical treatment. This data show that phytotherapy is still being 
practiced in Morocco. 
 
4.1.5. Use of Traditional Medicine according to the gender 
We have found that women (22.5%) use medicinal plants more frequently than men (16,4%); 
wich confirms results from previous studies (Hamdani S.E, 1984; El Beghdadi M, 1991; 
Jaouad L, 1992; Nabih M, 1992; Ziyyat A and al., 1997). This may be explained by the high 
rate of illiteracy among women in relation to men, as well as the transmission of information 
from mothers to daughters. When we compare the intragroup variation, the use of medicinal 
plant was markedly increased 60.60 ± 7.98 and 45.20 ± 5.58 respectively, when comparing 
women to men. The difference was significant (p<0.05). The age interval between 41 years 
and 60 years use more frequently TM compared to other age intervals.  
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In some ethnopharmacological studies (El Beghdadi M, 1991; Nabih M, 1992) the same 
results have been found. 
 
4.1.6. Use of Traditional Medicine according to the origin 
The origin and the educational level were also a variable, because in traditional medicine the 
statements of an illiterate or of an expert are not the same. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Use of Traditional Medicine according to the origin 
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4.1.7. Certainty and error biases 
Data collection relative to origin, place of residence, age as well as type, stage and 
localization of tumor have been established with the help of the person responsible of hospital 
register of NIO, and with the study of medical files of each questioned patient. The accuracy 
of information on the use of traditional medicine as well as the socio-professional class 
remains underestimated since it depends on the degree of the goodwill of participation. 
 
During the investigation, there was some reluctance from some patients about clearly and 
honestly answering questions concerning their use of medicinal plants, either out of fear of 
their clinician, or fear of the consequences of our investigation. The variable of sex has never 
been missing in our data. 
 
4.1.8. Medicinal plants used in traditional medicine by the patients of the National 
Institute of Oncology in Rabat 
Fiftyfive plants have been cited during this investigation of which Aristolochia longa, 
Trigonella foenum-graecum, Cassia absus and Nigella sativa are the most used (Table 3.3). 
Among these plants, 28 are proven to have anticancer activity (Table 3.4). 
 
4.1.9. The toxicity and side effects of medicinal plants 
The effect of the action of a drug results in the risk benefit ratio. It depends on the drug itself, 
dose, disease, other drugs consumed in parallel and the patient him self. Only the clinician can 
find the balance between the toxic doses and the therapeutic doses expected. However, the 
role of the clinician is lacking in Traditional Medicine, which explains the high rate of 
poisoning caused by this treatment. 
 
Moreover, there are plants that are proven to be toxic such as Pinus halepinsis, Peganum 
harmala, Aristolochia longa and Euphorbia resinifera, regardless of their toxicity these plants 
are used by patients in the INO, but have a degree of toxicity or side effects. Nevertheless, 
despite the existence of the modern medicine for cancer treatment, traditional medicine 
continues to be a viable health alternative for the large underprivileged section of the 
Moroccan population.  
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Table 4.3. Medicinal plants used in traditional medicine by the patients of the National Institute of Oncology in Rabat 
Scientific name Vernacular name Ecological distribution Part used Preparation Administration Types of Cancer Number of 
citation 
Anacardiaceae 
Pistacia lentiscus L. 
 
Drou 
 
ﻭﺮﺿ 
 
 
Mediterranean region 
 
Leaf 
 
Brut, Decoction 
 
Oral 
 
Digestive 
 
5 
Apiaceae 
Apium graveolens L 
Ammodaucus leucotrichus  
Carum carvi L. 
Coriandrum sativum L. 
Cuminum cyminum L. 
Daucus carota L.  
Foeniculum vulgare Mill. 
Petroselinum crispum Mill. 
Pimpinella anisum L. 
 
 
Krafess 
Kamoun sooufi 
Karwiya 
Qezbour 
Kamoun 
Khizzou 
Nafaâ 
Maâdanous 
Habbat hlawa 
 
ﺱﻑﺍﺭﻙ 
ﻲﻓﻮﺼﻟﺍ ﻥﻮﻣﺎﻛ 
ﺔﻳﻭﺮﻛ 
ﺭﻮﺑﺰﻗ 
ﻥﻮﻣﺎﻛ 
ﻭﺰﻴﺧ 
ﻊﻓﺎﻧ 
ﺱﻮﻧﺪﻌﻣ 
ﺓﻭﻼﺣ ﺔﺒﺣ 
 
Littoral, Mediterranean et Asia 
 
Europe, Asia occidental-Orient 
Africa 
 
Asia 
Mediterranean Basin  
Europe central, Macedonia. 
Chine et East 
 
Leaf  
Seed  
Seed  
Aerial parts 
Seed  
Root 
Seed  
Aerial parts 
Seed 
 
 
Decoction 
Grind with honey 
Grind with honey 
Grind with honey 
Grind with honey 
Decoction 
Decoction 
Decoction 
Decoction 
 
Oral 
Oral 
Oral 
Oral 
Oral 
Oral 
Oral 
Oral 
Oral 
 
Digestive, Kidney 
Lung  
Lung  
Digestive, Kidney 
Lung 
Digestive, Kidney 
Digestive 
Kidney 
Digestive, Kidney 
 
1 
4 
2 
3 
1 
5 
6 
3 
1 
 
Apocynaceae 
Nerium oleander L. 
 
Araliacées 
Panax ginseng C.A. Meyes. 
 
Arécacées 
Phoenix dactylifera 
 
 
Defla 
 
 
Jinsin 
 
 
Tamer 
 
ﺔﻠﻓﺩ 
 
 
ﻦﺴﻨﺟ 
 
 
ﺭﻡﺙﻝﺍ 
 
Africa du Nord, Asia (South 
West) 
 
Nord-East of china and of Korea 
 
 
Saudi and Gulf Country 
Nord Africa, 
 
Leaf  
 
 
Leaf  
 
 
Fruit 
 
Decoction 
 
 
Grind with honey 
 
 
Brut 
 
Mouthwash 
 
 
Oral 
 
 
Oral 
 
Gingival 
 
 
Lung 
 
 
Lymphoma 
 
1 
 
 
1 
 
 
2 
Aristelochiaceae 
Aristolochia longa L. 
 
 
Berraztam 
 
ﻢﻁﺯﺮﺑ 
 
 
 
 
Root 
 
 
Grind with honey 
 
 
Oral 
 
General 
 
98 
Boraginacées 
Borago officinalis 
 
Cruciferae 
Lepidium sativum L. 
 
Hoboub 
allikaah 
 
Hebb rchad 
 
ﺡﺍﻕﻝﻝﺍ ﺏﻭﺏﺡ 
 
 
ﺩﺎﺷﺮﻟﺍ ﺐﺣ 
 
 
 
 
 
 
 
Stamen 
 
 
Seed 
 
Grind with honey 
 
 
Grind with honey 
 
 
Oral 
 
 
Oral 
 
 
General 
 
 
Lung,, Digestive 
 
2 
 
 
9 
Capparaceae 
Capparis spinosa L. 
 
 
Kebbar 
 
ﺭﺎﺒﻜﻟﺍ 
  
Fruit 
 
Grind with honey 
 
 
Oral 
 
Lymphoma 
 
2 
Caryophyllaceae 
Corrigiola telephiifolia 
Herniaria glabra L 
 
 
Sarghina 
Hrasset lehjer 
 
ﺔﻨﻴﻏﺮﺻ 
ﺮﺠﺤﻟﺍ ﺖﺳﺍﺮﻫ 
  
Root 
Aerial parts 
 
 
Decoction 
 
 
Oral 
 
Digestive, Liver 
Digestive, Renal 
 
1 
1 
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Chenopodiaceae 
Chenopodium ambrosioides 
Haloxylon scoparium Pomel 
 
 
Mkhinza 
Eremt 
 
 
ﺓﺯﻥﻱﺥﻡ 
ﺖﻣﺮﻟﺍ 
 
 
Mexico 
 
 
Leaf 
Leaf, Fruit 
 
 
Decoction 
Decoction 
 
 
Oral 
Oral 
 
 
Amygdale 
Liver 
 
 
1 
1 
 
Compositae 
Artemisia absinthium L. 
Artemisia vulgaris 
Artemisia herba-alba 
Inula viscosa (L.) Ait. 
 
 
Chiba 
Chih 
Chih 
elkhorrassani 
Bagraman 
 
ﺍﺏﻱﺵﻝﺍ 
 ﺢﻴﺸﻟﺍ 
ﻲﻧﺎﺳﺮﺨﻟﺍ ﺢﻴﺸﻟﺍ 
ﻥﺎﻣﺮ%ﺑ 
 
 
 
Orient, Occident 
 
Tlemcen 
 
Leaf 
Aerial parts 
Aerial parts 
Leaf, 
Flower 
 
Infusion 
Infusion 
Infusion 
Grind with honey 
 
 
Oral 
Oral 
Oral 
Oral 
 
Digestive 
Digestive 
Digestive 
Breast 
 
1 
2 
1 
22 
Euphorbiaceae 
Euphorbia resinifera 
 
Fabaceae 
Cassia absus 
Cicer arietinum 
Vicia faba 
 
Iridacées 
Crocus sativus 
 
Lamiaceae 
Ajuga iva L. 
Lavandula officinalis L. 
Marrubium vulgare L. 
Mentha pulegium L. 
Origanum compactum Beneth 
Rosmarinus officinalis L. 
Salvia ofﬁcinalis L. 
Thymus ssp. 
 
 
Daghmous 
 
 
Habat albaraka 
Homos 
Foul 
 
 
Zâafran 
 
 
Chendgoura 
Khzama 
Marrîwet 
Fliyou 
Zaâtar 
Azîr 
Salmiya 
Zîtra 
 
ﺱﻭﻡﻍﺩﻝﺍ 
 
 
ﺓﻙﺭﺏﻝﺍ ﺓﺏﺡﻝﺍ 
ﺺﻤُﺤﻟﺍ 
ﻝﻭﻑﻝﺍ 
 
 
ﻥﺍﺮﻔﻋﺰﻟﺍ 
 
 
ﺓﺭﻮ$ﺪﻨﺸﻟﺍ 
ﺓﻡﺍﺯﺥ 
ﺕﻭﻱﺭﻡ 
ﻭﻱﻝﻑ 
ﺭﺕﻉﺯ 
ﺭﻱﺯﺁ 
ﺓﻱﻡﻝﺱ 
ﺓﺮﺘِﻋﺯ 
 
Morocco 
 
 
Saudi 
India and Mediterranean Basin 
Asia  
 
 
 
 
 
 
Mediterranean region 
Europe méridionale 
Zarifet, El-Meffrouche, Hafir 
 
Mediterranean   
 
Mediterranean 
 
Aerial parts 
 
 
Seed 
Seed 
Seed 
 
 
Stamen 
 
 
Rod, Leaf 
Leaf  
Rod, Leaf 
Rod, Leaf 
Rod, Leaf 
Leaf  
Leaf  
Rod, Leaf 
 
Grind with honey 
 
 
Grind with honey 
Grind with honey 
Grind with honey 
 
 
Decoction 
 
 
Grind with honey 
Infusion 
Decoction 
Infusion 
Infusion 
Decoction 
Infusion 
Infusion 
 
Oral 
 
 
Oral 
Oral 
Oral 
 
 
Oral 
 
 
Oral 
Oral 
Oral 
Oral 
Oral 
Oral 
Oral 
Oral 
 
General 
 
 
General 
Lung 
Lung 
 
 
General 
 
 
Breast 
The urinary and 
genital system 
Digestive, Gingival 
Digestive, Gingival 
Digestive 
Intestine, Lung 
Digestive 
 
 
8 
 
 
58 
1 
1 
 
 
3 
 
 
6 
9 
19 
7 
44 
4 
2 
1 
Leguminosae 
Trigonella foenum-graecum 
 
 
Halba 
 
ﺓﺏﻝﺡ 
  
Seed 
 
Grind with honey 
 
 
Oral 
 
Digestive 
 
60 
Liliacaea 
Allium cepa L. 
Allium sativum L 
 
Linaceae 
Linum usitatissimum 
 
Liliacées 
Aloe ferox Mill. 
 
Lythraceae 
Lawsonia inermis 
 
 
El Bassla 
Touma 
 
 
Zariat alkhatan 
 
 
Siber 
 
 
Henna 
 
 
ﻝﺹﺏ 
ﻡﻭﺙﻝﺍ 
 
 
ﻥﺍﺕﻙﻝﺍ ﺓﻉﻱﺭﺯ 
 
 
ﺭﺏﺹﻝﺍ 
 
 
ءﺍﻥﺡﻝﺍ 
 
 
 
 
 
 
Morocco, Argentina and Egypt 
 
 
Oriental Africa et méridionale 
 
 
La carie région de l’asie mineure 
 
 
Bulb 
Bulb 
 
 
Seed  
 
 
Leaf 
 
 
Flower 
 
 
Brut 
Brut 
 
 
Grind with honey 
 
 
Extraction 
 
 
Grind with water 
 
 
Oral 
Oral 
 
 
Oral 
 
 
Oral 
 
 
Cataplasm 
 
 
General 
General 
 
 
Lymphoma 
 
 
Digestive 
 
 
Skin 
 
 
1 
14 
 
 
13 
 
 
4 
 
 
5 
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Moracées 
Ficus carica 
 
Myrtaceae 
Myrtus communis L. 
 
Oléacées 
Olea europaea 
 
Pinacées 
Pinus  halepinsis mill 
 
Punicaceae 
Punica granatum L. 
 
 
 
 
Karmous 
 
 
Rihan 
 
 
Zaytoun 
 
 
Katran 
 
 
Rouman 
 
 
 
ﺱﻮﻣﺮﻛ 
 
 
ﻥﺍﺡﻱﺭﻝﺍ 
 
 
ﻥﻭﺕﻱﺯﻝﺍ 
 
 
ﻥﺍﺮﻄﻗ 
 
 
ﻥﺍﻡﺭ 
 
 
 
Mediterranean Region 
 
 
Ouest d’Asie sud, Europe 
 
 
Nord de l’Asie. 
 
 
Mediterranean Region 
 
 
Afrique orientale et méridionale 
 
 
 
Fruit 
 
 
Leaf  
 
 
Fruit 
 
 
Seed  
 
 
Rind 
 
 
 
Brut 
 
 
Decoction 
 
 
Extraction 
 
 
Extraction 
 
 
Decoction 
 
 
 
Oral 
 
 
Oral 
 
 
Oral 
 
 
Oral 
 
 
Oral 
 
 
 
Digestive 
 
 
Digestive 
 
 
Lung 
 
 
Esophagi 
 
 
Skin 
 
 
 
 
2 
 
 
3 
 
 
2 
 
 
1 
 
 
2 
Ranunculaceae 
Nigella sativa L 
 
Sapotaceae 
Argania spinosa 
 
Thymelaeaceae 
Thymelaea lhytroides 
 
Verbenaceae 
Verbena officinalis  
 
Zingiberacées 
Zingiber officinale roscoe 
 
Zygophylaceae 
Peganum  harmala L. 
 
Samouj,   
Haba Saoudaâ 
 
Argan 
 
 
Ftiticha , 
matnan 
 
Louiza 
 
 
Sknjbir 
 
 
alharmal 
 
 ﺝﻭﻥﺍﺱ 
ءﺍﺩﻭﺱﻝﺍ ﺓﺏﺡﻝﺍ 
 
ﻥﺎ#ﺭﺃ 
 
 
ﻥﺍﻥﺕﻡ , 
ﺓﺵﺕﻱﺕﻑ 
 
ﺓﺯﻱﻭﻝﻝﺍ 
 
 
ﺮﻴﺒﺠﻨﻜﺳ 
 
 
ﻝﻡﺭﺡﻝﺍ 
 
Bassin méditerranéen 
 
 
Endémique marocaine 
 
 
Endémique ibéro-marocaine 
 
 
Espèce cultivée dans les jardins 
des maisons 
 
Sud de l’Asie ; Pays tropicaux 
 
Seed  
 
 
Seed  
 
 
Aerial parts 
 
 
Leaf 
 
 
Root 
 
 
Seed 
 
Grind with honey 
 
 
Extraction 
 
 
Decoction 
 
 
Infusion 
 
 
Grind with honey 
 
 
Grind with honey 
 
 
Oral 
 
 
Oral 
 
 
Oral 
 
 
Oral 
 
 
Oral 
 
 
Oral 
 
General 
 
 
Skin 
 
 
Uterus 
 
 
Gallbladder 
 
General 
 
 
General 
 
54 
 
 
1 
 
 
2 
 
 
1 
 
 
1 
 
 
1 
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Table 4.4. List of plants reported to have anticancer activity 
Species Family Reference 
Pistacia lentiscus L. 
Petroselinum crispum Mill. 
Nerium oleander 
Panax ginseng C.A. Meyes 
Phoenix dactylifera 
Capparis spinosa L. 
Chenopodium ambrosioides 
Artimesia vulgaris 
Artemisia herba-alba 
Inula viscosa (L.) Ait. 
Euphorbia resinifera 
Cicer arietinum 
Crocus sativus 
Rosmarinus officinalis L. 
Salvia ofﬁcinalis L. 
Trigonella foenum-graecum 
Allium cepa L. 
Allium sativum L. 
Linum usitatissimum 
Ficus carica 
Olea europaea 
Pinus  halepinsis mill 
Punica granatum L. 
Nigella sativa L. 
Argania spinosa 
Verbena officinalis 
Zingiber officinale roscoe 
Peganum  harmala L. 
Anacardiaceae 
Apiaceae 
Apocynaceae 
Araliaceae 
Arécaceae 
Cruciferae 
Chenopodiaceae 
Compositae 
Compositae 
Compositae 
Euphorbiaceae 
Fabaceae 
Iridaceae 
Lamiaceae 
Lamiaceae 
Leguminosae 
Liliacaea 
Liliacaea 
Linaceae Moraceae 
Myrtaceae 
Oléaceae 
Pinaceae 
Punicaceae 
Ranunculaceae 
Sapotaceae 
Verbenaceae 
Zingiberaceae 
Zygophylaceae 
Balan K.V, 2007 
Hui Z and al., 2006 
Luay J.R and al.,  2001 
Shi S and al., 2011 
Biglari F and al., 2011 
Sze-Kwan L and al., 2009 
Ruffa M. J and al., 2002 
Nibret E and al., 2010 
Nibret E and al., 2010 
Danino O and al., 2009 
Lavie D and al., 1963 
Ajiaikebaier A and al., 2011 
Akshi H. A and al., 2009 
Shuwen C and al., 2001 
Toshiya M and al., 2002 
Jayadev R and al., 2004 
Jun Y and al., 2004 
Yoshiyuki M and al., 2010 
Abarzua S and al., 2007 
Sarfaraz Khan M and al., 2011 
Mijatovic S.A and al., 1955 
Volker M-S and al., 2011 
Oliveira L.P and al., 2010 
Worthen D.R and al., 1998 
El Babili F and al., 2010 
Ucar Turker A and al., 2010 
Kim E-C and al., 2005 
Changhong W and al., 2005 
 
4.2. Compounds isolated from the plant Thymelaea lythroides 
The genus Thymelaea Mill. (Thymlaeaceae) comprises 31 species of xerophyllous shrubs and 
herbs (Galicia-Herbada, 2006). Thymelaea lythroides, an ibero-endemic plant in Morocco, is 
popularly used as medicinal plant to treat otitis, diabetes, rheumatism, inflammation of the 
prostate and uterus cancer (Gmira et al., 2007). Thymelaea lythroides was selected according 
to an ethnopharmacological study of traditional plants used in Morocco by cancer patients as 
herbal therapeutics (Kabbaj et al., 2012). 
 
Fresh, healthy parts of Thymelaea lythroides have been collected from Maâmora forest in 
Rabat, Morocco. Voucher specimens were identified by Prof. FZ. ALAOUI, Department of 
Botany, Faculty of Sciences, Mohamed V University and Prof. Dr. M. IBN TATOU, 
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Scientific Institute of Rabat, Morocco. Reference samples are deposited as the herbarium of 
the Scientific Institute of Rabat, and a collection number (RAB 77777) has been assigned. 
 
 
 
 
 
 
 
 
 
Figure 4.5. HPLC chromatogram of methanol fraction of Thymelaea lythroides 
 
Comparison of the HPLC chromatograms of the different fractions of Thymelaea lythroides 
and the preliminary biological screening assays, i.e. antibacterial, antifungal, and cytotoxicity 
showed that the methanol fraction had the best range of secondary metabolites and the most 
active one (see Table 4.5 and Figure 4.2). 
 
Table 4.1. Preliminary biological screening assays of the different fractions of Thymelaea 
lythroides 
Fungal strain L5178Y  MRSA  Strep. pneumonia  Entero. 
Faecalis  
Ethylacetate Fraction  99.7%  >62,5µg/ml  >62.5µg/ml  n.a 
Hexane Fraction 125%  n.a >3.2µg/ml  n.a 
Methanol Fraction  99.7% >31.25µg/ml >62.2µg/ml >61.5µg/ml 
Water Fraction  99,7%  >31.25µg/ml  > 31.25µg/ml  >61.5µg/ml  
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O
N O
O
1
2
3
4
5
6
7
9
8
10
11
16
15
13
14
12
Compound isolated from the plant Thymelaea lythroides 
Bassiatin (1, Known) 
Bassiatin 
Synonym(s) 
 
 
CAS Registry Number 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
Optical rotation [α]D
26 
UV spectrum λmax 
(3S,6R)-4-Methyl-6-(l-methylethyl)-3 
phenylmethyl-l,4-perhydrooxazine-2,5-dione, 
(3S, 6R) Bassitin  
173008-70-3  
Thymelaea lythroides 
1 mg  
white powder 
C15H19NO3 
261,14 g/mol 
33.54 min (standard gradient) 
+ 176.09 (c 0.02, CHCl3) 
213.2 and 356.2 nm 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
No ionisation in the negative mode 
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1 was isolated from Thymelaea lythroides extracted with EtOAc. The EtOAc extract was 
portioned between n-hexane and 90% MeOH. The 90% MeOH fraction was chromatographed 
over silica gel F254 using gradient elution (n-hexane/EtOAc/CH2Cl2/MeOH). The fraction 
was subjected to a sephadex LH-20 column using CH2Cl2/MeOH (1:1) as eluent system, then 
purified by semi-preparative HPLC (Merck, Hitachi L-7100) using an Eurosphere 100–10 
C18 column (300 x 8mm, L x i.d.) with the following gradient (MeOH/H2O): 0 min, 10% 
MeOH; 5 min, 10% MeOH; 35 min 100% MeOH; 45 min, 100 % MeOH, which afforded 
white powder (yield, 1 mg). It showed UV absorbance at λmax (MeOH) 213.2 and 356.2 nm. 
Positive ESI-MS of 1 exhibited a prominent peak at m/z 261.9 [M+H]+ (base peak) indicating 
a molecular weight of 261 g/mol, which established a molecular formula of C15H19NO3. The 
1H NMR spectrum showed the presence of 19 protons signals, two methyl protons at (δH 0.26 
ppm) and (δH 0.85 ppm) assigned to H-8 and H-9; one N-methyl protons at (δH 3.14 ppm) 
assigned to 4-CH3; three methine protons at (δH 5.79 ppm) (δH 4.84 ppm) (δH 1.81 ppm) 
assigned to H-3, H-6 and H-7; one pair of methylene protons (δH 3.03-3.39 ppm) assigned to 
H-10 and five aromatic protons, four of them are overlapping at (δH 7.24-7.25 ppm) assigned 
to H-12, H-13, H-15 and H-16, the H-14 appears at (δH 7.18 ppm).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. 1H-1H NMR COSY 
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The 1H-1H NMR COSY showed the presence of four spin systems assigned H(3)H(10), 
H(6)→H(8), from H(7)H(9) and the aromatic ring system H(12)H(13)H(14)H(15)H(16), 
whereas the connection of these spin systems was established by inspection of 2J and 3J 
HMBC correlations (Figure 4.3 and 4.4).  
 
4-CH3 showed a correlation to the carbon C-3 (δC 58.0 ppm) and C-5 (δC 170.3 ppm), H-3 
showed a correlation to the carbon C-2 and C-5 appearing at (δC 172.3 ppm) and (δC 170.3 
ppm), the same H-6 showed a correlation to the two carbonyl carbons C-2 and C-5. On the 
other hand, H-10 showed correlations to the overlapping aromatic carbons, which were 
attributed to C-12, C-13, C-15 and C-16 (δC 129.8-130.0 ppm), as well as to an isolated 
aromatic carbon assigned to C-11 (δC 138.2 ppm), hence establishing the connection between 
the identified spin systems (Figure 4.3). Thus the structure of 1 was elucidated as 4-methyl-6-
(l-methylethyl)-3-phenylmethyl-l,4-perhydrooxazine-2,5-dione, consisting of one mole each 
of N-methylphenylalanine and 2-hydroxy-3-methylbutyric acid.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. Selected 13C-1H NMR HMBC correlations 
 
The optical rotations of 4 ([α]D + 176.09° (c 0.02, CH3Cl)) was compared with that of 
bassiatin [(3S,6R)-4-methyl-6-(1-methylethyl)-3-phenylmethyl-1,4-perhydrooxazine-2,5-di-
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one] ([α]D + 181.05° (c 0.024, CH3Cl)) and to the other three isomeric - (3R,6S)-, (3R,6R)-, 
(3S,6S)- compounds (Kagamizono et al., 1995). The structure of 1 was determined to be 
(3S,6R)-4-methyl-6-(l-methylethyl)-3-phenylmethyl-l ,4-perhydrooxazine-2,5-dione, (3S,6R) 
Bassitin.  
 
Table 4.6. Comparison of 1H and 13C NMR chemical shifts of 1 with Bassiatin  
(Kagamizono et al., 1995) 
 
Bassiatin is an unusual secondary metabolite to be obtained from plants. To the best of our 
knowledge, bassiatin was only described as natural product from the cultured broth of 
Beauveria bassiana (Kagamaizono et al., 1995), from the insect-body portions of Cordyceps 
cicadae (Kuo et al., 2002) and later isolated from the endophytic fungus Fusarium oxysporum 
J8-1-2 (Meng et al., 2011). This is the first report of this compound from the plant Thymelaea 
lythroides. This can possibly be explained by the presence of an endophyte, which produced 
bassiatin in large quantity to be detected in the host plant. 
 
 
 
 
 
 
 
 
 
 
 
Position 
1 Bassiatin 
δH  (mult.,  J in Hz) δC   δH  (mult.,  J in Hz) δC 
2 - 172.3 - 170.2 
3 5.79, 1H (dd, J= 12.6, 4.5 Hz) 58.0 5.47 (br d) 57.6 
4-CH3 3.14, 3H (s) 32.3 3.00 (s) 32.6 
5 - 170.3 - 169.5 
6 4.84, 1H (d, J= 8.9 Hz) 77.3 4.92 (d, 8.7 Hz) 75.7 
7 1.81, 1H (m) 31.3 2.02 (m) 29.9 
8 0.26, 3H (d, J= 6.9 Hz) 17.3 0.42 (d, J= 6.9 Hz) 17.8 
9 0.85, 3H (d, J= 6.6 Hz) 19.1 0.80 (d, J= 6.9 Hz) 18.5 
10 3.39, 1H (dd, J= 14.7, 4.6 Hz) 
3.03, 1H(dd, J= 14.7, 12.7 Hz) 
35.6 3.36 (dd, J= 14.5, 5.1 Hz) 
2.98 (dd, J= 14.5, 11.9 Hz) 
35.0 
11 - 138.2 - 136.9 
12, 16 7.25 - 7.24, 2H (m) 130.0 7.23 – 7.23 (m) 129.1 
13, 15 7.25 - 7.24, 2H (m) 129.8 7.23 – 7.23 (m) 128.8 
14 7.18, 1H (m) 128.1 7.17 (m) 127.0 
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Compound isolated from the plant Thymelaea lythroides   
Daphneone (2, Known)  
Daphneone 
Synonym(s) 
 
CAS Registry Number 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
UV spectrum λmax 
1-(4-Hydroxyphenyl)-5-phenylpentan-1-one; 
Daphneone 
936006-14-3  
Thymelaea lythroides 
105 mg 
colorless needle crystal 
C17H18O2 
254.12 g/mol 
29.34 min (standard gradient) 
200.6, 232.9 and 285.7 nm 
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2 was isolated from Thymelaea lythroides extracted with EtOAc. The EtOAc extract was 
portioned between n-hexane and 90% MeOH. The 90% MeOH fraction was chromatographed 
over silica gel F254 using gradient elution (n-hexane/EtOAc/CH2Cl2/MeOH). The fraction 
was subjected to a sephadex LH-20 column using CH2Cl2/MeOH (1:1) as eluent system, then 
purified by semi-preparative HPLC (Merck, Hitachi L-7100) using an Eurosphere 100–10 
C18 column (300 x 8mm, L x i.d.) with the following gradient (MeOH/H2O): 0 min, 10% 
MeOH; 5 min, 10% MeOH; 35 min 100% MeOH; 45 min, 100 % MeOH. Compound 2 was 
obtained as a mixture with compound 6 forming colorless needle crystals with colorless oil 
(yield, 3 mg). It showed UV absorbance at λmax (MeOH) 200.6, 232.9 and 285.7 nm. Positive 
and negative ESI-MS of 2 exhibited a prominent peak at m/z 255.3 [M+H]+ (base peak) and 
m/z 253.5 [M-H]- (base peak) indicating a molecular weight of 254 g/mol. The molecular 
formula of compound 2 was determined to be C17H18O2 based on the analysis of the 
molecular weight and 13C NMR data. The 1H NMR spectrum  (MeOD) (Table 4.7) displayed 
signals of a p-substituted aromatic protons at (δH 6.82 and 7.86 ppm; each 2H) assigned to H-
3', H-5', H-2' and H-6' respectively and mono-substituted aromatic protons at (δH 7.16 and 
7.23 ppm; each 2H) with (δH 7.13 ppm; 1H) assigned to H-2'', H-6'', H-3'', H-5'' and H-4'' 
respectively, indicated that there are two aromatic rings in the structure. In addition, four 
methylene protons at (δH 1.70 ppm; 4H), (δH 2.65 ppm; 2H) and (δH 2.95 ppm; 2H) assigned to 
H-3, H-4, H-5 and H-2 respectively. The 13C NMR spectrum indicated the presence of 17 
carbon signals displayed of four aliphatic methylene carbons, nine aromatic methine carbons 
and four quaternary carbons, one carbonyl carbon and one oxygenated quaternary carbon. The 
1H-1H COSY NMR spectrum (Figure 4.5.A) showed 4 spin systems assigned for H(2')H(3'), 
H(5')H(6'), from H(2) to H(5) and the aromatic ring from H(2'')to H(6''), whereas the 
connection of these spin systems was established by inspection of 2J and 3J HMBC 
correlations (Figure 4.5.B). 
 
 
 
 
  
 
 
 
Figure 4.5 A) 1H-1H COSY correlations B) selected 13C-1H NMR correlations of 2 
 
H-5 showed a correlations to the overlapping aromatic carbons, which were attributed to C-2'' 
and C-6'' (δC 129.9 ppm), as well as to an isolated aromatic carbon assigned to C-1'' (δC 144.1 
A  B 
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ppm), these correlations indicated that the mono-substituted aromatic ring is connected to the 
side chain of four methylene groups at C-1''. On the other hand, the second p-substituted 
aromatic ring is connected to a hydroxyl group at C-4' (δC 164.30 ppm) and to carbonyl group 
at C-1' (δC 130.6 ppm), these connection were confirmed with the correlations between the 
overlapping aromatic protons H-3' and H-5' to the C-4' and from the overlapping aromatic 
protons H-2' and H-6' to the carbon C-1 (δC 202.28 ppm). Furthermore, the carbonyl carbon 
C-1 (δC 202.28 ppm) was connected to side chain of four methylene groups at C-2 (δC 39.43 
ppm), which was confirmed with the correlation between H-2 to C-1, thus, establishing the 
connection between the identified spin systems. 
 
The identification was further corroborated by comparison of UV, 1H, 13C NMR, mass 
spectral data as well as [α]D value of 2 with those previously published data for Daphenone 
(Zhang et al., 2006). 
 
Daphenone was previously isolated from some species of Daphne including, Daphne odora, 
which is the first biological source report (Zhang et al., 2006), from Daphne giraldii Nitsche 
(Sun et al., 2006) and from Daphne acutiloba (Huang et al., 2012). This the first report of 
Daphenone from the species Thymelaea lythroides. 
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Compound isolated from the plant Thymelaea lythroides 
(+)-Daphneolone (3, Known) 
(+)-Daphneolone 
Synonym(s) 
 
 
CAS Registry Number 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
Optical rotation [α]D
26 
UV spectrum λmax 
1-Pentanone, 3-hydroxy-1-(4-hydroxyphenyl) 
-5-phenyl-, (+)- 
Daphneolone 
54835-64-2 
Thymelaea lythroides 
105 mg 
colorless needle crystal 
C17H18NO3 
270 g/mol 
25.20 min (standard gradient) 
+ 35 (c 1.0, CHCl3) 
213.7 and 283.1 nm 
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3 was isolated from Thymelaea lythroides extracted with EtOAc. The EtOAc extract was 
portioned between n-hexane and 90% MeOH. The 90% MeOH fraction was chromatographed 
over silica gel F254 using gradient elution (n-hexane/EtOAc/CH2Cl2/MeOH). The fraction 
was subjected to a sephadex LH-20 column using CH2Cl2/MeOH (1:1) as eluent system, then 
purified by semi-preparative HPLC (Merck, Hitachi L-7100) using an Eurosphere 100–10 
C18 column (300 x 8mm, L x i.d.) with the following gradient (MeOH/H2O): 0 min, 10% 
MeOH; 5 min, 10% MeOH; 35 min 100% MeOH; 45 min, 100 % MeOH, which afforded 
colorless needle crystal (yield, 3 mg). It showed UV absorbance at λmax (MeOH) 213.7 and 
283.1 nm. Positive and negative ESI-MS of 3 exhibited a prominent peak at m/z 271.1 
[M+H]+ (base peak) and m/z 269.3 [M-H]- (base peak) indicating a molecular weight of 270 
g/mol with a 16 mass unit decrease compared to 2. To fulfill the molecular weight, the 
presence of one hydroxyl group was supposed. The molecular formula of compound 3 was 
determined to be C17H18NO3 based on the analysis of the molecular weight and 
13C NMR 
data.  
 
The 1H NMR spectrum (MeOD) (Table 4.3) displayed the same aromatic protons signals as 
compound 2, indicating that there are also two aromatic rings in the structure. In addition, two 
typical AMX system at (δH 3.02 ppm ; 1H, dd, J= 17.6, 8.5 Hz, assigned to H-2A), (δH 3.13 
ppm ; 1H, dd, J= 17.6, 2.6 Hz, assigned to H-2M) and (δH 4.21 ppm ; 1H, m, assigned to H-3X) 
together with the second AMX2 system at (δH 2.75 ppm ;  1H, m, H-5A), (δH 2.89 ppm ; 1H, 
m, H-5M) and (δH 1.81 ppm ; 2H, m, H-4X1 and H-4X2) indicate that there are three methylene 
protons and one methine proton with hydroxyl group substitution. The 1H-1H COSY NMR 
spectrum showed the same spin systems as daphenone (Figure 4.6). 
 
 
 
 
  
 
 
Figure 4.6. 1H-1H COSY correlations of 3 
 
 
The optical rotation of 3 was close to the rotation reported in the literature for (+)-
daphneolone (Zhuang et al., 1982).  
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The identification was further corroborated by comparison of UV, NMR, MS data as well as 
[α]D value of 3 and those previously published data for daphneolone (Zhuang et al., 1982). 
Daphnelone was previously isolated from some species of Daphne including, Daphne odora, 
which is the first biological source report (Kogiso et al., 1974), from Daphne tangutica 
(Zhuang et al., 1982), from Daphne mezereum (Kreher et al., 1990), from Daphne 
pedunculata (Xu et al., 2008), from Daphne giraldii (Wu et al., 2009), from Daphne bholua 
(Chen et al., 2009), from Daphne retusa (Hu et al., 2011), from Daphne papyracea var. 
crassiuscula (Wei et al., 2012) and from Daphne genkwa (Chen et al., 2013). This the first 
report of Daphnelone from the species Thymelaea lythroides. 
 
Table 4.7. The 1H and 13C chemical shifts of 2 and 3  
 
 
 
 
 
 
 
 
 
 
 
Position 
2 3 
δH  (mult.,  J in Hz) δC   δH  (mult.,  J in Hz) δC 
1 - 202.28 - 202.28 
2 2.95 (2H, t, J= 6.96 Hz) 39.43 3.02 (1H, dd, J= 17.6, 8.5 Hz) 
3.13 (1H, dd, J= 17.6, 2.6 Hz) 
44.3 
3 1.70 (2H, m) 26.17 4.21 (1H, m) 67.2 
4 1.70 (2H, m) 32.85 1.81 (2H, m) 38.1 
5 2.65 (2H, t, J= 7.14 Hz) 37.29 2.75 (1H, m) 
2.89 (1H, m) 
31.9 
1' - 130.66 - 130.66 
2' 7.86 (2H, d, J=8.82 Hz) 132.40 7.90 (2H, d, J=8.82 Hz) 132.40 
3' 7.23 (2H, t, J= 7.56 Hz) 116.80 6.86 (1H, d, J=8.82 Hz) 116.80 
4' - 164.30 - 164.30 
5' 7.23 (2H, t, J= 7.56 Hz) 116.80 6.86 (1H, d, J=8.82 Hz) 116.80 
6' 7.86 (2H, d, J=8.82 Hz) 132.40 7.90 (2H, d, J=8.82 Hz) 132.40 
1'' - 144.17 - 144.17 
2'' 7.16 (2H, d, J= 6.96 Hz) 129.99 7.24 (2H, d, J= 6.96 Hz) 129.99 
3'' 6.82 (1H, d, J=8.82 Hz) 127.29 7.25 (2H, t, J= 7.56 Hz) 127.29 
4'' 7.13 (1H, t, J= 7.32 Hz) 129.87 7.19 (1H, t, J= 7.32 Hz) 129.87 
5'' 6.82 (1H, d, J=8.82 Hz)  127.29 7.25 (2H, t, J= 7.56 Hz) 127.29 
6'' 7.16 (2H, d, J= 6.96 Hz) 129.99 7.24 (2H, d, J= 6.96 Hz) 129.99 
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Compound isolated from the plant Thymelaea lythroides 
(-)-Wikstromol (4, Known) 
(-)-Wikstromol 
Synonym(s) 
 
 
CAS Registry Number 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
Optical rotation [α]D
25 
UV spectrum λmax 
2(3H)-Furanone,dihydro-3-hydroxy-3,4bis[(4-
hydroxy-3-methoxyphenyl)methyl]-,(3S-cis); 
(-)-Nortrachelogenin;(-)-Wikstromol;  
34444-37-6 
Thymelaea lythroides 
2 mg 
colorless powder 
C20H22O7 
374 g/mol 
19.6 min (standard gradient) 
- 38.5 (c 1.0, CHCl3) 
280.9 nm 
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4 was isolated from Thymelaea lythroides extracted with EtOAc. The EtOAc extract was 
portioned between n-hexane and 90% MeOH. The 90% MeOH fraction was chromatographed 
over silica gel F254 using gradient elution (n-hexane/EtOAc/CH2Cl2/MeOH). The fraction 
was subjected to a sephadex LH-20 column using CH2Cl2/MeOH (1:1) as eluent system, then 
purified by semi-preparative HPLC (Merck, Hitachi L-7100) using an Eurosphere 100–10 
C18 column (300 x 8mm, L x i.d.) with the following gradient (MeOH/H2O): 0 min, 10% 
MeOH; 5 min, 10% MeOH; 35 min 100% MeOH; 45 min, 100 % MeOH, which afforded 
colorless powder (yield, 2 mg). It showed UV absorbance at λmax (MeOH) 280.9 nm. Positive 
and negative ESI-MS of 4 exhibited a prominent peak at m/z 375.0 [M+H]+ (base peak) and 
m/z 373.3 [M-H]- (base peak) indicating a molecular weight of 374 g/mol. The molecular 
formula of compound 4 was determined to be C20H22O7 based on the analysis of the 
molecular weight and 13C NMR data.  
 
The 1H NMR spectrum (MeOD) (Table 4.8) displayed signals of two- tri-substituted aromatic 
systems at (δH 6.70 ppm ; 4H) assigned to H-1, H-1', H-4 and H-4' with (δH 6.59 ppm ; 2H) 
assigned to H-5 and H-5', in addition, two methoxy protons at (δH 3.78 ppm and 3.81 ppm) 
assigned to H-10 and H-10', three methylene protons at (δH 2.48-2.79 ppm), (δH 2.85-3.12 
ppm) and (δH 3.98 ppm) assigned to H-7', H-7 and H-9' and one methine proton at (δH 2.44 
ppm) assigned to H-8'.  
 
13C NMR and DEPT NMR spectrum showed the presence of two oxygenated methyl carbons, 
two aliphatic methylene carbons, one oxygenated methylene carbon, one aliphatic methine 
carbon, six aromatic methine carbons, four oxygenated aromatic quaternary carbons, two 
aromatic quaternary carbons, one oxygenated aliphatic quaternary carbon and one carbonyl 
carbon.   
 
The 1H-1H COSY showed the presence of four spin systems assigned for H(4-4')H(5-5'), a 
continuous spin system H(7')→H(9') and a spin system between the protons of the three 
methylene groups as showed in the Figure 4.7.A.  
 
The HMBC-NMR spectra (Figure 4.7.B) showed the connection between the previously 
mentioned spin systems. The cross peak of the proton H-7' to the aromatic carbons, which 
were attributed to C-1', C-5' and C-6', indicated that the aromatic ring is connected to the 
aliphatic side at the C-6'. In opposite, from the protons H-7 to the aromatic carbons assigned 
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to C-1, C-5 and C-6, indicating that the aromatic ring is connected to the aliphatic side at the 
C-6. Furthermore, the cross peak from the proton H-7 to the carbonyl carbons C-9 and C-8 
and in the opposite, from the H-7' to the carbons C-9' and C-8' showed that the partial 
structure 1 and 2 (Figure 4.8) was connected at C-8 and at the carbonyl carbon C-9, these 
connections were confirmed with the correlations between the proton H-8' and the carbon C-8 
and from H-9' to the carbonyl carbon C-9, thus establishing the connection between the 
identified spin systems. 
 
 
 
 
 
Figure 4.7. A) 1H-1H COSY correlations B) Selected 13C-1H NMR correlations of 4 
 
Table 4.8. 1H and 13C NMR chemical shifts of  (-)-wikstromol (4) 
N° 4 
δH δC 
1 6.70, 1H (m) 113.9a 
2 - 146.3e 
3 - 149.1f 
4 6.59, 1H (ddd, J= 1.92, 8.01, 12.39 Hz) 116.3b 
5 6.70, 1H (m) 122.6c 
6 - 128.5 
7 3.98, 2H (d, J= 13.8 Hz) 42.1 
8 - 77.7 
9 - 77.6 
10 3.81, 3H (s)x 56.6d 
1' 6.70, 1H (m) 115.3a 
2' - 146.3e 
3' - 149.1f 
4' 6.59, 1H (ddd, J= 1.92, 8.01, 12.39 Hz) 116.4b 
5' 6.70, 1H (m) 124.2c 
6' - 122.1 
7' 2.48, 1H (dd, J= 9.37, 13.35 Hz) 
2.79, 1H (dd, J= 4.77, 13.35 Hz) 
32.3 
8' 2.44, 2H (qd, J= 4.72, 8.13, 8.60, 8.60 Hz) 44.7 
9' 3.98, 2H (d, J= 8.13 Hz) 72.1 
10' 3.78, 3H (s)x 56.7d 
        a, b, c, d, f, x could be opposite 
 
 
 
   
     Partial structure 1           Partial structure 2 
Figure 4.8. The partial structure 1 and 2 
A  B 
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The optical rotation was found to be [α]D
25 - 38.5 (c 1.0, CHCl3). 
 
The identification was further corroborated by comparison of UV, 1H, 13C NMR, mass 
spectral data as well as [α]D value of 2 and those previously published data for (-)-wikstromol 
(Sefkow, 2001). 
 
(-)-Wikstromol was reported for the first time from Wikstroemia viridiflora (Tandon and 
Rasiiig, 1976). Then from Cedrus deodara (Piniaceae) (Rao et al., 2002) and from 
Didymochlaena truncatula (Hypodematiaceae) (Cao et al., 2006). We report here the 
presence of wikstromol in T. lythroides for the first time. 
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Compound isolated from the plant Thymelaea lythroides 
δ-Sesamin (5, Known) 
δ-Sesamin 
Synonym(s) 
 
CAS Registry Number 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
Optical rotation [α]D
25 
UV spectrum λmax 
Tetrahydro-1,4-bis[3,4 
(methylenedioxy)phenyl ]-1H,3H-furo[3,4-
c]furan; δ-Sesamin 
607-80-7 
Thymelaea lythroides 
2 mg 
colorless oil 
C20H18O6 
382 g/mol 
29.50 min (standard gradient) 
- 60 (c 1.0, CHCl3) 
210.1 and 274.7 nm 
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5 was isolated from Thymelaea lythroides extracted with EtOAc. The EtOAc extract was 
portioned between n-hexane and 90% MeOH. The 90% MeOH fraction was chromatographed 
over silica gel F254 using gradient elution (n-hexane/EtOAc/CH2Cl2/MeOH). The fraction 
was subjected to a sephadex LH-20 column using CH2Cl2/MeOH (1:1) as eluent system, then 
purified by semi-preparative HPLC (Merck, Hitachi L-7100) using an Eurosphere 100–10 
C18 column (300 x 8mm, L x i.d.) with the following gradient (MeOH/H2O): 0 min, 10% 
MeOH; 5 min, 10% MeOH; 35 min 100% MeOH; 45 min, 100 % MeOH, which afforded 
colorless powder (yield, 2 mg). It showed UV absorbance at λmax (MeOH) 280.9 nm. Positive 
ESI-MS of 5 exhibited a prominent peak at m/z 355.1 [M+H]+ (base peak) and m/z 253.5 [M-
H]- (base peak) indicating a molecular weight of 354 g/mol. The molecular formula of 
compound 5 was determined to be C20H18O6 based on the analysis of the molecular weight 
and 13C NMR data.  
 
Table 4.9. Comparison of 1H and 13C NMR chemical shifts of (+)-sesamin (5) 
N° 5 
δH δC 
1 3.08, 1H (m)  137.0 
2 4.70, 1H (d, J= 3.95 Hz) 87.8 
3 - 149.9 
4A 
4M 
3.84, 1H (dd; J= 3.77, 9.10 Hz) 
4.22, 1H, dd; J= 6.80, 9.10 Hz 
73.2 
73.2 
5 3.08, 1H (m) 109.5 
6 4.70, 1H (d, J= 3.95 Hz) 121.1 
7 - - 
8A 
8M 
3.84, 1H (dd; J= 3.77, 9.10 Hz) 
4.22, 1H, dd; J= 6.80, 9.10 Hz 
73.2 
73.2 
1' - 137.0 
2' 6.88, 1H (d; J= 1.72 Hz) 108.1 
3' - 149.9 
4' - 149.1 
5' 6.78, 1H (d; J= 7.76 Hz) 109.5 
6' 6.84, 1H (dd; J= 1.05, 7.92 Hz) 121.1 
7' 5.92, 2H (d; J= 1.46 Hz) - 
1'' - 137.0 
2'' 6.88, 1H (d; J= 1.72 Hz) 108.1 
3'' - 149.9 
4'' - 149.1 
5'' 6.78,1H (dd, J= 7.76 Hz) 109.5 
6'' 6.84, 1H (dd; J= 1.05, 7.92 Hz) 121.1 
7'' 5.92, 2H (d; J= 1.46 Hz) - 
 
The 1H NMR spectrum (MeOD) (Table 4.9) displayed 18 protons signals: a typical AMX 
system at (δH 3.84 ppm; 2H, dd; J= 3.77, 9.10 Hz, H-4A and H-8A), (δH 4.22 ppm; 2H, dd; J= 
6.80, 9.10 Hz, H-4M and H-8M) and (δH 3.08 ppm; 2H m, H-1X and H-5X) indicating the 
presence of two overlapping methylene protons, each one was connected to one methine 
proton; 2 overlapping -O-CH2-O- at (δH 6.78 ppm) assigned to H-7' and H-7''; two overlapped 
  Results 
  87 
 
O
O
O
O
O
O
2
1
4
5
8
6
1'
2'
3'
4'
5'
6'
7'
2''
1''
5''
4''
3''
6''
7''
O
O
O
O
O
O
2
1
4
5
8
6
1'
2'
3'
4'
5'
6'
7'
2''
1''
5''
4''
3''
6''
7''
methine protons at (δH 4.70 ppm) assigned to H-1 and H-5; six aromatic protons of two tri-
substituted benzene moieties at (δH 6.78 ppm) assigned to H-2' and H-2'', (δH 6.84 ppm) 
assigned to H-6' and H-6'' and (δH 6.88 ppm) assigned to H-5' and H-5''.  
 
The 1H-1H COSY showed the presence of four spin systems assigned for H(5-5')H(6-6'), a 
continuous spin system H(4)→H(6), H(1)H(2)H(8) and spin system between the protons 
H(1)H(5) as shown in the Figure 4.9.A.  
 
   
 
 
 
 
 
 
Figure 4.9. A) 1H-1H COSY correlations B) selected 13C-1H NMR correlations of 5 
 
The 1H-13C MBC NMR spectra showed the connection between the previously mentioned 
spin systems. H-4 showed correlations to the overlapping aromatic carbons, which were 
attributed to C-2'' and C-6'' (δC 129.9 ppm), as well as to an isolated aromatic carbon assigned 
to C-1'' (δC 144.1 ppm), these correlations indicated that the tri-substituted aromatic ring is 
connected to the 3,7-O-bicyclooctane moieties at C-1''. The same correlations appeared for 
the other tri-substituted aromatic ring, from H-8 to the overlapping aromatic carbons C-2' and 
C-6', together with C-1', to confirm that the second tri-substituted aromatic ring was 
connected to the 3,7-O-bicyclooctane moieties at C-1'. On the other hand, the two overlapping 
-O-CH2-O- showed correlations to the overlapped aromatic carbons C-3'-C-3'' and to C-4'-C-
4'', to prove that -O-CH2-O- was connected to the tri-substituted aromatic ring at C-3' and C-4' 
for the first one, and at C-3'' and C4'' for the second aromatic ring, thus establishing the 
connection between the identified spin systems. 
 
The identification was further corroborated by comparison of UV, 1H, 13C NMR, mass 
spectral data as well as [α]D value (Lin et al., 2004) of 5 with those published data for (+)-
sesamin. 
 
A  B 
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(+)-Sesamin is a natural product, isolated for the first time from Piper sylvaticum (Banerji and 
Dhara, 1974), then from Artemisia argentea (El-Emary and Attia, 1988). Later, 5 was 
reported from Thymelaeaceae family (Takaku et al., 2001), from Plectranthus mollis 
(Kulkarni et al., 2012), and from Sesamum indicum (Yoshida et al., 2007). This is the first 
report of this compound from genus Thymelaea. 
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Compound isolated from the plant Thymelaea lythroides 
Daphnoretin (6, Known) 
Daphnoretin 
Synonym(s) 
 
 
CAS Registry Number 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
UV spectrum λmax 
Coumarin, 7-hydroxy-6-methoxy-3,7'-oxydi- 
(7CI,8CI); Daphnoretin; NSC 291852; 
Thymelol 
2034-69-7 
Thymelaea lythroides 
19 mg 
faint yellow needle crystals 
C19H12O7 
252 g/mol 
22.84 min (standard gradient) 
200.0, 259.9 and 344.9 nm 
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6 was isolated from Thymelaea lythroides extracted with EtOAc. The EtOAc extract was 
portioned between n-hexane and 90% MeOH. The 90% MeOH fraction was chromatographed 
over silica gel F254 using gradient elution (n-hexane/EtOAc/CH2Cl2/MeOH). The fraction 
was subjected to a sephadex LH-20 column using CH2Cl2/MeOH (1:1) as eluent system, then 
purified by semipreparative HPLC (Merck, Hitachi L-7100) using an Eurosphere 100–10 C18 
column (300 x 8mm, L x i.d.) with the following gradient (MeOH/H2O): 0 min, 10% MeOH; 
5 min, 10% MeOH; 35 min 100% MeOH; 45 min, 100 % MeOH, which afforded colorless 
powder (yield, 19 mg). It showed UV absorbance at λmax (MeOH) 200.0, 259.9 and 344.9 nm. 
Positive and negative ESI-MS of 6 exhibited a prominent peak at m/z 353.1 [M+H]+ (base 
peak) and m/z 351.3 [M-H]- (base peak) indicating a molecular weight of 352 g/mol. The 
molecular formula of compound 6 was determined to be C19H12O7 based on the analysis of 
the molecular weight and 13C NMR data.  
 
The 1H NMR spectrum of 6 (Table 4.10) displayed 12 proton signals, one methoxy group at 
(δH 3.82 ppm) assigned to 6-CH3, one hydroxyl group signal at (δH 10.30 ppm) assigned to 7-
OH, five aromatic protons at (δH 6.87 ppm), (δH 7.12 ppm), (δH 7.19 ppm), (δH 7.22 ppm), and 
(δH 7.72 ppm), which were assigned to H-8, H-6', H-8', H-5 and H-5', three heterocyclic 
protons at (δH 6.39 ppm), (δH 7.88 ppm) and (δH 8.05 ppm) assigned to H-3', H-4 and H-4'.  
 
The 1H-1H COSY showed the presence of two spin systems assigned for H(5')H(6') and 
between the protons H(3')H(4') as shown in the Figure 4.10.A 
 
Furthermore, 13C-1H long range couplings of 2J and 3J observed in 13C-1H heteronuclear 
multiple bond coherence (HMBC) spectrum gave the following linkages  (Figure 4.10.B) :  
(A) Cross peaks from H-4' to C-2', C-3', C-4a' and C-8a', From H-5' to C-4' and C-4a', from 
H-8' to C-8a' and C-7'. These correlations indicated that A is 1-benzopyran-2-one, the core of 
coumarin compounds, which is oxygenated at C-7'. On the other hand, the same correlations 
could be seen for the selected cross peaks of (B), from H-4 to C-2, C-3, C-4a and C-8a, from 
H-5 to C-4 and C-4a, from H-8 to C-8a and C-7, in addition, from 6-CH3 to C-6. These 
correlations indicated that B is an other benzopyrone, which is tri-substituted with a methoxy 
group at carbon 6 and a hydroxygroup at C-7 and also an oxygenated carbon at C-3. Thus, the 
partial structure A and B were connected at the C-7'-O- and C-3-O-positions.  
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Figure 4.10. A) 1H-1H COSY correlations B) selected 13C-1H NMR correlations of 6 
 
The identification was further corroborated by comparison of UV, 1H, 13C NMR, mass 
spectral data as well as [α]D value of 6 with those data published for Daphnoretin. (Ho et al., 
2010). 
 
Daphnoretin has been previously isolated for first time from Ladino clover (Fabaceae) 
(Livingston et al., 1964), then later in some genus of the Thymelaeaceae family Daphne, 
including Wikstroemia, Daphnopsis, Edgeworthia, Thymelaea, Diarthron, Dirca, Enkleia and 
Peddiea (Zhang et al., 2008), However, this the first report of Daphnoretin from the species 
Thymelaea lythroides.  
 
Table 4.10. Comparison of 1H and 13C NMR chemical shifts of 5 with Daphnoretin 
 (Wing et al., 2010) 
N° 5 Daphnoretin 
δH δH 
1 - - 
2 - - 
3 6.42 (1H, d, J= 9.6 Hz) 6.37 (1H, d, J= 9.6 Hz) 
4 
4a 
8.11 (1H, d, J= 9.5 Hz) 
- 
8.03 (1H, d, J= 9.5 Hz) 
- 
5 7.78 (1H, d, J= 8.6 Hz) 7.71 (1H, d, J= 8.6 Hz) 
6 
6-OCH3 
7,18 (1H, dd, J= 8.6, 2.4 Hz) 
3.89 (3H, s) 
7.11 (1H, dd, J= 8.6; 2.4 Hz) 
3.77 (3H, s) 
7 
7-OH 
- 
10.30 (1H, s) 
- 
10.23 (1H, s) 
8 
8a 
7.23 (1H, d, J= 2.4 Hz) 
- 
7.17 (1H, d, J= 2.4 Hz) 
- 
1' - - 
2' - - 
3' - - 
4' 
4a' 
7.91 (1H, s) 
- 
7.86 (1H, s) 
- 
5' 7.25 (1H, s) 7.21 (1H, s) 
6' - - 
7' 
8' 
- 
6.96 (1H, s) 
- 
6.87 (1H, s) 
8a' - - 
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Compound isolated from the plant Thymelaea lythroides 
Rutarensin (7, Known) 
Rutarensin 
Synonym(s) 
 
 
CAS Registry Number 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
Optical rotation [α]D
26 
UV spectrum λmax 
6'-ester with 7-(β-D-glucopyranosyloxy)-6-
methoxy-3-[(2-oxo-2H-1-benzopyran-7-
yl)oxy]-2H-1-benzopyran-2-one; Rutarensin 
119179-04-3 
Thymelaea lythroides 
5.7 mg 
yellow needle crystal 
C31H20O16 
658 g/mol 
21.51 min (standard gradient) 
- 2.0 (c 0.017, DMSO)  
201.2, 338.8 and 370 nm 
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7 was isolated from Thymelaea lythroides extracted with EtOAc. The EtOAc extract was 
portioned between n-hexane and 90% MeOH. The 90% MeOH fraction was chromatographed 
over silica gel F254 using gradient elution (n-hexane/EtOAc/CH2Cl2/MeOH). The fraction 
was subjected to a sephadex LH-20 column using CH2Cl2/MeOH (1:1) as eluent system, then 
purified by semi-preparative HPLC (Merck, Hitachi L-7100) using an Eurosphere 100–10 
C18 column (300 x 8mm, L x i.d.) with the following gradient (MeOH/H2O): 0 min, 10% 
MeOH; 5 min, 10% MeOH; 35 min 100% MeOH; 45 min, 100 % MeOH, which afforded 
colorless powder (yield, 19 mg). It showed UV absorbance at λmax (MeOH) 201.2, 338.8 and 
370 nm. Positive and negative ESI-MS of 7 exhibited a prominent peak at m/z 658.9 [M+H]+ 
(base peak) and m/z 657.1 [M-H]- (base peak) indicating a molecular weight of 658 g/mol. 
The prominent fragment ion peak of 352 (m/z 353.2 [M+H]+ and 351.2 [M-H]-) in EI-MS 
suggested the presence of a daphnoretin in the molecule. The molecular formula of compound 
7 was determined to be C31H20O16 based on the analysis of the molecular weight and 
13C 
NMR data.  
 
From the 1H NMR of 7 (Table 4.11) a daphnoretin system and hexopyranose was suggested 
with the presence of unassigned signals: two methylene (δH 2.62 ppm), (δH 2.72 ppm) and one 
methyl group (δH 1.33 ppm). Thus, the glucose moiety is bound at CO-1" (δC 102.0 ppm) to 
daphnoretin. A daphnoretin-7-ß-D-glucoside is already known as daphnorin (Tschesche et al., 
1963) (Figure 3.11).  
 
 The 13C NMR spectrum of 7 showed all signals of daphnorin, whereas the signal for C-6'' of 
glucose was found to be at lower field than expected (+ 3 ppm) and the signal for C-5'' of 
glucose was shifted upfield (- 3 ppm), indicating that an acylation must be present at position 
C-6'' of glucose. Further possibilities of acylation at C-2'', C-3'', and C-4'' of glucose were 
excluded by comparison with data given in literature (Kashiwada et al., 1986; Adegawa et al., 
1986). 
 
 
 
 
 
Figure 4.11. Structure of Daphnorin (R= H) 
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Table 4.11. Comparison of 1H and 13C NMR chemical shifts of 7 with Rutarensin 
N° 7 Rutarensin 
δH δC δH δC 
1 - - - - 
2 - 161.3 - 159.6 
3 - 139.3 - 137.3 
4 
4a 
7.74 (1H, s) 
- 
131.3 
114.5 
7.87 (1H, s) 
- 
130.1 
112.4 
5  7.22 (1H, s) 110.8 7.28 (1H, s) 109.8 
6 
6-OCH3 
- 
3.90 (3H, s) 
148.4 
57.2 
- 
3.80 (3H, s) 
146.5 
56.1 
7 - 150.8 - 149.0 
8 
8a 
7.20 (1H, s) 
- 
105.5 
148.8 
7.23 (1H, s) 
- 
103.1 
146.9 
1' - - - - 
2' - 162.8 - 160.1 
3' 6.32 (1H, d, J= 9.54 Hz) 116.4 6.39 (1H, d, J= 9.8 Hz) 114.1 
4' 
4a' 
7.91 (1H, d, J= 9.6 Hz) 
- 
145.4 
114.5 
8.05 (1H, d, J= 9.8 Hz) 
- 
144.2 
114.7 
5' 7.61 (1H, d, J= 8.52 Hz) 131.0 7.72 (1H, d, J= 8.7 Hz) 129.9 
6' 7.07 (1H, dd, J= 2.4 Hz) 115.2 7.15 (1H, dd, J= 8.7; 2.5 Hz) 113.8 
7' - 159.2 - 156.9 
8' 
8a' 
1'' 
2'' 
3'' 
4'' 
5'' 
6'' 
 
1''' 
2'''a 
2'''b 
3''' 
3'''-CH3 
4'''a 
4'''b 
5''' 
7.04 (1H, d, J=2.34 Hz) 
- 
5.05 (1H, d, J= 7.62 Hz) 
3.56 (1H, m) 
3.51 (1H, m) 
3.51 (1H, m) 
3.76 (1H, m) 
4.51 (1H, dd, J=2.1, 11.82 Hz) 
4.20 (1H, dd, J=7.32, 11.94 Hz) 
- 
2.61 (2H, s) 
 
- 
1.32 (3H, s) 
2.75 (2H, m) 
2.75 (2H, m) 
- 
105.8 
156.8 
102.0 
74.8 
77.9 
71.8 
75.8 
64.7 
64.7 
172.6 
45.9 
45.9 
70.9 
27.9 
46.4 
46.4 
177.7 
7.26 (1H, d, J= 2.5 Hz) 
- 
5.16 (1H, d, J= 6.9 Hz) 
3.10-3.50 (1H, m) 
3.10-3.50 (1H, m) 
3.10-3.50 (1H, m) 
3.75 (1H, m) 
4.25 (1H, dd, J= 11.5; 2.0 Hz) 
4.03 (1H, dd, J= 11.5; 6.5 Hz) 
- 
1.93 (1H, AB syst. J= 15.3 Hz) 
2.20 (1H, AB syst. J= 15.3 Hz) 
- 
1.06 (1H, s) 
2.30 (1H, AB syst. J= 13.4 Hz) 
2.38 (1H, AB syst. J= 13.4 Hz) 
- 
104.6 
155.2 
99.6 
73.0 
76.5 
69.6 
73.9 
62.8 
62.8 
170.8 
47.0 
47.0 
68.8 
28.3 
47.0 
47.0 
176.0 
 
Moreover, the 13C NMR spectrum of 7 showed six further signals, which were characterized 
by DEPT-experiments as two carbonyl-carbons (δC 172.6 and 177.7 ppm) one quaternary 
carbon (δC 70.9 ppm), two methylene-carbons (δC 45.9 and 46.4 ppm) and one methyl group 
(δC 27.9 ppm). These data indicated that the glucose moieties is connected to a partial 
structure A at CO-6''.  
 
The COSY NMR spectrum showed the same correlations as Daphnoretin and those of 
glucose. 13C-1H long range couplings of 2J and 3J observed in a 13C-1H heteronuclear multiple 
bond coherence (HMBC) spectrum gave the same linkages as Daphnoretin as well as those of 
the glucose. Furthermore, the partial structure A showed the selected following linkages 
(Figure 4.12): From H-2''' to C-1''', C-3''', C-4''' and 3'''-CH3; from H-4''' to C-2''', C-3''', 3'''-
CH3 and C-5''' and from the protons of 3'''-CH3 to C-3''', C-2''' and C-4'''. From these results, it 
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was concluded that the substituent at C-6" of the glucose was 3-hydroxy-3-methylglutaric 
acid. 
 
 
 
 
Figure 4.12. Selected correlations of partial structure A 
 
The identification was further corroborated by comparison of UV, 1H, 13C NMR, mass 
spectral data as well as [α]D value of 7 with those published for rutarensin (Fischer et al., 
1988). 
 
Rutarensin was described for the first time as a constituent of cell cultures of Ruta chalepensis 
L. (Rutaceae), then from of Edgeworthia chrysantha (Thymelaeacea). Further acylglycosides 
esterified at C-6 of glucose with 3-hydroxy-3-methylglutaric acid are palustroside from 
Ledurn palustre L., the tubeimosides from Bolbostemma puniculatum, one pyridoxin 
glucoside from Pisum satioum L. and the betacyanin glucosides from Phyllocactus hybridus, 
Celosia cristata and Iresine herbstii (Centrospermae). (Kreher et al., 1990). This is the first 
report of Rutarensin from Thymelaea lythroides. 
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Compound isolated from the plant Thymelaea lythroides 
trans-Tiliroside (8, Known) 
trans-Tiliroside 
Synonym(s) 
 
CAS Registry Number 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
Optical rotation [α]D
26 
UV spectrum λmax 
Kaempferol-3-O-β-D-(6''-O-(E)-p-
coumaroyl)glucopyranoside; trans-Tiliroside 
20316-62-5 
Thymelaea lythroides 
20 mg 
yellowish powder  
C30H26O13 
594 g/mol 
24.0 min (standard gradient) 
- 65 (C 1.0, CHCl3)  
267.0 and 315.0 nm 
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8 was isolated from Thymelaea lythroides extracted with EtOAc. The EtOAc extract was 
portioned between n-hexane and 90% MeOH. The 90% MeOH fraction was chromatographed 
over silica gel F254 using gradient elution (n-hexane/EtOAc/CH2Cl2/MeOH). The fraction 
was directly purified by semi-preparative HPLC (Merck, Hitachi L-7100) using an 
Eurosphere 100–10 C18 column (300 x 8mm, L x i.d.) with the following gradient 
(MeOH/H2O): 0 min, 10% MeOH; 5 min, 10% MeOH; 35 min 100% MeOH; 45 min, 100 % 
MeOH, which afforded colorless powder (yield, 19 mg). It showed UV absorbance at λmax 
(MeOH) 267.0 and 315.0 nm. Positive and negative ESI-MS of 8 exhibited a prominent peak 
at m/z 695.0 [M+H]+ (base peak) and m/z 695.3 [M-H]- (base peak) indicating a molecular 
weight of 694 g/mol. The molecular formula of compound 8 was determined to be C30H26O13 
based on the analysis of the molecular weight and 13C NMR data.  
 
The 1H NMR of 7 (Table 4.12) displayed 26 proton signals, a kaempferol and hexopyranose 
was suggested with the presence of coumarin acid. The 13C NMR of 7 showed the presence of 
30 signals carbons (Table 4.12). 
 
The 1H-1H COSY (Figure 4.13.A) spectra showed 6 spin systems, H(2'')H(3''), H(5'')H(6''), 
H(2''')H(3'''), H(5''')H(6'''), H(7''')H(8''') and a continuous spin system H(1'')→(6''). 
 
The 1H-13C HMBC exhibited the selected following linkage: from H-8 to C-4 and C-9, from 
H-7-OH to C-7, C-6 and C-8, from H-4'-OH to C-4', C-5' and C-3', from H-2' to C-1' and C-1, 
from H-6' to C-1' and C-1, from H-4'''-OH to C-4''', C-3''' and C-5'', from H-7''' to C-1''', C-2''' 
and C-6''', from H-8''' to C-1''' and from H-6'' to C-9''' as shown in Figure 4.13. B. 
 
 
 
 
 
 
 
 
 
Figure 4.13. A) 1H-1H COSY correlations. B) Selected 1H-13C HMBC correlation of 8 
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The identification was further corroborated by comparison of UV, 1H, 13C NMR, mass 
spectral data as well as [α]D value of 7 with those published for trans-Tiliroside 
(Budzianowski et al., 1995). 
 
trans-Tiliroside or kaempferol-3-O-β-D-(6’’-E-p-coumaroyl)-glucopyranoside is an acylated 
glucoside of kaempferol, first isolated from Rosa canina and Tilia argentea and then from 
several Tiliaceae (Budzianowski et al., 1995), later from Daphne genkwa (Song et al., 2009), 
and from Edgeworthia gardneri (Xu et al., 2012) of the Thymeleaceae family. This is the first 
report of trans-Tiliroside from Thymelaea lythroides. 
 
Table 4.12. Comparison of 1H and 13C NMR chemical shifts of 8 with trans-Tiliroside 
N° 8 trans-Tiliroside 
δH δC δH δC 
1 - - - - 
2 - 156.4  156.4 
3 - 133.0 - 133.0 
4 - 177.3 - 177.3 
5 - 161.1 - 161.1 
5-OH 
6 
12.57 (1H, s) 
6.15 (1H, d, J= 2.06 Hz) 
- 
98.7 
12.60 (1H, s) 
6.18 (1H, d, J= 2.1 Hz) 
- 
98.7 
7 - 164.1 - 164.1 
7-OH 
8 
10.83 (1H, s) 
6.39 (1H, d, J= 2.06 Hz) 
- 
93.6 
10.87 (1H, s) 
6.41 (1H, d, J= 2.1 Hz) 
- 
93.6 
9 - 156.3 - 156.3 
10 - 103.8 - 103.8 
1' - 120.7 - 120.7 
2' 
3' 
7.98 (1H, d, J= 8.8 Hz) 
6.86 (1H, d, J= 8.8 Hz) 
130.1 
115.7 
8.02 (1H, d, J= 8.9 Hz) 
6.88 (1H, d, J= 8.9 Hz) 
130.0 
115.7 
4' - 159.9 - 159.9 
4'-OH 10.14 (1H, s) - 10.18 (1H, s) - 
5' 6.86 (1H, d, J= 8.8 Hz) 115.7 6.88 (1H, d, J= 8.9 Hz) 115.7 
6' 
1'' 
2'' 
2''-OH 
3'' 
3''-OH 
4'' 
4''-OH 
5'' 
6''a 
6''b 
1''' 
2''' 
3''' 
4''' 
4'''-OH 
5''' 
6''' 
7''' 
8''' 
9''' 
7.98 (1H, d, J= 8.8 Hz) 
5.45 (1H, d, J= 7.5 Hz) 
3.25 (1H, m) 
5.16 (1H, s) 
3.25 (1H, m) 
5.21 (1H, s) 
3.25 (1H, m) 
5.43 (1H, s) 
3.25 (1H, m) 
4.31 (1H, dd, J= 2.2, 11.9 Hz) 
4.03 (1H, dd, J= 6.4, 11.8 Hz) 
- 
7.37 (1H, d, J= 8.5 Hz) 
6.81 (1H, d, J= 8.6 Hz) 
- 
10.00 (1H, s) 
6.81 (1H, d, J= 8.6 Hz) 
7.37 (1H, d, J= 8.5 Hz) 
7.33 (1H, d, J= 15 Hz) 
6.11 (1H, d, J= 15 Hz) 
- 
130.1 
100.9 
74.2 
 
76.2 
 
69.9 
 
74.1 
62.9 
 
124.9 
130.7 
115.0 
159.7 
- 
115.0 
130.7 
144.5 
113.6 
166.1 
8.02 (1H, d, J= 8.9 Hz) 
5.48 (1H, d, J= 7.5 Hz) 
3.20-3.35 (1H, m) 
5.23 (1H, s) 
3.20-3.35 (1H, m) 
5.27 (1H, s) 
3.20-3.35 (1H, m) 
5.50 (1H, s) 
3.20-3.35 (1H, m) 
4.30 (1H, dd, J= 2, 11.7 Hz) 
4.06 (1H, dd, J= 6.3, 11.7 Hz) 
- 
7.39 (1H, d, J= 8.8 Hz) 
6.81 (1H, d, J= 8.8 Hz) 
- 
10.06 (1H, s) 
6.81 (1H, d, J= 8.8 Hz) 
7.39 (1H, d, J= 8.8 Hz) 
7.37 (1H, d, J= 16 Hz) 
6.14 (1H, d, J= 16 Hz) 
- 
130.1 
100.9 
74.2 
 
76.2 
 
69.9 
 
74.0 
62.9 
 
124.8 
130.7 
115.0 
159.7 
- 
115.0 
130.7 
144.5 
113.6 
166.1 
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4.3. Bioactivity test results for compounds isolated from the plant Thymelaea lythroides 
The isolated compounds were subjected to cytotoxicity and protein kinase bioassays. Some of 
the isolated pure compounds were also subjected to Hsp 90 inhibitor assays. The results are 
shown in Tables 4.13 and Table 4.14. 
 
Table 4.13. Cytotoxicity test results for the compounds isolated from Thymelaea lythroides  
Nr.  Compounds tested L5178Y growth 
in %* 
(Conc. 10 µg/mL) 
- Control 0 
3 (+)-Dapheolone 83.3 
4 (-)-Wikstromol 7.6 
5 δ-Sesamin 26.7 
6 Daphnoretin -10.7 
7 Rutarensin 6 
8 trans-Tiliroside 28.7 
   
*Data provided by Prof. W. E. G. Müller, Mainz 
The coumarin (+)-Daphneolone showed moderate activity against L5178Y cell line, while no 
activity was detected for the other compounds. 
 
Table 4.14. Protein kinase assay results for the compounds isolated from Thymelaea 
lythroides 
Compound tested 
(Conc. 1µg/mL) 
Activity on various protein kinases based on IC50 [g/mL]* 
A
K
T
1 
A
L
K
 
A
R
K
 5
 
A
ur
or
a-
B
 
A
X
L
 
F
A
K
 
IG
F
 1
-R
 
M
E
K
 1
 w
t 
M
E
T
 w
t 
N
E
K
 2
 
N
E
K
 6
 
P
IM
 1
 
P
L
K
 1
 
P
R
K
 1
 
S
R
C
 
V
E
G
F
-R
2 
Bassiatin  0 0 0 M 0 M M 0 0 0 0 0 0 0 0 M 
(+)-Dapheolone 0 0 0 M 0 0 0 0 0 0 0 0 0 0 0 0 
(-)-Wikstromol 0 0 0 M 0 M M 0 0 0 0 0 0 0 0 0 
δ-Sesamin 0 0 0 M 0 M M 0 0 0 0 0 0 0 0 0 
Daphnoretin 0 0 0 M 0 M M 0 0 0 0 0 0 0 0 M 
Rutarensin 0 0 0 A M M A 0 0 M M 0 0 0 0 A 
tran-Tiliroside 0 A 0 A M M M 0 M M 0 S 0 0 0 A 
          * Data provided by ProQinase, Freiburg. 
S: strongly active, A: active, M: moderately active, 0: not active  
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The isolated compounds of Thymelaea lythroides were subjected to biochemical protein 
kinase activity assays using 16 different human protein kinases. Only compounds Tiliroside 
and Rutarensin inhibited several of the tested kinases.  
 
The IC50 values observed for both compounds were in the low micromolar range against some 
protein kinases which inhibition is known to confer antitumoral effects. 
 
The Hsp 90 chaperone showed no activity for all compounds isolated from Thymelaea 
lythroides. 
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4.4. Compounds isolated from the endophytic fungus Chaetomium aureum 
Five endophytic fungi were isolated from the Moroccan medicinal plant Thymelaea 
lythroides, namely Alternaria sp., Chaetomium aureus, Epicoccum nigrum, Cladosporium sp. 
and Pleospora sp.  Comparison of the HPLC chromatograms of the EtOAc extracts of all pure 
strain cultures and the preliminary biological screening assays, i.e. antibacterial, antifungal, 
and cytotoxicity showed that Chaetomium aureum is the most stable and active strain (Table 
4.15). 
 
The fungal strain of Chaetomium aureum (EMBL accession number HF546136) (Kabbaj et 
al., 2012) was identified based on analysis of the DNA sequences of internal transcribed 
spacer regions of its ribosomal RNA gene. A voucher strain (strain designation MM10S2-1) is 
kept in the Institute of Pharmaceutical Biology and Biotechnology, Düsseldorf, Germany.  
 
 
 
 
 
   
 
 
 
Figure 4.14. Photos of Chaetomium aureum  
 
The pure fungal strain was cultivated on 11 media medium. Interestingly, chemical screening 
studies indicated a clear difference between C. aureum extracts obtained from liquid 
Wickerham medium, rice media culture, pulses media cultures and legumes media cultures. 
Comparison of the HPLC chromatograms of the EtOAc extracts of all cultures showed a 
different chemical pattern. While the rice culture extract showed (+)-sclerotiorin (9) as major 
substance, two unstable main components were detected in liquid cultures, with no traces of 
(+)-sclerotiorin (Figure 4.15). From the 10 others media, pulses media cultures showed the 
presence of the same two major compounds as in liquid cultures with the presence of (+)-
sclerotiorin as minor compound, in legumes media steroids have been detected as major 
compounds.  
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In this part the investigation results on the natural products produced by Chaetomium aureum 
when grown on solid rice medium are presented. 
 
Table 4.15. Preliminary biological screening assays of the five pure strains 
Fungal strain L5178Y  MRSA  Strep. pneumonia  Entero. Faecalis  
Epicocom nigrum  100,3%  >62,5µg/ml  >31,25µg/ml  >62,5µg/ml  
Alternaria sp.  95,5%  >31,25µg/ml  >62,5µg/ml  >31,25µg/ml  
Cladosporium sp  25,2%  n.a n.a n.a 
Chaetomium aureum  99,7%  >62,5µg/ml  > 62,5µg/ml  >62,5µg/ml  
Pleospora sp.  101,3%  n.a >125µg/ml  n.a 
 
  A- Solid rice media    B- liquid Wickerham medium 
 
 
 
 
 
 
 
C- Ten solid media cultures  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15. Comparison of the 11 media cultures of Chaetomium aureum. A- Solid rice 
media. B- liquid Wickerham medium. C- Ten solid media cultures 
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Compound isolated from the endophytic fungus Chaetomium aureum 
(+)-Sclerotiorin (9, Known) 
(+)-Sclerotiorin 
Synonym(s) 
 
 
CAS Registry Number 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
Optical rotation [α]D
26 
UV spectrum λmax 
6H-2-Benzopyran-6,8(7H)-dione, 5-chloro-3-
(3,5-dimethyl-1,3-heptadienyl)-7-hydroxy-7-
methyl-, acetate (8CI) 
549-23-5 
Chaetomium aureum 
105 mg 
yellow crystals 
C21H23ClO5 
390 g/mol 
32,01 min (standard gradient) 
+515 (c 1.0, CHCl3) 
220, 288 and 370 nm 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
???????????????????????????????????????????????? ????????
????????
???????
???????
???????
???????
???????
???????
???????
???????
???????
???????
???????
???????
???????
???????
???????
????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
 
[M+H]+  [M-H]- 
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9 was isolated from Chaetomium aureum grown at room temperature for 30 days in Fernbach 
flasks on solid rice medium. The EtOAc extract was portioned between n-hexane and 90% 
MeOH. The MeOH fraction was chromatographed over a successive Sephadex LH-20 column 
using CH2Cl2/MeOH (1:1) as eluent (repeated twice) then purified by silica gel F254 (Merck, 
Darmstadt, Germany) using gradient elution (n-hexane/EtOAc/CH2Cl2/MeOH), which 
afforded yellow needles (yield, 105 mg). It showed UV absorbance at λmax (MeOH) 220, 288 
and 370 nm. Positive and negative ESI-MS showed molecular ion peaks at m/z 391, [M+H]+ 
(base peak) and m/z 389, [M-H]- (base peak), respectively, indicating a molecular weight of 
390 g/mol.  
 
The 1H NMR (Table 4.16) showed five methyl group, which appeared at (δH 0.89, 1.03, 1.55, 
1.92 and 2.11 ppm), assigned to 6'-CH3, 5'-CH3, 7-CH3, 3'-CH3, and 7''-CH3 respectively; one 
methylene group, which appeared as AB spin system at (δH 1.36 and 1.47 ppm), assigned to 
6'- CH2; and six methine proton at (δH 2.57, 5.80, 6.53, 6.88, 7.18 and 8.16 ppm), assigned to 
5'-CH, 4'-CH, 1'-CH, 4-CH, 2'-CH and 1-CH.  
 
The 13C NMR showed the presence of 21 resolved signals, which were assigned to five 
methyl carbons, one methylene carbon, six sp2 methine carbons, four sp2 quaternary carbons, 
three oxygenated sp2 quaternary carbons and three carbonyl carbons.  
 
Analyses of 1H-1H NMR COSY revealed the presence of two spin systems, as showed in 
Figure 4.16.A.  
 
Furthermore, 13C-1H long range couplings of 2J and 3J observed in the 13C-1H heteronuclear 
multiple bond coherence (HMBC) spectrum gave the following linkages  (Figure 4.16.B): 
from H-1 (δH 8.14 ppm) to C-3 (δH 159 ppm), C-4a (δH 139.8 ppm), C-8 (δH 192 ppm) and C-
8a (δH 115.5 ppm); from H-4 to C-3, C-1' (δH 117 ppm), C-4a, and C-5 (δC 110 ppm); from 
H3-7-CH3 (δC 1.52 ppm) to C-7 (δC 85.4 ppm), C-6 (δC 186,2 ppm) and C-8; from H3-7''-CH3 
to C-7'' (δC 170,1 ppm); from H-1' (δC 6.50 ppm) to C-2' (δC 142.8 ppm), C-3' (δC 133.5 ppm), 
C-3 and C-4 (δC 106.7 ppm); from H-2' (δH 7.16 ppm) to C- 1', C-3', C-4' (δC 148.3 ppm), C-
3'-CH3 (δC 12.1 ppm) and C-3; from H3-3'-CH3 (δH 1.90 ppm) to C-2', C-4' and C-3'; from H-
4' (δH 5.77 ppm) to C-2', C-3'-CH3, C-5' (δC 35.4 ppm) and C-6' (δC 30.4 ppm); from H3-5'-
CH3 (δH 1.01) to C-6', C-5' and C-4'; from H2-6' (δH 1.33, 1.44) to C-4', C-5', C-5'-CH3 (δC 
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1H-1H COSY correlation
13C-1H HMBC correlations
13C-1H HMBC correlations (J4)
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A  B 
20.1 ppm) and C-6'-CH3 (δC 11.82 ppm) and from H3-6'-CH3 (δH 0.86 ppm) to C-5', C-5'-CH3 
and C-6'. The connection of the acetyl group was confirmed by the chemical shift of C-7'' (δC 
170,1 ppm) assigned to an ester bond and the long-rang coupling of J4 observed from H3-7''-
CH3 to C-7 in 
13C-1H NMR spectrum (Figure 4.16.B). Furthermore, the chemical shift of C-1 
(δC 154.1 ppm) and C-3 (δC 159.6 ppm) indicated the presence of an oxygenated carbon 
between both carbons and the correlation between the H-1 and the C-3 confirms ring closure. 
Thus, these data indicated that 9 was found to be 6H-2-Benzopyran-6,8(7H)-dione-5-chloro-
3-(3,5-dimethyl-1,3-heptadienyl)-7-hydroxy-7-methyl-, acetate (8CI). On the basis of the 
coupling constants of H-1' with H-2' and the chemical shift of the neighbor carbon of C-5', the 
configurations of these two double bonds were both determined to be E. 
 
The identification was further corroborated by comparison of UV, 1H, 13C NMR, mass 
spectral data as well as [α]D value of 9 with those data previously published for (+)-
sclerotiorin (Natsume et al., 1988). 
 
The compound was previously reported from Penicillium sclerotiorum, P. multicolor, P. 
implicatum, P. hirayamae, P. frequentans, P.faveolata, lichen mycobionts of Pyrenula 
japonica, ascommycete T. luteus and from unidentified fungus 98F134 (Gregory and Turner, 
1963; Takenaka et al., 1963; Takenaka et al., 2000; Periyasamy et al., 2012; Li et al., 2010; 
Chidananda et al., 2006). This is the first finding of this compound from Chaetomium 
aureum.  
 
 
 
 
 
 
Figure 4.16. A) 1H-1H COSY correlations of 1 B) selected 13C-1H HMBC correlations 
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Compound isolated from the endophytic fungus Chaetomium aureum 
Isochromophilone VII (10, Known) 
Isochromophilone VII 
Synonym(s) 
 
 
CAS Registry Number 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
Optical rotation [α]D
26 
UV spectrum λmax 
6,8(2H,7H)-Isoquinolinedione, 7-(acetyloxy)-
5-chloro-3-(3,5-dimethyl-1,3-heptadienyl)-7-
methyl- (9CI);  
175448-30-3 
Chaetomium aureum 
1 mg 
yellow needles 
C21H25ClO6 
408 g/mol 
32.40 min (standard gradient) 
+563 (c 1.0, MeOH) 
370.7, 370.3 and 374.2 nm 
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[M+H]+  [M-H]- 
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10 was isolated from Chaetomium aureum grown at room temperature for 30 days in 
Fernbach flasks on solid rice medium. The EtOAc extract was portioned between n-hexane 
and 90% MeOH. The MeOH fraction was chromatographed over a successive sephadex LH-
20 column using CH2Cl2/MeOH (1:1) as eluent (repeated twice), then purified by semi-
preparative HPLC (Merck, Hitachi L-7100) using a Eurosphere 100–10 C18 column (300 x 
8mm, L x i.d.) with the following gradient (MeOH/H2O): 0 min, 10% MeOH; 5 min, 10% 
MeOH; 35 min, 100% MeOH; 45 min, 100 % MeOH, which afforded yellow needles (yield, 
1 mg). It showed UV absorbance at λmax (MeOH) 370.7, 370.3 and 374.2 nm. Positive and 
negative ESI-MS showed molecular ion peaks at m/z 409.1 [M+H]+ (base peak) and m/z 
407.2 [M-H]- (base peak), respectively, indicating a molecular weight of 408 g/mol. The 
molecular formula of 10 was determined to be C21H25O6C1.  
 
The 1H NMR spectra (MeOD) (Table 4.16) showed 24 proton signals. To fulfill the molecular 
formula, the presence of one hydroxyl group was suggested.  
 
From the 1H-1H COSY spectrum, three spin system, H-4'→H-6'-CH3, between the two 
protons of Hα-1-Hβ-1 and between H-1' and H-2' were determined (Figure 4.17).  
 
 
 
 
 
 
Figure 4.17. 1H-1H COSY correlations of 10 
 
13C-1H long range couplings of 2J and 3J observed in the HMBC spectrum showed cross 
peaks from H-3'-CH3 (δH 1.82 ppm) to C-2' (δC 142.9 ppm), C-3' (δC 132.2 ppm) and C-4' (δC 
148.1 ppm), forming the 3,5-dimethyl-1,3-heptadienyl moiety containing the above two 
proton sequences. The cross peaks from H-2' (δH 7.07 ppm), H-1' (δH 6.04 ppm) and H-4 (δH 
6.18 ppm) to C-3 (δC 162.2 ppm), from H-4 to C-l' (δC 118.2 ppm) and from H-l' to C-4 
revealed the presence of an extended conjugation system. 
 
Furthermore, the cross peaks from H2-l (δH 4.02, 4.74 ppm) to C-3, C-4a (δC 142.8 ppm) and 
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C-8a (δC 67.9 ppm), and from H-4 to C-3 and C-8a, and 
13C shifts of C-l (δC 70.0 ppm) and C-
3 revealed a pyran ring. The HMBC NMR showed correlations from H-7''-CH3 (δC 2.12 ppm) 
to C-7" (δC 169.7 ppm). The presence of another 6-membered ring was suggested because of 
the cross peaks from C-7-CH3 (δC 1.83 ppm) to C-6 (δC 185.4 ppm), C-7 (δC 83.4 ppm) and 
C-8. (δC 197.1 ppm), from H-l to C-8, and from H-4 to C-5 (δC 121.0 ppm) in the HMBC 
spectrum and the degree of unsaturation. The UV-spectrum also revealed that the structure 
contained a continous conjugated ketone. Finally the remaining hydroxyl group, acetyl group 
and Cl should be attached to C-8a, C-7 and C-5, respectively, due to the 13C chemical shifts. 
Taken together, the structure was comparable with previously published data for 
isochromophilone VII isolated from Penicillium sp. FO-4164 (Yang et al., 1995). 
 
Isochromophilone VII was isolated only from Penicillium sp. FO-4164 (Yang et al., 1995), 
this is the first report of Isochromophilone VII from Chaetomiun aureum. 
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Compound isolated from the endophytic fungus Chaetomium aureum 
Sclerotioramin (11, Known) 
Sclerotioramin 
Synonym(s) 
 
 
CAS Registry Number 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
Optical rotation [α]D
26 
UV spectrum λmax 
1H-2-Benzopyran-6,8(7H,8aH)-dione, 7-
(acetyloxy)-5-chloro-3-(3,5-dimethyl-1,3-
heptadienyl)-8a-hydroxy-7-methyl- (9CI) 
34695-81-3 
Chaetomium aureum 
7 mg 
red needles  
C21H24ClNO4 
389 g/mol 
30.35 min (standard gradient) 
+505 (c 1.0, MeOH) 
203.2, 352.1 and 370.6 nm 
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11 was isolated from Chaetomium aureum grown at room temperature for 30 days in 
Fernbach flasks on solid rice medium. The EtOAc extract was portioned between n-hexane 
and 90% MeOH. The MeOH fraction was chromatographed over a successive Sephadex LH-
20 column using CH2Cl2/MeOH (1:1) as eluent (repeated three times) then purified by semi-
preparative HPLC (Merck, Hitachi L-7100) using a Eurosphere 100–10 C18 column (300 x 
8mm, L x i.d.) with the following gradient (MeOH/H2O): 0 min, 10% MeOH; 5 min, 10% 
MeOH; 35 min, 100% MeOH; 45 min, 100 % MeOH, which afforded red needles (yield, 7 
mg). It showed UV absorbance at λmax (MeOH) 203.2, 352.1 and 370.6 nm. Positive and 
negative ESI-MS showed molecular ion peaks at m/z 390.4 [M+H]+ (base peak) and m/z 
388.3 [M-H]- (base peak), respectively, indicating a molecular weight of 389 g/mol. The 
molecular formula of 11 was assigned as C21H24ClNO4. To achieve the molecular formula, 
the presence of one secondary amine group was suggested.  
 
The 1H NMR spectra (MeOD) (Table 4.16) showed 23 protons signals, which were almost 
identical to sclerotiorin except the chemical shift of 2 signals at (δH 8.03 ppm) and (δH 7.10 
ppm), assigned to H-1 and H-4. In the 13C NMR showed the presence of 21 resolved signals, 
which were almost the same as sclerotiorin except the chemical shift of 3 signals at (δC 139.6 
ppm), (δC 144.9 ppm) and (δC 112.5 ppm), assigned to C-1, C-3 and C-4.  
 
The 2D NMR, 1H-1H NMR COSY and 13C-1H NMR HMBC showed the same correlation as 
sclerotiorin. The 15N-1H NMR HMBC showed the cross peaks from one nitrogen signal, N 
(δN -351.7 ppm) to H-1 (δH 8.03 ppm), H-4 (δH 7.10 ppm) and H-1' (δH 6.40 pmm). Thus, 
these data indicated the presence of nitrogen in the position 2.  
 
The identification was further corroborated by comparison of UV, 1H, 13C NMR, mass 
spectral data as well as [α]D value of 11 with the data previously published for (+)-
sclerotioramin (Wang et al., 2010).  
 
Sclerotioramin is a natural product, which has been isolated, together with sclerotiorin, from 
the mycelium of P. multicolour and P. sclerotiorum grown under special conditions (Page et 
al., 1957). The compound was previously also reported from P. citreonigrum (Wang et al., 
2010) from Diaporthe sp (Zang et al., 2012), from Penicillium implicatum (Yuzuru et al., 
1959). But this is the first report of this compound from Chaetomium aureum. 
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[M-H+OAc]- 
Compound isolated from the endophytic fungus Chaetomium aureum 
Sclerotioramin (12, Known) 
Isochromphilone VI 
Synonym(s) 
 
 
 
CAS Registry Number 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
Optical rotation [α]D
26 
UV spectrum λmax 
6,8(2H,7H)-Isoquinolinedione, 7-(acetyloxy)-
5-chloro-3-[(1E,3E,5S)-3,5-dimethyl-1,3-
heptadienyl]-2-(2-hydroxyethyl)-7-methyl-, 
(7R)- (9CI) 
167173-91-3 
Chaetomium aureum 
5 mg 
red needles  
C23H28ClNO5 
433 g/mol 
28.2 min (standard gradient) 
+489 (c 1.0, MeOH) 
 236.9, 306.9 and 371.0 nm 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
??????????????????????????????????????????????????? ????????
????????
????????
????????
????????
????????
????????
????????
????????
????????
????????
????????
????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
 
[M+H]+ 
  Results 
  112 
 
N
Cl
O
O
O 1
3
4
4a
5
6
7
8
8a
1'
2'
3'
4'
5'
6'
O
7''
OH
9
10
N
Cl
O
O
O 1
3
4
4a
5
6
7
8
8a
1'
2'
3'
4'
5'
6'
O
7''
OH
9
10
12 was isolated from Chaetomium aureum grown at room temperature for 30 days in 
Fernbach flasks on solid rice medium. The EtOAc extract was portioned between n-hexane 
and 90% MeOH. The MeOH fraction was chromatographed over a successive sephadex LH-
20 column using CH2Cl2/MeOH (1:1) as eluent (repeated twice) then purified by semi-
preparative HPLC (Merck, Hitachi L-7100) using a Eurosphere 100–10 C18 column (300 x 
8mm, L x i.d.) with the following gradient (MeOH/H2O): 0 min, 10% MeOH; 5 min, 10% 
MeOH; 35 min, 100% MeOH; 45 min, 100 % MeOH, which afforded red needles (yield, 5 
mg). It showed UV absorbance at λmax (MeOH) 236.9, 306.9 and 371.0 nm. Positive and 
negative ESI-MS showed molecular ion peaks at m/z 434.16 [M+H]+ (base peak) and m/z 
492.22 [M-H+OAc]- (base peak), respectively, indicating a molecular weight of 433 g/mol, 
with a 44 mass unit increase compared to sclerotioramin, which established a molecular 
formula of C23H28ClNO5.  
 
The 1H NMR spectra (MeOD) (Table 4.16) showed 28 protons signals, which were almost 
identical to sclerotioramin except the presence of two more signals at (δH 3.84 ppm) and (δH 
4.23 ppm), assigned to H-9 and H-10. In the 13C NMR showed the presence of 23 resolved 
signals, which were almost the same as sclerotioramin except the presence of two more 
signals at (δC 61.1 ppm) and (δC 57.4 ppm), assigned to C-9 and C-10.  
 
From the 1H-1H COSY spectrum, three spin system, H-4'→H-6'-CH3, between the two 
protons H-9 and H-10 and between H-1' and H-2' were determined (Figure 3.18.A).  
 
 
 
 
 
 
Figure 4.18. A) 1H-1H COSY correlations B) selected 13C-1H HMBC correlations of 12 
 
The more important correlations of 13C-1H long range couplings of 2J and 3J observed in the 
HMBC spectrum are the cross peaks from H-1 (δH 8.16 ppm) to C-9 (δC 57.4 ppm) and from 
H-9 (δH 3.84 ppm) to C-1 (δC 138.0 ppm), which confirm that the proton of NH in 
sclerotioramin has been replaced by a side chain of two carbons and a hydroxyl group (CH2-
CH2-OH) (Figure 4.18.B).  
A  B 
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The identification was further corroborated by comparison of UV, 1H, 13C NMR, mass 
spectral data as well as [α]D value of 12 with the previously published data for (+)-
isochromophilone VI (Arai et al., 1995). 
 
Isochromophilone VI was previously reported from Penicillium multicolor FO-3216 (Arai et 
al., 1995), from Diaporthe sp. (Zang et al., 2012), howerver, this is the first report of this 
compound from Chaetomium aureum. 
 
Table 4.16. 1H and 13C NMR chemical shifts of sclerotion and its derivatives  
 
 
 
 
 
 
 
 
 
No. 
sclerotiorin Isochromophilone VII Sclerotioramin Isochromophilone VI 
δC δH δH δC δH δC δH 
1 154.1 8.14 (s) 3.96 (d, J= 12.46 Hz) 
4.74 (d, J= 12.47 Hz) 
139.6 8.03 (s) 138.0 8.16 (s) 
2 - - - - - - - 
3 159.5 - - 144.9 - 146.4 - 
4 106.7 6.85 (s) 6.27 (s) 112.5 7.10 (s) 112.6 7.19 (s) 
4a 139.8 - - 148.3 - 148.3 - 
5 110.2 - - 101.1 - 101.2 - 
6 186.3 - - 185.9 - 185.5 - 
7 85.5 - - 85.9 - 86.2 - 
7-CH3 22.3 1.52 (s) 1.80 (s) 23.8 1.51 (s) 23.8 1.51 (s) 
7'' 170.1 - - 171.5 - 171.5 - 
7''-CH3 19.6 2.09 (s) 2.07 (s) 20.1 2.12 (s) 20.1 2.12 (s) 
8 192.7 - - 195.0 - 195.1 - 
8a 115.2 - - 115.8 - 114.8 - 
9 - - - - - 57.4 4.23 (dd, J= 4.86; 5.46 Hz) 
10 - - - - - 61.1 3.84 (dd, J= 4.38; 5.16 Hz) 
1' 117.3 6.50 (d, J= 15.7 Hz) 6.22 (d, J= 15.53 Hz) 118.3 6.40 (d, J= 16.22 Hz) 117.2 6.57 (d, J= 15.49 Hz) 
2' 142.8 7.16 (d, J= 15.7 Hz) 7.02 (d, J=15.59 Hz) 143.4 7.16 (d, J= 16.22 Hz) 144.4 7.10 (d, J= 15.44 Hz) 
3' 133.5 - - 133.8 - 133.8 - 
3'-CH3 12.1 1.90 (s) 1.84 (d, J= 1.05 Hz) 12.5 1.91 (s) 12.6 1.92 (s) 
4' 148.3 5.77 (d, J= 9.7) 5.65 (d, J= 9.72 Hz) 148.9 5.74 (d, J= 9.74 Hz) 148.7 5.78 (d, J= 9.75 Hz) 
5' 35.4 2.54 (m) 2.54 (m) 36.2 2.55 (m) 36.2 2.53 (m) 
5'-CH3 20.1 1.01 (d, J= 6.61) 1.01 (d, J= 6.55 Hz) 20.5 1.03 (d, J= 6.68 Hz) 20.5 1.03 (d, J= 6.66 Hz) 
6' 30.4 1.33-1.44 (m) 1.33-1.44 (m) 31.1 1.34-1.48 (m) 31.1 1.37-1.47 (m) 
6'-CH3 11.8 0.86 (t, J= 7.4, 7.4 Hz) 0.87 (t, J= 7.45; 7.45 Hz) 12.3 0.89 (t, J= 7.42; 7.42 Hz) 12.3 0.90 (t, J= 7.5; 7.3 Hz) 
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Compound isolated from the endophytic fungus Chaetomium aureum 
Sclerotioramin (13, New) 
SB 236050 
Synonym(s) 
 
 
CAS Registry Number 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
Optical rotation [α]D
20 
UV spectrum λmax 
1H, 3H-Pyrano[4,3-b][1]benzopyran-9-
carboxylic acid, 4,10-dihydro-7,8-dihydroxy-
1-methoxy-3-methyl-10-oxo- 
335377-65-6 
Chaetomium aureum 
40 mg 
grau powder 
C15H14O8 
322 g/mol 
22.04 min (standard gradient) 
+35.6 (c 1.0, CHCl3)  
220.5, 316.0 and 370.0 nm 
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13 was isolated from Chaetomium aureum grown at room temperature for 30 days in 
Fernbach flasks on solid rice medium. The EtOAc extract was portioned between n-hexane 
and 90% MeOH. The MeOH fraction gave a precipitate, which was washed several times 
with methanol until obtaining grey powder (yield, 40 mg). It showed UV absorbance at λmax 
(MeOH) 220.5, 316.0 and 370.0 nm. Positive and negative ESI-MS showed molecular ion 
peaks at m/z 344.9 [M+H+Na]+ (base peak) and m/z 321.2 [M-H]- (base peak), respectively, 
indicating a molecular weight of 322 g/mol. The molecular formula of 13 was assigned as 
C21H24ClNO4.  
 
The 1H NMR (DMSO-d6) (Table 4.17) showed one methyl group at (δH 1.30 ppm) assigned to 
H-2-CH3, one methoxy group at (δH 3.28 ppm) assigned to H-4-OCH3, one methylene proton 
at (δH 2.67 ppm) and (δH 2.58 ppm) assigned to H-1, two aliphatic proton CH at (δH 4.22 
ppm) and (δH 5.36 ppm) assigned to H-2 and H-4 respectively, one aromatic proton at (δH 
6.87 ppm) assigned to H-11 and three hydroxyl group at (δH 9.47, 11.21 and 12.81 ppm) 
assigned to H-10-OH, H-9-OH and H-15-OH. The 13C NMR and DEPT NMR showed the 
presence of 21 resolved signals, which were assigned to one methyl carbon (δC 20.3 ppm) 
assigned to 2-CH3, one methylene carbon (δC 33.1 ppm) assigned to C-1, three methine 
carbons (δC 61.7, 93.8 and 102.1 ppm) assigned to C-2, C-4 and C-11 respectively, two 
carbonyl carbons (δC 172.1 and 167.5 ppm) assigned to C-6 and C-15 and seven sp
2 
quaternary carbons.  
 
The 1H-1H COSY spectra showed the presence of one spin system from H(1)→H(2)→H(2-
CH3) as shown in the Figure 4.19.A. 
 
 
 
 
 
 
Figure 4.19. A) 1H-1H COSY correlations B) selected 1H-13C HMBC correlations of 13 
 
The 1H-13C HMBC spectra (Figure 4.19.B) showed the selected following correlations: The 
cross peak from H-2-CH3 to C-2 and C-1, from H-1 to C-2, C-14 and C-5, from H-4-OCH3 to 
C-4, from H-4 to C-5 and C-6, from H-11 to C-10, C-12, C-7 and C-9, from H-9-OH to C-8 
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and C-9, from H-10-OH to C-10 and C-11, from H-15-OH to C-7, C-8 and C-15. 
 
The identification was further corroborated by comparison of UV, 1H, 13C NMR, mass 
spectral data of 13 and the previously published data for SB 236050 (Payne et al., 2002). 
 
Regarding the structure of SB 236050, which has two chiral carbon centers at C-2 and C-4, 
the relative stereochemistry was determined by REOSY NMR spectra as shown in Figure 
4.20.  
 
 
 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.20. 1H-1H ROESY correlations 
 
The H-4 correlated with H2-CH3, H-1, H-4-OCH3 and H-2 (see Figure 4.17). 
1H-1H ROESY 
spectra permitted the assignment of the cis-stereochemistry of SB 236050 to be as shown in 
Figure 4.17, which is reported for the first time. The absolute stereochemistry could not be 
confirmed yet.  
 
H-4/ H-2-CH3 
H-4/ H-1 
H-4/ H-4-O-CH3 
H-4/ H-2 
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SB 236050 was previously reported from Chaetomium funicola (Payne et al., 2002). From the 
best of our knowledge, the relative stereochemistry of SB 236050 was not previously reported 
in the literature. This is the first report of the stereochemistry of SB 236050 isolated from 
Chaetomium aureum. 
 
Table 4.17. Comparison of 1H and 13C NMR chemical shifts of 13 with SB 236050  
(Payne et al., 2002) 
N° 13 (DMSO) SB 236050 (DMSO) 
δH δC δH δC 
1 2.58 (1H, dd, J= 10.92, 17.71 Hz) 
2.67 (1H, dd, J= 3.76, 17.7 Hz) 
33.1 2.56 (1H, dd, J= 12, 15 Hz) 
2.67 (1H, dd, J= 4, 15 Hz) 
33.2 
2 4.23 (1H, m) 61.7 4.21 (1H, m) 61.9 
2-CH3 1.30 (3H, d, J= 6.23) 20.3 1.28 (1H, d, J= 6 Hz) 20.5 
3 - - - - 
4 5.36 (1H, s) 93.8 5.35 (1H, s) 99.0 
4-OCH3 3.40 (3H, s) 54.9 3.37 (1H, s) 55.0 
5 - 112.3 - 112.1 
6 - 172.1 - 172.2 
7 - 114.9 - 115.4 
8 6.87 (1H, s) 119.1 6.84 (1H, s) 119.0 
9 - 141.3 - 141.8 
9-OH 9.47 - - - 
10 - 151.8 - 152.4 
10-OH 11.21 - - - 
11 - 102.1 - 102.2 
12 - 149.9 - 150.2 
13 - - - - 
14 - 162.3 - 162.3 
15 - 167.5 - 167.8 
15-OH 12.84 - - - 
     a, b, c, d, f, x could be opposite 
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Compound isolated from the endophytic fungus Chaetomium aureum 
Xanthoradone D1 (14, New) 
Xanthoradone  D1  
Synonym(s) 
 
 
 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
Optical rotation [α]D
20 
UV spectrum λmax 
1,4-Naphthalenedione, 6-[(3R)-3,4-dihydro-
9,10-dihydroxy-7-methoxy-3-methyl-1-oxo-
1H-naphtho[2,3-c]pyran-8-yl]-1,5-dihydroxy-
2-methoxy 
Chaetomium aureum 
3 mg 
Orange-brown powder  
C26H20O10 
492 g/mol 
30.89 min (standard gradient) 
 +305 (c 1.0, CHCl3)  
202.9, 220.0 and 265.1 nm 
 
 
 or 
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14 was isolated from Chaetomium aureum grown at room temperature for 30 days in 
Fernbach flasks on solid rice medium. The EtOAc extract was portioned between n-hexane 
and 90% MeOH. The MeOH fraction was chromatographed over a successive sephadex LH-
20 column using CH2Cl2/MeOH (1:1) as eluent (repeated three times) then purified by semi-
preparative HPLC (Merck, Hitachi L-7100) using a Eurosphere 100–10 C18 column (300 x 
8mm, L x i.d.) with the following gradient (MeOH/H2O): 0 min, 10% MeOH; 5 min, 10% 
MeOH; 35 min, 100% MeOH; 45 min, 100 % MeOH, which afforded orange-brown powder 
(yield, 3 mg). It showed UV absorbance at λmax (MeOH) 202.9, 220.0 and 265.1 nm. Positive 
and negative HR-ESI-MS exhibited a prominent peak at m/z 515.09 [M+H+Na]+ (base peak) 
and m/z 491.17 [M-H]- (base peak), respectively, indicating a molecular weight of 492 g/mol, 
which established a molecular formula of C26H20O10.  
 
The 1H NMR spectrum (Table 4.18) showed the presence of one olefinic methyl group, which 
appeared as one doublet at (δH 1.57 ppm), assigned to 2-CH3; two methoxy group, which 
appeared at (δH 3.84 and 4.21 ppm), assigned to 8-OCH3 and 3'-OCH3 respectively; one 
olefinic methine group at (δH 4.79 ppm), assigned to 2-CH, one olefinic methylene group, 
which appeared as two doublet of doublet, assigned to 3-CH2 and four aromatic methine 
group, which appeared at (δH 6.68, 6.96, 7.72 and 7.74 ppm), assigned to 7'-CH, 6-CH, 7'-CH 
and 6'-CH and three hydroxyl group at (δH 9.75, 11.53 and 13.88 ppm), assigned to 10-OH, 
9’-OH and 12-OH respectively.  
 
The 13C NMR spectrum (in CDCl3) showed 26 resolved signals, which were assigned to one 
methyl carbon, one methylene carbon, four sp2 methine carbons, one oxygenated methine 
carbon, two oxygenated methyl carbons, eight sp2 quaternary carbons, six oxygenated sp2 
quaternary carbons and three carbonyl carbons.  
 
Analyses of 1H-1H NMR COSY revealed the presence of two spin systems, as shown in 
Figure 4.21, the aromatic spin system composed of H-6' and H-7' and the second spin system 
from 2-CH3 to 5-CH. Furthermore, 
13C-1H long range couplings of 2J and 3J observed in 13C-
1H heteronuclear multiple bond coherence (HMBC) spectrum gave the following linkages  
(Figure 4.22): (A) Cross peaks from H2-3 (δH 2.96 ppm) to C-14 (δC 20.4 ppm), C-2 (δC 76.2 
ppm), C-13 (δC 99.4 ppm), C-5 (δC 115.7 ppm) and C-4 (δC 133.4); from H-5 (δH 6.95 ppm) 
to C-3 (δC 34.3 ppm), C-6 (δC 140.1 ppm), C-7 (δC 97.7 ppm), C-11 (δC 107.8 ppm), C-13 and 
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C-12 (δC 162.7 ppm); from H-7 (δH 6.66 ppm) to C-5, C-8 (δC 159.9 ppm), C-9 (δC 109.6 
ppm), C-11; from H3-14 (δH 1.56 ppm) to C-2 and C-3; from H3-15 (δH 3.86 ppm) to C-8; 
from OH-10 (δH 9.74 ppm) to C-9, C-11 and C-10 (δC 155.0 ppm) and from OH-12 (δH 13.85 
ppm) to C-11, C-12 and C-13. Furthermore, the chemical shift of C-2 (δC 76.2 ppm) indicated 
the presence of an oxygenated carbon and that the OH-12 (δH 13.85 ppm) is shifted to a lower 
field explains the presence of an ester bond between C-2 and C-13. This connection was 
confirmed by the chemical shift of C-1 (δC 171.3 ppm), which is typical for an ester group. 
Thus, these data indicated that 14 was found to have a dihydronaphthopyranone skeleton.  
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Figure 4.21. 1H-1H NMR COSY 
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Figure 4.22. Selected 13C-1H HMBC correlations 
 
(B) Cross peaks from H-6' (δH 7.71 ppm) to C-4' (δC 180.0 ppm), C-5' (δC 129.9 ppm), C- 7' 
(δC 139.8 ppm) and C-10' (δC 111.8 ppm); from H-7' (δH 7.58 ppm) to C-6' (δC 119.4 ppm), 
C-8' (δC 130.6 ppm), C-9' (δC 158.9 ppm) and C-9; from OH-9' (δH 11.51 ppm) to C-8', C-9' 
and C-10'; from H3-11' (δH 4.19 ppm) to C-3' (δC 141.0 ppm). Therewith, the chemical shifts 
of C-1' (δC 185.0 ppm) and C-4' (δC 180.0 ppm) indicated the presence of two carbonyl 
carbons derived from quinone skeleton and the UV absorption at 165.1 nm confirmed the 
proposed structure. Thus, these data confirmed that 14 has another dihydronaphthoquinone 
skeleton. 
 
The connection between the two dihydronaphthopyranone and dihydronaphthoquinone 
substructures was established by the presence of the correlation between H-7' and C-9, 
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between OH-10 and C-9 and between H-7' and C-8' confirming that they are connected at C-
9-C-8'. The structure of 14 was elucidated as shown in Figure 3.20. The structure satisfied the 
degree of unsaturation and the molecular formula. Finally, 14 was identified as a new natural 
product for which the name xanthoradone D1 was given. 
 
Regarding the stereochemistry of xanthoradone D1, which has one chiral carbon center at C-2, 
the structure was suggested as shown as in Figure 4.23 by TDDFT ECD calculations of their 
solution conformers. 
 
 
 
 
 
 
Figure 4.23. The structure of xanthorathode D1 
 
The comparison of the 1H NMR spectra of 14 and xanthoradone A (Yamazaki et al., 2009) 
(Table 4.15) showed a close relation-ship between both compounds except for the presence of 
an additional methyl group at (δH 2.21 ppm) and the absence of a hydroxyl group in 
xanthoradone A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Results 
  123 
 
Peak #8 100% at 30.90 min
-10,0
70,0
200 250 300 350 400 450 500 550 595
%
nm
265.1
220.0202.9
No spectra library hits found!
O
O
OH OH
O
OH
O
O
O
1
2
3
4
5
6
7
8
9
10
11
12
13
8'
7'
6'
5'
4'
3'
2'
1'
10'
9'
HO
14
15
11'
H
O
O
OH OH
O
OH
O
O
O
1
2
3
4
5
6
7
8
9
10
11
12
13
8'
7'
6'
5'
4'
3'
2'
1'
10'
9'
HO
14
15
11'
H
Compound isolated from the endophytic fungus Chaetomium aureum 
Xanthoradone D2 (15, New) (Mixture with its atropisomers xanthoradone D1) 
Xanthoradone  D2  
Synonym(s) 
 
 
 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
Optical rotation [α]D
20 
UV spectrum λmax 
1,4-Naphthalenedione, 6-[(3R)-3,4-dihydro-
9,10-dihydroxy-7-methoxy-3-methyl-1-oxo-
1H-naphtho[2,3-c]pyran-8-yl]-1,5-dihydroxy-
2-methoxy 
Chaetomium aureum 
5 mg 
Orange-brown powder  
C26H20O10 
492 g/mol 
30.89 min (standard gradient) 
+3 (c 1.0, CHCl3)  
202.9, 220.0 and 265.1 nm 
 
 
                                                                      and 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
??????????????????????????????????????????????????????????????????????????????????????? ????????
?????
?
????
????
????
????
?????
?????
?????
?????
?????
?????
?????
?????
?????
?????
?????
????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
 
[M+H]+ [M-H]- 
???????????????????????????? ????????
?
????
????
????
????
?????
?????
????????????
????
??
????
??
????
??
????
??
????
??
????
??
  Results 
  124 
 
???????????????????????????????????????????????????????????? ????????
????
?
???
????
????
????
????
????
????
????
????
????
????
????
????
????
???
?
???
?
???
?
????
??
????
??
????
??
????
??
????
??
????
??
15 was isolated from Chaetomium aureum grown at room temperature for 30 days in 
Fernbach flasks on solid rice medium. The EtOAc extract was portioned between n-hexane 
and 90% MeOH. The MeOH fraction was chromatographed over a successive sephadex LH-
20 column using CH2Cl2/MeOH (1:1) as eluent (repeated three times) then purified by semi-
preparative HPLC (Merck, Hitachi L-7100) using a Eurosphere 100–10 C18 column (300 x 
8mm, L x i.d.) with the following gradient (MeOH/H2O): 0 min, 10% MeOH; 5 min, 10% 
MeOH; 35 min, 100% MeOH; 45 min, 100 % MeOH, Compound 15 was obtained as a 
mixture with compound 14 forming an orange-brown powder (yield, 5 mg). It showed UV 
absorbance at λmax (MeOH) 202.9, 220.0 and 265.1 nm. Positive and negative LC-ESI-MS of 
the mixture exhibited a prominent peak at m/z 493.2 [M+H]+ (base peak) and m/z 491.3 [M-
H]- (base peak), respectively, indicating a molecular weight of 492 g/mol, which established a 
molecular formula of C26H20O10 identical to that of 14. 
 
In 1H NMR spectrum (Table 4.18) showed the same protons signals as xanthoradone D1, 
which are almost overlapped protons with proportion of (1:3). In Figure 4.24, the proton at 
(δH 7.57 ppm) assigned to H-6' of one of the isomers is very close to the proton at (δH 7.58 
ppm) assigned to H-6' of the other one.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.24. 1H NMR of the overlapped proton H-6' and H-7'  
 
Hence, 15 was identified as an stereoisomer of 14 for which the name xanthoradone D2 is 
proposed. Even though a mixture was used, we were able to successfully determine the 
absolute configuration of both compounds with the help of the TDDFT ECD calculations. 
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Compound isolated from the endophytic fungus Chaetomium aureum 
Xanthoradone E1 and xanthoradone E2 (16/17, New) 
Xanthoradone  E1 / Xanthoradone  E2 
Synonym(s) 
 
 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
Optical rotation [α]D
20 
UV spectrum λmax 
1,4-Naphthalenedione, 6-[(3R)-3,4-dihydro-9,10-
dihydroxy-7-methoxy-3-methyl-1-oxo-1H-
naphtho[2,3-c]pyran-8-yl]-5-hydroxy-2-methoxy 
Chaetomium aureum 
6 mg 
Orange-brown powder  
C26H20O9 
476 g/mol 
32.92 min (standard gradient) 
+1 (c 1.0, CHCl3)  
220.1, 264.8 and 377.7 nm 
 
 
                                                                      or 
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16 was isolated from Chaetomium aureum grown at room temperature for 30 days in 
Fernbach flasks on solid rice medium. The EtOAc extract was portioned between n-hexane 
and 90% MeOH. The MeOH fraction was chromatographed over a successive Sephadex LH-
20 column using CH2Cl2/MeOH (1:1) as eluent (repeated three times), then purified by semi-
preparative HPLC (Merck, Hitachi L-7100) using a Eurosphere 100–10 C18 column (300 x 
8mm, L x i.d.) with the following gradient (MeOH/H2O): 0 min, 10% MeOH; 5 min, 10% 
MeOH; 35 min, 100% MeOH; 45 min, 100 % MeOH, Compound 16 was obtained as a 
mixture with compound 16 forming an orange-brown powder (yield, 6 mg).  It showed UV 
absorbance at λmax (MeOH) 220.1, 264.8 and 377.7 nm. Negative ESI-MS of 16/17 exhibited 
a prominent peak at m/z 475.3 [M-H]- (base peak), indicating a molecular weight of 476 
g/mol, which established a molecular formula of C26H20O9 with a 16 mass unit decrease 
compared to 14/15. The absence of one hydroxyl group was supposed. 
 
In 1H NMR spectrum (Table 4.18) showed the presence of 20 protons signals, which are 
almost overlapped with the proportional of (1:1). The proton signals are identical to those of 
14/15 (Table 4.15), except the presence of one more aromatic proton at (δH 6.11 ppm) and the 
absence of one hydroxygroup at (δH 10.89 ppm). 
  
 
 
 
 
 
 
 
 
Figure 4.25. The comparison of H-C-3' of 14/15 and 16/17 in 13C-1H HMBC NMR  
 
The 13C NMR spectrum (in CDCl3) showed 26 resolved signals, which are almost identical to 
those of 14/15, except the chemical shift of 3 carbons, C-1' that in 14/15 was at (δC 186.0 
ppm) and in 16/17 C-1' moved to (δC 190.7 ppm), C-2' that was upfield at (δC 159.0 ppm) in 
14/15 compared to 16/17 (δC 110.1 ppm) and C-3' that was downfield (δC 141.0 ppm) in 
H-11' / C-3' 
H-15 / C-8 
H-15 / C-8 
H-11' / C-3' 
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14/15 compared to 16/17 (δC 161.3 ppm). These data confirm that the hydroxyl group in the 
position 2' of 14/15 is absent in the mixture of compounds 16/17. 
 
The 1H-1H NMR COSY of 16/17 spectra showed the same correlations as 14/15. 
Furthermore, 13C-1H long range couplings of 2J and 3J observed in 13C-1H heteronuclear 
multiple bond coherence (HMBC) spectrum of 16/17 gave the same linkages as 14/15 except 
of the presence of one more cross peaks from H-2' (δH 6.11 ppm) to C-1' (δC 190.7 ppm), C-3' 
(δC 161.3 ppm), C-4' (δC 179.4 ppm) and C-10' (δC 114.2 ppm) as shown in Figure 3.23. 
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Figure 4.26. Selected 13C-1H HMBC NMR correlations of 16/17 
 
Hence, 16/17 was identified as mixture of two xanthoradones derivative for which the name 
xanthoradone E1 and E2 are proposed. 
 
The stereochemistry of xanthoradones E1 and E2, which has one chiral carbon center at C-2 , 
was determined by TDDFT ECD calculations of their solution conformers.  
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Table 4.18. 
1H and 13C NMR chemical shifts of xanthoradones A, D and E 
(Yamazaki et al., 2009) 
 
 
 
 
 
 
 
 
 
 
 
 
Position 
Xanthoradone A 
(in CDCl3) 
Xanthoradone E 
(in CDCl3) 
Xanthoradone D 
(in CDCl3) 
δC δH δC δH δC δH 
1 
2 
3 
 
 
 
4 
5 
6 
7 
8 
9 
10 
10-OH 
11 
12 
12-OH 
13 
14 
15 
1' 
2' 
2'-OH 
3' 
4' 
5' 
6' 
7' 
8' 
9' 
9'-OH 
10' 
11' 
12' 
171.5 
76.8 
34.7 
 
 
 
133.5 
116.1 
140.0 
98.1 
160.3 
109.0 
154.7 
 
108.4 
162.7 
 
99.7 
20.7 
56.0 
190.6 
109.6 
 
160.9 
179.8 
129.8 
121.3 
147.2 
130.6 
159.7 
 
112.0 
56.6 
20.5 
- 
4.79 m 
ax: 3.00 dd 
(J= 17.0, 10.0 Hz) 
eq: 3.06 dd 
(J= 17.0, 4.0 Hz) 
- 
6.99 s 
- 
6.71 s 
- 
- 
- 
9.73 s 
- 
- 
13.9 s 
- 
1.57 d (J= 7.0 Hz) 
3.84 s 
- 
6.08 s 
- 
- 
- 
- 
7.67 s 
- 
- 
- 
12.5 s 
- 
3.92 s 
2.21 s 
171.5 
76.5 
34.7 
 
 
 
133.4 
116.1 
141.7 
98.1 
160.6 
109.6 
155.3 
 
108.1 
162.4 
 
99.8 
20.8 
56.0 
190.7 
110.1 
 
161.3 
179.4 
130.4 
119.1 
138.3 
131.5 
159.5 
 
114.2 
56.7 
- 
- 
4.79 m 
ax: 2.99 dd 
(J= 16.2, 10.4 Hz) 
eq: 3.05 dd 
(J= 16.1, 3.4 Hz) 
- 
6.96 s 
- 
6.68 s 
- 
- 
- 
9.76 s 
- 
- 
13.87 s 
- 
1.57 d (J= 3.1 Hz) 
3.85 s 
- 
6.11 s 
- 
- 
- 
- 
7.77 d (J= 7.7 Hz) 
7.60 d (J= 7.6 Hz) 
- 
- 
12.6 s 
- 
3.93 s 
- 
171.3 
76.7 
34.8 
 
 
 
133.8 
116.0 
140.2 
98.1 
160.3 
109.6 
155.2 
 
108.0 
162.7 
 
99.4 
20.1 
55.4 
186.0 
159.0 
 
141.0 
180.2 
129.9 
119.4 
139.7 
130.4 
159.3 
 
111.9 
60.8 
- 
- 
4.77 m 
ax: 2.99 dd 
(J= 15.8, 10.4) 
eq: 3.05 dd 
(J= 16.1, 3.4) 
- 
6.96 s 
- 
6.68 s 
- 
- 
- 
9.75 s 
- 
- 
13.88 s 
- 
1.56 d (J=6.3) 
3.84 s 
- 
- 
- 
- 
- 
- 
7.73 d (J= 7.5 Hz) 
7.6 d (J= 7.6 Hz) 
- 
- 
11.5 s 
- 
4.2 s 
- 
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Table 4.19. 
1H chemical shifts of the atropisomers of xanthoradone D and E 
 
 
 
 
 
 
 
 
 
 
Position 
Xanthoradone E 
(in CDl3) 
Xanthoradone D 
(in DMSO) 
δH of D-1 δH of D-2 δH of E-1 δH of E-2 
1 
2 
3 
 
 
 
4 
5 
6 
7 
8 
9 
10 
10-OH 
11 
12 
12-OH 
13 
14 
15 
1' 
2' 
2'-OH 
3' 
4' 
5' 
6' 
7' 
8' 
9' 
9'-OH 
10' 
11' 
- 
4.78 m 
ax: 2.99 dd 
(J= 16.2, 10.4 Hz) 
eq: 3.04 dd 
(J= 16.0, 3.3 Hz) 
- 
6.96 s 
- 
6.68 s 
- 
- 
- 
9.76 s 
- 
- 
13.86 s 
- 
1.56 d (J=3.0 Hz) 
3.85 s 
- 
6.11 s 
- 
- 
- 
- 
7.77 d (J= 7.6 Hz) 
7.60 d (J= 7.6 Hz) 
- 
- 
12.60 s 
- 
3.93 s 
- 
4.79 m 
ax: 2.99 dd 
(J= 16.2, 10.4 Hz) 
eq: 3.05 dd 
(J= 16.1, 3.4 Hz) 
- 
6.96 s 
- 
6.68 s 
- 
- 
- 
9.76 s 
- 
- 
13.87 s 
- 
1.57 d (J= 3.1 Hz) 
3.85 s 
- 
6.11 s 
- 
- 
- 
- 
7.77 d (J= 7.7 Hz) 
7.60 d (J= 7.6 Hz) 
- 
- 
12.60 s 
- 
3.93 s 
- 
4.86 m 
ax: 3.00 dd 
(J= 15.1, 10.9 Hz) 
eq: 3.14 dd 
(J= 15.7, 2.7 Hz) 
- 
7.15 s 
- 
6.95 s 
- 
- 
- 
9.63 br 
- 
- 
13.69 br 
- 
1.45 d (J= 6.2) 
3.79 s 
- 
- 
10.89 br 
- 
- 
- 
7.58 d (J= 7.6 Hz) 
7.53 d (J= 7.6 Hz) 
- 
- 
11.85 s 
- 
3.92 s 
- 
4.86 m 
ax: 2.99 dd 
(J= 15.8, 11.6) 
eq: 3.14 dd 
(J= 15.7, 2.7) 
- 
7.15 s 
- 
6.95 s 
- 
- 
- 
9.63 br 
- 
- 
13.69 br 
- 
1.45 d (J=6.2) 
3.79 s 
- 
- 
10. 89 br 
- 
- 
- 
7.57 d (J= 7.5 Hz) 
7.53 d (J= 7.6 Hz) 
- 
- 
11.85 s 
- 
3.92 s 
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Compound isolated from the endophytic fungus Chaetomium aureum 
Chaetoresorcinol (18, New) 
Chaetoresorcinol 
Synonym(s) 
 
 
Biological source 
Sample amount 
Physical Description 
Molecular Formula 
Molecular Weight 
Retention time HPLC 
UV spectrum λmax 
Chaetoresorcinol 
 
 
Chaetomium aureum 
6 mg 
red oil 
C26H20O9 
385 g/mol 
32.92 min (standard gradient) 
220.1, 264.8 and 377.7 nm 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
????????????????????????????????? ????????
??????
??????
?
?????
?????
?????
?????
?????
?????
?????
?????
?????
??????
??????
??????
??????
??????
??????
??????
??????
??????
??????
??????
??????
??????
?????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
 
[M-H]- [M+H+Na]+ 
0,0 10,0 20,0 30,0 40,0 50,0 60,0
-500
2.000
5.000
KFZ120807 #15 CA-M7.11 UV_VIS_1
mAU
min
1
 -
 3
2
,9
7
7
2
 -
 4
4
,5
8
0
WVL:235 nm
Peak #15 100% at 33.75 min
-10,0
70,0
200 250 300 350 400 450 500 550 595
%
nm
234.7
201.8
338.4
Library Hit: 8E-7-4-4-2 963.90
HO O
OH
HO
1
2
3
4
6
5
1'
2'
3'
4' 5'
6'
7'
8'
9'
10'
11'
12'
13'
14'
15'
16'
18'
17'
  Results 
  131 
 
18 was isolated from Chaetomium aureum grown at room temperature for 30 days in 
Fernbach flasks on solid rice medium. The EtOAc extract was portioned between n-hexane 
and 90% MeOH. The MeOH fraction was chromatographed over a successive sephadex LH-
20 column using CH2Cl2/MeOH (1:1) as eluent (repeated three times), then purified by semi-
preparative HPLC (Merck, Hitachi L-7100) using a Eurosphere 100–10 C18 column (300 x 
8mm, L x i.d.) with the following gradient (MeOH/H2O): 0 min, 10% MeOH; 5 min, 10% 
MeOH; 35 min, 100% MeOH; 45 min, 100 % MeOH. Compound 18 was obtained as a red oil 
and showed three UV maxima at 201, 234 and 338 nm. ESIMS exhibited strong 
pseudomolecular base peak at m/z 385.3 [M-H]- in the negative mode, indicating a molecular 
weight of 386 g/mol. The chemical formula of 18 was deduced as C24H33O4 from the 
prominent peak appearing at m/z 409.2351 [M+Na]+ in the HRESIMS (calcd for C24H34O4Na 
409.2355).   
 
13C and DEPT experiments (Table 4.20) exhibited 24 carbon atoms attributable to one olefinic 
methyl group, ten methylenes, eight olefinic methines, four quaternary carbons, and one 
carbonyl carbon.  
 
Analysis of 2D NMR data indicated that 18 is a resorcinol derivative containing a side chain 
of 18 carbons.  
 
1H-1H COSY confirmed the presence of three spin systems assigned for CH3(17')H(16'), a 
continuous spin system CH2(1')→CH2(14') and the resorcinol ring system H(2)H(4)H(6), 
whereas the connection of these spin systems was established by inspection of 2J and 3J 
HMBC correlations (Figure 4.27). 
 
CH2-14' showed a 
2
J correlation to the olefinic quaternary carbon C-15' (δC 135.2 ppm) and 
3
J 
correlations to C-16' and C-18', appearring at δC 136.5 and 172.0 ppm, respectively (Figure 
4.28). A strong 3J correlation was also detected for the olefinic proton H-16' to C-14' (δC 35.9 
ppm), the latter correlating also with the methyl group CH3-17' via a 
4
J correlation. On the 
other hand, the aliphatic methylene protons CH2-1' correlated to two overlapping aromatic 
carbons, which were attributed to C-4 and C-6 (δC 108.0 ppm), as well as to an isolated 
aromatic carbon assigned to C-5 (δC 144.1 ppm), thus, establishing the connection between 
the identified spin systems. 
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Figure 4.27. 1H -1H COSY NMR correlations of 18 
 
The configuration of the double bonds at C-2', C-4' and C-15' of the side chain was obtained 
by comparison of the observed chemical shifts of the respective carbons with 13C NMR data 
of 5-heptadeca-8'Z,11'Z-dienylresorcinol (Barrow et al., 1991; Jin and Zjawiony, 2006). 5-
heptadeca-8'Z,11'Z,16-trienylresorcinol and 5-heptadeca-9'E,11'Z,16-trienylresorcinol (Jin and 
Zjawiony, 2006). For instance, ∆2',3' and ∆15',16' were assigned to have E-configuration since 
the neighboring carbons C-1' and C-14' resonated at about δC 35 ppm, whereas the allylic 
carbon of C-5' (C-6') appeared upfield (δC 28.6 ppm) in comparison to C-1' and C-14' and 
hence indicated a Z-configuration for the double bond ∆4',5'. This is in agreement with other 
known congeners (Suzuki et al., 1996) where the allylic carbon of an E-configurated double 
bond resonates more downfield than that of a Z-configurated one. The configuration of the 
∆
15',16' double bond was further confirmed by a ROESY experiment, where the olenific proton 
H-16' showed a strong correlation with CH2-14' (Figure 4.29). Accordingly, 18 was identified 
as a new natural product for which the name chaetorcinol is proposed. 
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Figure 4.28. Selected 13C-1H HMBC NMR correlations of 18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.29. Selected 1H -1H ROESY NMR correlations of 18 
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Table 4.20. 
1H and 13C NMR data of 18 in MeOH at 600 MHz for 1H and 150 for 13C. 
Position 
18 
δC δH 
1 159.7 - 
2 101.1 6.08 (1H, s) 
3 161.7 - 
4 108.0 6.13b (1H, s) 
5 144.1 - 
6 108.0 6.14b (1H, s) 
1' 34.7 3.35c (1H, br) 
2' 131.05 5.54 (1H, m) 
3' 125.3 6.35 (1H, m) 
4' 124.7 6.38 (1H, m) 
5' 133.8 5.52 (1H, m) 
6' 28.6 2.20 (2H, m) 
7' 30.34a 1.44 (2H, m) 
8' 30.38a 1.33 (2H, m) 
9' 30.44a 1.33 (2H, m) 
10' 30.63a 1.33 (2H, m) 
11' 30.69a 1.25 (2H, m) 
12' 30.76a 1.25 (2H, m) 
13' 30.86 1.37 (2H, m) 
14' 35.9 2.22 (2H, m) 
15' 135.2 - 
16' 136.5 5.97 (q, J=7.1 Hz) 
17' 15.9 1.92 (d, J=7.1 Hz) 
18' 172.0 - 
a,b may be exchangeable 
 c overlapped with solvent peak 
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4.5. Bioactivity test results for compounds isolated from the endophytic fungus 
Chaetomium aureum 
The isolated compounds were subjected to cytotoxicity (Table 4.21), protein kinase bioassays 
(Table 4.22) and Hsp 90 chaperone inhibition assays (Figure 4.30). The new compounds were 
also subjected to antibacterial tests (Table 4.23). 
 
Table 4.21. Cytotoxicity test results for the compounds isolated from endophytic fungus 
Chaetomium aureum  
Nr.  Compounds tested L5178Y growth 
in %* (Conc. 10 µg/mL) 
 
- 
 
Control 
 
0 
13 SB 236050 87 
14 Xanthoradone D1 -3.5 
14/15 Xanthoradone D1 + 
Xanthoradone D2 
- 3.5 
16/17 
 
 
Xanthoradone E1 + 
Xanthoradone E2 
 
1.6 
   
*Data provided by Prof. W. E. G. Müller, Mainz 
Only SB 236050 showed moderate activity against L5178Y cell line, whereas no activity was 
detected for the other compounds. 
 
Table 4.22. Protein kinase assay results for the compounds isolated from endophytic fungus 
Chaetomium aueum 
 
Compound tested 
(Conc. 1µg/mL) 
Activity on various protein kinases based on IC50 [g/mL]* 
A
K
T
1 
A
L
K
 
A
R
K
 5
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ur
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B
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 w
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E
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 w
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N
E
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N
E
K
 6
 
P
IM
 1
 
P
L
K
 1
 
P
R
K
 1
 
S
R
C
 
V
E
G
F
-R
2 
(+)-Sclerotiorin  A A M S M A A 0 S A A A M M A A 
(+)-Isochromophilone IV 0 0 0 M 0 M M 0 0 0 0 M 0 0 M 0 
(+)-Sclerotioramin 0 M 0 M 0 M A 0 0 0 0 0 0 0 A A 
SB 236050 0 0 0 S 0 M M 0 0 M 0 M M 0 0 M 
Chaetoresorcinol 0 A 0 A M A S 0 M A M 0 0 0 A A 
  * Data provided by ProQinase, Freiburg. 
S: strongly active, A: active, M: moderately active, 0: not active 
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The results of the protein kinase assay showed a different activity profile than the cytotoxicity 
assay results. (+)-Sclerotiorin was active against most of protein kinases in spite of their low 
activity in the cytotoxicity assay, whereas its derivatives, isochromophilone VI and 
sclerotioramin inhibited only few of the tested enzymes. On the other hand, the new 
compounds, chaetoresorcinol and SB 236050, were also active against the tested protein 
kinases.  
 
Table 4.23. Antibacterial test results for the new compounds isolated from endophytic fungus 
Chaetomium aureum  
 
 
 
Nr. 
 
 
 
Name 
 
The Minimum Inhibitory Concentration 
M
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A
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A
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. 
F
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a
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s 
13 SB 236050 n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a 
14 Xanthoradone D1 n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a 
14/15 Xanthoradone D1 + 
Xanthoradone D2 
n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a 
16/17 Xanthoradone E1 + 
Xanthoradone E2 
n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a 
18 Chaetoresorcinol n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a n.a 7.81 
            * Data provided by Mr. Pretsch, Vienna. 
 
Chaetoresorcinol was moderately active against only Asp. Fumigatus, whereas the other 
compounds were not active. 
 
 
 
 
 
 
 
 
  Results 
  137 
 
O
Cl
O
O
HO
O
Cl
O
O
O
O
A 
B 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.30.  Effect of 1-6 on the Hsp90 chaperoning machine in vitro. A- PR hormone 
binding activity was reconstituted using rabbit reticulocyte lysate without (RL) or with 
metabolites KFZ-1: (+)-Sclerotiorin, KFZ-2: (+)-Isochromophilone VI, KFZ-3: SB 236050, 
KFZ-5: Chaetoresorcinol, KFZ-7: Sclerotioramin and KFZ-8: Isochromophilone VII. 17-
AAG is used as a positive control. B- Samples from (A) were used for analysis of protein 
complexes by SDS-PAGE and Coomassie blue staining. PR22 indicates the PR antibody 
incubated with RRL. PR indicates the PR alone with no RRL.   
 
As shown in (Figure 4.30), sclerotiorin efficiently inhibits the recovery of PR hormone 
binding activity using RRL. Sclerotiorin showed similar efficiency to that of 17-AAG, the 
classical inhibitor of Hsp90, whereas the other compounds showed much less activity than 
sclerotiorin. 
 
Cytotoxicity test showed that sclerotiorin is not toxic to breast cancer cell line Hs578T, 
MCF7, MDA-MB-231, MDA-MB-453, Prostate cancer cell line LNCaP and cervical cancer 
cell line HeLa.  
 
In an attempt to increase the cytotoxicity of sclerotiorin, a deacetylation was carried out. 
 
H2SO4 
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Figure 4.31. Comparison of 1H NMR and the molecular weight of sclerotiorin and 
deacetylsclerotiorin 
 
The 1H NMR (DMSO) of deacetylsclerotiorin showed the abscence of the methyl group at (δH 
2.11 ppm) and the presence of a broad proton signal at (δH 4.6 ppm) assigned to the hydroxyl 
group, which replaced the acetyl group. 
 
  
 
 
 
 
 
 
 
 
 
Figure 4.32. Comparison of sclerotiorin (2) and deacetylsclerotiorin (6). A- effect increasing 
concentration of sclerotiorin (2) and dacetylsclerotiorin (6) on PR hormone binding activity. 
B- Effect of  sclerotiorin (2) and dacetylsclerotiorin (6) on PR protein complexes. Molecular 
chaperones are indicated on the right. HC represents the heavy chains of the PR antibody 
PR22. 
   2 (µM)             6 (µM) 
   2 (µM)             6 (µM) 
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The deacetylated sclerotiorin (6) is relatively less efficient in inhibiting the Hsp90 in vitro. 
The mechanism by which sclerotiorin and deacetylsclerotiorin inactivate the Hsp90 machine 
is not clear but it seems to be different from that of the 17-AAG. 
 
As compared to 17-AAG, protein complexes analysis showed that sclerotiorin and 
deacetylsclerotiorin lower the level of Hsp90 without increase of Hop (Figure 4.32.B). 
Furthermore, deacetylsclerotiorin does not increase Hsp70 level in PR complexes (Figure 
4.32.B).  
 
 
 
Figure 4.33. A- Comparison of the effect of sclerotiorin (2) and deacetylsclerotiorin (6) on 
cell survival of the breast cancer cell line Hs578T using MTS assay. B- Deacetylsclerotiorin 
(6) inhibits the growth of breast cancer cell line MDA-MB-231 and prostate cancer cell line 
LNCaP. C- Western blot analysis comparing the effect of sclerotiorin (2) and 
deacetylsclerotiorin (6) on the expression of Hs70, Hsp40 and GR. b-actin is used as a loading 
control.  
 
Surprisingly, at inhibitory concentrations, deactylsclerotiorin becomes cytotoxic to Hs578T, 
MDA-MB-231 and LNCaP cell lines over a period of 48h (Figure 4.33.A-B). Western blot 
analysis (Figure 4.33.C) showed that sclerotiorin induces overexpression of Hsp70 and 
degradation of Hsp90 client proteins such as glucocorticoid receptor in Hs578T cells, 
indicating that the Hsp90 machine may be inhibited in vivo. It is worth noting however, that 
sclerotiorin also induces degradation of the heat shock protein 40 (Hsp40) (Figure 4.33.C) 
which may contribute to some of sclerotiorin’s cytotoxicity.   
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5. Discussion 
5.1. The use of medicinal plants in Morocco 
The ethnopharmacological approach has been the platform for research programs with the 
objective to study plants used in traditional medicine in different cultures and to select one of 
the most used medicinal plant for its anticancer effect. For this, the choice of the National 
Institute of Oncology was taken based on the heterogeneous origin and the different socio-
professional level of the patients, which are coming from different regions of Morocco. 
 
In Morocco, the use of medicinal plants for therapeutic purposes is considered by many 
people as not being very efficient, but for being at least well tolerated because it is natural and 
is part of “soft” medicine. In all regions of Morocco, each home has a stock of medicinal 
plants that are used as home pharmacy for a number of diseases (Weniger, 1991). Moreover, 
people have free access to medicinal plants “without prescription” (Claisse, 1990). 
 
Furthermore, the majority of patients who use medicinal plants have a low income and live far 
from the hospital, which explains their resorting to medicinal plants to be cured. The origin 
and their educational level were also a variable because in traditional medicine, the statements 
of an illiterate or of an expert are not the same. Many studies have shown that traditional 
medicine is still used allover Morocco. To approve the biological activity of each plant 
scientifically, plant extracts must be evaluated for their suspected biological effect. 
 
5.2. Selection of interesting medicinal plants based on an ethnopharmacology survey 
Fifty-five plants have been cited during this investigation. Among these plants 28 are proven 
to have anticancer activity. Aristolochia longa, Trigonella foenum-graecum, Cassia absus and 
Nigella sativa are the most used plants. However, there are plants that have been found to be 
toxic such as Pinus halepinsis, Peganum harmala, Aristolochia longa and Euphorbia 
resinifera. Regardless of their toxicity these plants are used by patients in the INO 
irrespective of the degree of toxicity or side effects. 
 
Thymelaea lythroides was used by two patients, which have uterus cancer. The plant was 
taken as tea three times a day. Side effects by using this plant were not observed, in contrary 
to the effects of chemotherapy, but the effectiveness was similar. 
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From the best of our knowledge, Thymelaea lythroides has not been yet investigated for their 
anti-cancer activity, even though many herbalists have recommended the use of this plant for 
that purpose. 
 
5.3. Chemical diversities of the genus Thymelaea secondary metabolites 
Thymelaeaceae is a medium size family of dicotyledons comprising about 1200 species 
distributed in 67 genera and occurs in all continents in latitudes south of 40°N.  It is found in 
both temperate and tropical regions, but is more diverse in the southern than in northern 
hemisphere (Ferreira et al., 2009).  
 
 Thymelaea genera have a lot of uses in folk medicine.  Over the years, this species has been 
used as a laxative, diuretic, antibacterial, antitussive, expectorant, antiparasitic and also as an 
antitumor agent (Ferreira et al., 2009). 
 
Thymelaea Mill. comprises 31 species of xerophyllous shrubs and herbs. Thymelaea is a 
Mediterranean genus belonging to a primarily tropical and subtropical family. The genus 
Thymelaea is poorly investigated. Only 4 species are studied: T. hirsute, T. passerine, T. 
tartonraira and T. microphylla. The Table 5.1 summarizes the bioactive metabolites reported 
from the genus Thymelaea. 
 
Table 5.1. Bioactive metabolites from the genus Thymelaea (Borris et al., 1988) 
Compounds Species References 
 
Coumarins 
Daphnetin 
Daphnetin-8-ß-D-glucoside 
Daphnin 
Daphnoretin 
 
Daphnorin 
Esculetin 
Scopoletin 
Sphondin 
Umbelliferone 
 
Flavonoids 
Genkwanin 
Genkwanin-5-O-ß-D-
  
 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea tartonraira 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea passerina 
Thymelaea hirsuta 
Thymelaea passerina 
 
Thymelaea tartonraira 
Thymelaea tartonraira 
 
 
Rizk et al., 1975 
Rizk et al., 1975 
Rizk et al., 1975 
Rizk et al., 1975; Rizk et al., 1972 
Garcia-Grandos, 1980 
Rizk et al., 1975 
Rizk et al., 1975 
Rizk et al., 1975 
George and Rishi, 1982 
Rizk et al., 1975 
George and Rishi, 1982 
 
Garcia-Grandos, 1980 
Garcia-Grandos, 1980 
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primeverosyl 
Kaempferol 
Orientin 
Vicenin-2 
 
Vitexin 
 
Triterpenes 
ß-Amyrin 
 
Betulin 
Erythrodiol 
Lanosterol 
Lupeol 
 
Sterols 
Campesterol 
Cholesterol 
ß-sitosterol 
 
ß-sitosterol-ß-D-glucoside 
 
Stigmasterol 
 
Lipids 
n-Docosanol 
n-Heptacosane 
n-Hexacosanol 
n-Nonacosane 
n-Octacosane 
n-Octacosanol 
 
n-Tetracosanol 
n-Triacontane 
 
Fatty acids 
Arachidic acid 
Dihydromalvalic acid 
Linoleic acid 
Linolenic acid 
Myristic acid 
Oleic acid 
Palmitic acid 
Stearic acid 
 
Thymelaea tartonraira 
Thymelaea tartonraira 
Thymelaea hirsuta 
Thymelaea tartonraira 
Thymelaea tartonraira 
 
 
Thymelaea hirsuta 
Thymelaea passerina 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
 
 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea passerina 
Thymelaea hirsuta 
Thymelaea passerina 
Thymelaea hirsuta 
 
 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
 
 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
Thymelaea hirsuta 
 
Garcia-Grandos, 1980 
Garcia-Grandos, 1980 
Nawwar et al., 1977 
Garcia-Grandos, 1980 
Garcia-Grandos, 1980 
 
 
Garcia-Grandos, 1980 
George and Rishi, 1982 
Garcia-Grandos, 1980 
Garcia-Grandos, 1980 
Garcia-Grandos, 1980 
Garcia-Grandos, 1980 
 
 
Rizk et al., 1974 
Garcia-Grandos, 1980 
Rizk et al., 1975 
George and Rishi, 1982 
Rizk et al., 1972 
George and Rishi, 1982 
Gharbo et al., 1970 
 
 
Rizk et al., 1974 
Rizk et al., 1974 
Rizk et al., 1974 
Rizk et al., 1974 
Rizk et al., 1974 
Rizk et al., 1974 
Rizk et al., 1974 
Rizk et al., 1974 
Rizk et al., 1974 
 
 
Rizk et al., 1974 
Rizk et al., 1974 
Rizk et al., 1974 
Rizk et al., 1974 
Rizk et al., 1974 
Rizk et al., 1974 
Rizk et al., 1974 
Rizk et al., 1974 
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5.4. Methodologies for profiling of the metabolites 
Isolation and structure elucidation processes enrich the chemistry of natural products (Butler, 
2004). Hence, interesting fungal strains can be elected to be screened, which together with the 
use of spectroscopic methods in addition to chemoinformatics can be used as part of an 
effective dereplication protocol (Larsen et al., 2005). Secondary metabolites profiling is not 
an easy task to be applied since natural products display very diverse chemical structures. 
Thus, a single analytical method does not exist, which is capable of profiling all natural 
products in the investigated extract (Wolfender et al., 2005). However, advanced analytical 
and spectroscopic techniques, like the hyphenated techniques linked with HPLC, can provide 
a good idea about the substructures and/or functional groups in the chemical structure. 
 
5.4.1. HPLC/UV 
With the advancement of HPLC as well as much more stable and better columns for high 
resolution separation, combined with fast UV diode array detectors, it has become easy to 
acquire the UV spectrum of practically every single component from an extract, provided a 
suitable chromophore is existing. Consequently the UV spectrum has turned into one of the 
most readily accessible pieces of information related to structure of natural products that 
increased the interest in exploiting its usefulness (Cannall, 1998). 
 
In the present study, a lot of chemical compounds that share similar chromophoric functions 
were examined by the hyphenated HPLC/UV-photodiode array detection (LC/UVDAD) 
technique, which showed very often similar UV spectra, even though there were significant 
differences in additional non-chromophoric functions. 
 
5.4.2. HPLC/ESI-MS 
Electrospray ionization mass spectrometry (ESI-MS) and the associated techniques provided 
the scientific community with a highly versatile method for studies of secondary metabolites. 
ESI-MS is a soft and sensitive ionization technique which can be adjusted to produce mainly 
protonated or sodiated ions (assuming positive ESI) from a wide range of natural products 
(Smedsgaard and Frisvad, 1996). Moreover, this method is also useful in establishing the 
related secondary metabolites. In the context of the present study, this proved extremely 
valuable in detecting azaphilone derivatives (9, 10, 11 and 12) and xanthoradone derivatives 
(14, 15, 16 and 17).  
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5.5. Secondary metabolites isolated from the plant Thymelaea lythroides 
Thymelaea lythroides is growing wild in Mâamora forest, called by Moroccan people as 
“Methnan” and used as a folk remedy for otitis, diabetes, rheumatism and inflammation of the 
prostate (Gmira et al., 2007). 
 
Eight compounds were isolated from areal parts of Thymelaea lythroides including one 
depsipeptide (1), two coumarins (2, 3), one dicoumarin (4), two lignans (5, 6), one flavonoid 
glucoside (7) and one dicoumarin glycoside (8). 
 
4.5.1. Depsipeptides 
Natural or synthetic compounds having sequences of amino and hydroxy carboxylic acid 
residues (usually α-amino and α-hydroxy acids), exhibit commonly but not necessarily 
regularly alternating units. In cyclodepsipeptides the residues are connected in a ring (IUPAC, 
1997). 
 
Romidepsin is an epsipeptide and is a member of the bicyclic peptide class of histone 
deacetylase inhibitors and was first isolated as a fermentation product from Chromobacterium 
violaceum by the Fujisawa Pharmaceutical Company (Yurek-George et al., 2007). It is being 
used in the treatment of some cancers where it is thought to reactivate silenced genes. 
 
The depsipeptide etamycin, a newly isolated natural product from a marine actinomycete, 
shows potent activity in vitro and in mice against MRSA (Haste et al., 2010). It was first 
observed to have a positive role on gene expression in 1990. A clinical trial was conducted in 
1996 for treating T cell lymphoma (Piekarz and Bates, 2004). Another natural depsipeptide 
HDAC inhibitor is spiruchostatin A (Yusuke et al., 2006). 
 
5.5.2. Coumarins 
Coumarin is a fragrant compound in the benzopyrone chemical class and is a colorless 
crystalline substance in its standard state. It is found naturally in many plants. Coumarins are 
used in the pharmaceutical industry as precursor molecules in the synthesis of a number of 
synthetic anticoagulant pharmaceuticals similar to dicoumarol. Coumarins have shown many 
biological activities, but are approved for only a few medical uses as pharmaceuticals. 
Reported coumarin activity includes anti-HIV, anti-tumor, anti-hypertension, anti-arrhythmia, 
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anti-inflammatory, anti-osteoporosis, antiseptic, and analgesic activity. It is also used in the 
treatment of asthma and lymphedema (Liu et al., 2011). 
 
5.5.3. Flavonoids 
Flavonoids are polyphenolic compounds that are ubiquitous in nature. Over 4,000 flavonoids 
have been identified. The widespread distribution of flavonoids, their variety and their 
relatively low toxicity compared to other active plant compounds (for instance alkaloids) 
mean that many animals, including humans, ingest significant quantities in their diet. 
Preliminary research indicates that flavonoids may modify allergens, viruses, and 
carcinogens, and so may be biological "response modifiers". In vitro studies show that 
flavonoids also have anti-allergic, anti-inflammatory, anti-microbial, anti-cancer, anti-
diarrheal and antiviral activities (Spencer, 2008; Yamamoto et al., 2001; Cushnie et al., 2005; 
Cushnie and Lamb, 2011; de Sousa et al., 2007; Schuier et al., 2005; González et al., 1990).  
 
5.5.4. Lignans 
Lignans are polyphenols found in plants. Their precursors are found in a wide variety of 
plant-based foods, including seeds, whole grains, legumes, fruits, and vegetables. 
Lignan-rich foods are part of a healthful dietary pattern, but the role of lignans in the 
prevention of hormone-associated cancers, osteoporosis, and cardiovascular diseases is not 
yet clear. 
 
5.6. Biosynthesis of the secondary metabolites 
Secondary metabolites are organic molecules that are not involved in the normal growth and 
development of an organism, while primary metabolites play a key role in the survival of the 
species, playing an active function in the photosynthesis and respiration. Most of the 
secondary metabolites are classified based on their biosynthetic origin. Before looking at 
individual pathways in detail, it is helpful to consider the overall pathway of carbon from 
carbon dioxide and the photosynthetic formation of sugars. This is shown in Figure 5.1.  
 
In this context a distinction may be drawn between primary and secondary metabolic 
pathways. The former are involved in the storage and release of energy and in the synthesis of 
essential cellular constituents such as the amino acids and the nucleic acids. The latter involve 
the biosynthesis of the metabolites, which are characteristic of each species. Different classes 
of these metabolites are often associated to a narrow set of species within a phylogenetic 
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group and constitute the bioactive compounds in several medicinal, aromatic, colorant, and 
spice plants and/or functional foods. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Photosynthesis, respiration, leaf and water exchange and translocation of sugar in 
plant (Silverstein et al., 2008) 
 
In this context a distinction may be drawn between primary and secondary metabolic 
pathways. The former are involved in the storage and release of energy and in the synthesis of 
essential cellular constituents such as the amino acids and the nucleic acids. The latter involve 
the biosynthesis of the metabolites, which are characteristic of each species. Different classes 
of these metabolites are often associated to a narrow set of species within a phylogenetic 
group and constitute the bioactive compounds in several medicinal, aromatic, colorant, and 
spice plants and/or functional foods. 
 
In essence, secondary metabolism utilizes a limited number of metabolites available from 
primary metabolism in novel ways. Four major pathways have emerged and two of them in 
particular show a considerable degree of structural homogeneity (Scheme 5.1). In the first, the 
“isoprene pathway”, the precursor is mevalonic acid derived from acetyl-CoA. In the 
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second, the “polyketide pathway”, the primary metabolites are the CoA derivatives of lower 
fatty acids together with their carboxylated derivatives; typical examples are acetyl-CoA and 
malonyl-CoA, propionyl-CoA and methylmalonyl-CoA, and butyryl-CoA and eth- ylmalonyl-
CoA. Multiple condensations lead to polyketomethylene structures; thus, 1 acetyl- CoA and n 
malonyl-CoA yield CH 3 -CO-(CH 2 - CO) n -CoA, and 1 propionyl-CoA and n methyl- 
malonyl-CoA give CH 3 -CH 2 -CO-(CH[CH 3 ]- CO) n -CoA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5.1. The major biosynthesis pathways of secondary metabolites  
 
The remaining two major pathways are less easily summarized because of the structural 
diversity of the secondary metabolites. The “shikimate pathway” uses shikimic acid itself as 
the primary metabolite or, alternatively, either an intermediate involved in shikimate 
formation or a further primary metabolite derived from shikimate (e.g., isochorismate). Many 
aromatic products originate in this way, as well as some nonaromatic, cyclohexane structures. 
Finally, the fourth major pathway involves secondary metabolites constructed from “amino 
acids” as precursors; many plant alkaloids are formed in this way. In some cases, secondary 
metabolite formation requires more than one amino acid. While these four pathways are the 
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major biosynthetic routes to secondary metabolites, there are still other possibilities such as 
the compounds that are derived directly from carbohydrates without cleavage of the carbon 
chain and those derived from intermediates of the tricarboxylic acid cycle. Moreover, many 
secondary metabolites are biosynthesized by a mixed process involving a combination of two 
(or more) of these major pathways. A classic example is the ergot alkaloid biosynthesis 
involving the amino acid, tryptophan, and addition of a single isoprene unit. 
 
5.6.1. Biosynthesis pathway of the isolated compounds from Thymelaea lythroides 
All isolated compounds were derived from the shikimate biosynthesis pathway. The shikimate 
pathway provides an alternative route to aromatic compounds, particularly the aromatic amino 
acids L-phenylalanine, L-tyrosine, and L-tryptophan. This pathway is employed by 
microorganisms and plants, but not by animals; accordingly, the aromatic amino acids feature 
among the essential amino acids for man and have to be obtained in the diet. A central 
intermediate in the pathway is shikimic acid, a compound which had been isolated from 
plants of Illicium species (Japanese ‘shikimi’) many years before its role in metabolism had 
been discovered. Phenylalanine and tyrosine form the basis of phenylpropane units found in 
many natural products, e.g. coumarins, lignans, and flavonoids, and along with tryptophan are 
precursors of a wide range of alkaloid structures. 
 
Nevertheless, distinct differences in the basic biosynthetic pathways exist. For example, 
plants and microorganisms can synthesize their amino acids from simple building blocks, 
whereas most animals lost this ability in the course of their adaptation to heterotrophic life. 
Thus, many biosynthetic pathways are regarded as specific for certain groups of organisms. 
The ability to form thousands of structurally diverse natural products due to secondary 
metabolism is considered a typical feature of plants and microbes. 
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5.7. Bioactivity of the isolated compounds from Thymelaea lythrodies 
5.7.1 Bioactivity of coumarins and dicoumarins isolated from T. lythroides 
Coumarins and dicoumarins derivatives isolated from T. lythroides were subjected to 
cytotoxicity testing toward L5178Y (mouse lymphoma) cell line. (+)-Dapheolone (3) was the 
most active of the compounds, whereas daphnoretin (6) and rutarensin (7) were found to be 
inactive. However, dapheolone and daphnoretin were inactive in the protein kinase inhibition 
assay, nevertheless the dicoumarin glucosides rutarenside (7) was active against Aurora-B, 
IGF 1-R and VEGF-R2, which suggests that rutarensin can not pass through the cell 
membrane. Furthermore, all compounds were inactive in the Hsp 90 chaperone machinery 
inhibition assay.  
 
Despite the activity of rutarensin against the mentioned protein kinases, it was inactive against 
the Hsp 90 chaperone machinery, indicating that the mechanism of the inhibition of the 
protein kinases could not have an interaction with protein kinases. 
 
5.7.2. Bioactivity of lignans isolated from T. lythroides 
(-)-Wiksromol (4) and δ-sesamin (5) were inactive against cytotoxicity tests toward the 
L5178Y (mouse lymphoma) cell line, protein kinase inhibition assay and Hsp 90 chaperone 
machinery inhibition assay, although in the literature, (-)-wikstromol (4) has cytotoxic 
potential against human cancer cell lines (Singh et al., 2007), and δ-sesamin (5) showed mild 
antiplasmodial activities and cytotoxicity (IC50 3.37 and 3.50 µg/mL resp.) without 
noticeable toxicity on mammalian normal cells (Risoleta et al., 2011). 
 
5.7.3. Bioactivity of flavonoid glycosides isolated from T. lythroides 
The flavonoid glycosides trans-tilliroside (8) was inactive against cytotoxicity tests toward 
the L5178Y (mouse lymphoma) cell line, which suggested that trans-tilliroside protein kinase 
activity against Aurora-B, ALK and VEGF-R2 is not occuring be in vivo, as the compound 
can not enter in the cell. 
 
5.7.3. Bioactivity of depsipetides isolated from T. lythroides 
Bassiatin (1) was inactive against cytotoxicity test toward the L5178Y (mouse lymphoma) 
cell line, protein kinase inhibition assay and Hsp 90 chaperone machinery inhibition assay, 
however, bassiatin was reported to have cytotoxicity activity against breast cancer cells 
(MCF-7) (Li et al., 2012). 
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5.8. Selection of the interesting endophytic fungus strains isolated from Thymelaea 
lythroides 
Five endophytic fungus strains, Chaetomium aureum, Pleospora sp., Cladosporieum sp., 
Alternaria sp. and Epicoccum nigrum, were isolated from healthy stem tissues of Thymelaea 
lythroides (Thymelaeaceae). The pure fungus strains were cultivated on rice solid medium. 
Preliminary biological assay (antibacterial and cytotoxicity assay) with the analysis of HPLC 
chromatogram of the EtOAc extracts of the five pure fungus strains showed that extracts of 
Chaetomium aureum were much more active, displaying a variety of chemical classes based 
on analysis of UV spectra.  
 
This fungus strain was cultivated more than five times under the same conditions to evaluate 
its stability. All extracts showed the same HPLC chromatogram, which reinforces the choice 
of this fungus as a subject of the study by the factor of stability.  
 
5.9. Choice of culture media 
Medium composition and culture conditions are one of the factors having great impact on 
growth and production of secondary metabolites from microorganisms (Bills, 1995). The 
physiology of secondary metabolism has often been ignored and still few of the regulatory 
features involved in the biosynthesis of natural products have been elucidated. Thus it is 
important to grow the organism in different media in order to have a broad range of secondary 
metabolites as possible candidates for a given strain to increase the chance to generate novel 
drug candidates (Larsen et al., 2005). Furthermore, some natural products are only produced 
under certain environmental conditions and only when all trace metals, phosphate and other 
medium factors are present in certain ranges of concentrations (Knight et al., 2003). 
 
Thus, optimal media for good metabolite production can change for different genera being 
investigated (Larsen et al., 2005). 
 
Different and relatively easy to control conditions to investigate in a discovery program 
include growing cultures at both solid and liquid conditions, incubation at two or more 
temperatures, incubation at two or more shaker speeds, incubation for at least two different 
time periods, media with at least two different pH levels, choosing carbon and nitrogen 
sources at different concentrations, high- or low phosphate content, adding trace minerals etc. 
(Knight et al., 2003). 
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Some authors strongly argue in favor of using solid substrate fermentations in studies of 
fungal metabolites since fungi, unlike other microorganisms, typically grow in nature on solid 
substrates such as wood, roots and leaves of plants (Nielsen et al., 2004). On the other hand, 
some believe and argue that all metabolites can be expressed in liquid culture by varying 
carbohydrate composition, nitrogen source, oxygen tension, pH, redox potential, water 
activity, as the right conditions will produce intracellular conditions that will trigger 
production of a certain metabolite. It was found that metabolites associated to spore or 
sclerotia formation are often produced under solid conditions, whereas the production of other 
metabolites is enhanced under liquid conditions (Larsen et al., 2005, Nielsen et al., 2004). 
 
In a screening effort aimed at the discovery of novel natural products, which includes a 
variety of different strains, one has to focus on a limited set of parameters, since otherwise the 
sheer number of extracts generated will easily be overwhelming. Thus, in this study selected 
fungal strain was cultured in liquid (Wickerham) medium as well as on eleven solid mediums. 
Bioactivity and chemical profiles of the obtained extracts from all cultures were compared 
and subjected to further investigation.  
 
HPLC chromatograms of the EtOAc extracts of liquid and solid cultures showed different 
chemical patterns for the fungal strain investigated in this study. Moreover, when EtOAc 
extracts of liquid and solid cultures were compared, it was found that the yield of dry extract 
obtained from rice cultures was higher than that the others media. However, it cannot be 
excluded that this finding, at least to a certain degree, was due to the fact that more polar 
material, e.g. sugars or amino acids, were extracted from the culture medium in the case of the 
solid rice cultures compared to the liquid medium. 
 
4.10. Chemical diversities of the genus Chaetomium secondary metabolites 
Fungi have proved to be a rich source of a huge number of secondary metabolites with a large 
variety of chemical structures and diverse biological activities. Fungal metabolites are of 
considerable importance as new lead compounds for medicine as well as for plant protection 
(Zhang et al., 2012). 
 
Chaetomium is a large genus of the fungal family Chaetomiaceae (subdivision Ascomycota) 
which contains over one hundred of both marine- and terrestrial-derived species. Members of 
this filamentous fungal genus, Chaetomium atrobrunneum, C. funicola, C. globosum and C. 
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strumarium, are most commonly found in soil, air, and plant debris, and are encountered as 
causative agents of infections in humans. In the past decades, fungi of the Chaetomium genus 
have been revealed to be a rich source of fascinating and structurally complex natural 
products. To date, more than 200 compounds have been reported from this genus. A huge 
number of new and bioactive secondary metabolites associated with unique and diverse 
structural types, such as chaetoglobosins, epipolythiodioxopiperazines, azaphilones, 
depsidones, xanthones, anthraquinones, chromones, terpenoids, and steroids, have been 
isolated and identified. Many of the compounds have been reported to possess significant 
biological activities, such as antitumor, antimalarial, cytotoxic, enzyme inhibitory, antibiotic, 
phytotoxic, phytotoxic and other activities (Zhang et al., 2012). 
 
5.11. Secondary metabolites isolated from the endophytic fungi Chaetomium aureum 
In this investigation, 18 compounds were isolated from the endophytic fungi Chaetomium 
aureum including four azaphilones derivatives (9-12), one pyranochromone (13), four 
xanthones derivatives (14-17) and one alkylresorcinol (resorcinolic lipid) (18). 
 
One azaphilone derivative (19) was semi-synthetic from one of the isolated compounds.  
 
5.11.1. Azaphilones 
The azaphilones are a family of structurally diverse fungal polyketides possessing a 
pyranoquinone ring systems and containing a chiral quaternary center and a highly 
oxygenated bicyclic core, and sometimes bearing a five membered lactone ring. To date, 29 
compounds of this class have been discovered in the genus Chaetomium, some of them 
displayed antifungal, antibacterial, antimalarial and selectively cytotoxic activities (Zhang et 
al., 2012). 
 
5.11.2. Pyranochromones 
From the genus Chaetomium only three pyranochromones, SB236050, SB238569, and 
SB236049, were identified from a strain of Chaetomium funicola, which are metallo-ß-
lactamase inhibitors in the Bacillus cereus II enzyme assay. Of these compounds SB238569 
was the most active. Analysis of the crystal structure of SB236050 complexed in the active 
site of CfiA indicates that SB236050 exhibits key polar interactions with Lys184, Asn193, 
and His162 and a stacking interaction with the indole ring of Trp49 in the flap, which is in the 
closed conformation over the active site groove (Payne et al., 2002). 
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5.11.3. Xanthones 
Xanthones are a structurally diverse group of natural products, derived from plants, lichens, 
and fungi, with a broad range of biological activities. Two xanthones, O- 
methylsterigmatocystin and sterigmatocystin were first isolated in 1979 from cultures of 
Chaetomium thielavioideum. 
 
5.11.4. Alkylresorcinols 
Alkylresorcinols, also known as resorcinolic lipids, are phenolic lipids composed of long 
aliphatic chains and resorcinol-type phenolic rings. Alkylreosorcinol have been found to have 
multiple biological activities, including antimicrobial, molluscicidal, and antitumor properties. 
 
5.12. Biosynthesis of isolated secondary metabolites from the endophytic fungi 
Chaetomium aureum 
All isolated compounds are derived from the polyketide biosynthesis pathway. Polyketides 
constitute a large class of natural products grouped together on purely biosynthetic grounds. 
In addition to exhibiting a staggering range of functional and structural diversity, they boast a 
wealth of medicinally important activities, including antibiotic, anticancer, antifungal, 
antiparasitic and immunosuppressive properties. Even before the full extent of their utility 
was known, scientists became interested in how these complicated molecules are assembled. 
Their diverse structures can be explained as being derived from poly-β-keto chains.  
 
The formation of the poly-β-keto chain could be envisaged as a series of Claisen reactions, 
the reverse of which are involved in the β-oxidation sequence for the metabolism of fatty 
acids. Thus, two molecules of acetyl-CoA could participate in a Claisen condensation giving 
acetoacetyl-CoA, and this reaction could be repeated to generate a poly-β-keto ester of 
appropriate chain length (Scheme 5.3). 
 
 
Scheme 5.3. The formation of the poly-β-keto chain 
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5.13. Bioactivity of isolated secondary metabolites from the endophytic fungi 
Chaetomium aureum 
5.13.1. Bioactivity of azaphilone derivatives isolated from Chaetomium aureum  
Sclerotiorin (9) inhibits efficiently the Hsp90 machine chaperoning activity. Sclerotiorin 
showed similar effectiveness to that of 17-AAG (Geldanalycin derivative), the classical 
inhibitor of Hsp90.  However, sclerotiorin has no cytotoxic effect on breast cancer Hs578T, 
MDA-MB-231 and prostate cancer LNCaP cell lines. Interestingly, deacetylation of 
sclerotiorin increases its cytotoxicity toward the tested cell lines over a period of 48h. 
Sclerotiorin showed also strong activity against all of the tested protein kinases except MEK 1 
wt. In the best of our Knowledge, the protein kinase MEK 1 wt is not Hsp 90 client protein 
(Jiao et al., 2011; Citri et al., 2006), which concord with the result of its resistance at (+)-
sclerotiorin.  
 
 
 
Figure 5.2. Diversity of established Hsp90 clients within the human kinome. 
 
Hsp90 client kinases are represented by red letters on an elliptical gray background, whereas 
non-clients appear in white letters on a rectangular black background. The overall structure of 
the scheme was based on a previously published analysis of the human kinome. 
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Table 5.2. Distribution of Hsp90 clients within kinase families 
 
 
 
 
 
The tabulation of the diversity of Hsp90 clientele according to kinase families. The data is 
based on data available in the literature. 
 
- Sclerotiorin inhibits the Hsp90 chaperoning of progesterone receptor (PR) in vitro 
Sclerotiorin efficiently inhibited the recovery of PR hormone binding activity using RRL 
(Figure 3.5.1). Sclerotiorin showed similar efficiency to that of 17-AAG, the classical 
inhibitor of Hsp90. Importantly, the oxygen atom of the heterocycle is essential for this 
inhibitory activity. Indeed, sclerotioramine and isochromophilone VI, where a nitrogen atom 
replaces the oxygen atom, are inactive. This is in line with previous reports showing that 
sclerotioramine and isochromophilone VI were unable to inhibit the activity of cholesterol 
ester transfer protein (CETP) (Tomoda et al., 1999). Isochromophilone VII showed much less 
activity than sclerotiorin. 
 
- Sclerotiorin is not cytotoxic to breast cancer Hs578T cells 
The cytotoxicity assay showed that sclerotiorin is not toxic to breast cancer cell line Hs578T  
and MCF7, MDA-MB-231, MDA-MB-453, prostate cancer cell line LNCaP and cervical 
cancer cell line HeLa. This is in contrast to a report showing that sclerotiorin induces 
apoptosis in colon cancer (HCT-116) cells through the activation of BAX, and down-
regulation of BCL-2 (Giridharan et al., 2012). 
 
- Deacetylsclerotiorin is less efficient at inhibiting the Hsp90 chaperoning of 
progesterone receptor (PR) in vitro than sclerotiorin. 
The deacetylated sclerotiorin was relatively less efficient in inhibiting the Hsp90 in vitro than 
sclerotiorin. The mechanism by which sclerotiorin and deacetylsclerotiorin inactivate the 
Hsp90 machine is not clear but it seems to be different from that of the 17-AAG. As 
compared to 17-AAG, protein analysis of complex formation by SDS-PAGE showed that 
sclerotiorin and deacetylsclerotiorin lower the level of Hsp90 without increase of Hop. 
Furthermore, deacetylsclerotiorin did not increase Hsp70 level in PR complexes.  
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- Deacetylsclerotiorin is cytotoxic to cancer cells 
At inhibitory concentrations, deacetylsclerotiorin becomes cytotoxic to Hs578T, MDA-MB-
231 and LNCaP cell lines over a period of 48h. For Western blotting, cell lines were 
harvested at 48 h and cell lysates were made. 10 µg of each protein lysate was analyzed by 
Western blotting using home made antibodies (HMGR) for GR, for Hsp70 and for Hsp40 and 
sc-47778 (Santacruz) for β-actin. Western blot analysis showed that sclerotiorin induces 
overexpression of Hsp70 and degradation of Hsp90 client proteins such as glucocorticoid 
receptor in Hs578T cells, indicating that the Hsp90 machine may be inhibited in vivo. It is 
worth noting however, that sclerotiorin also induces degradation of the heat shock protein 40 
(HSP40) which may contribute to some of sclerotiorin’s cytotoxicity.  
 
- Mechanism of action of Sclerotiorin  
Sclerotiorin and several isochromophilone analogues were also shown to inhibit gp120-CD4 
binding (Sun et al., 1996) and the activity of cholesterol ester transfer protein (CETP) 
(Tomoda et al., 1999).  From these studies, it was concluded that the electrophilic sites at the 
C6 and C8 position are required for the sclerotiorin inhibition but the chlorine atom at the C-5 
position and the acetyl residue at the C-7-OH are not. Furthermore, the oxygen atom of the 
heterocycle is also essential since sclerotioramine and isochromophilone VI where the oxygen 
atom is replaced by a nitrogen atom are less active. Long ago, sclerotiorin has been reported 
to react with primary amine (Eade et al. 1957) and this was the proposed mechanism for 
inactivation of CETP implying that sclerotiorin modifies primary amines such as lysine 
residues or the N-terminal amino acid in the CETP (Tomoda et al., 1999). It is very possible 
that the inhibitory activity of sclerotiorin toward the Hsp90 machine could be through its 
reactivity with amine groups of components such as Hsp90, Hsp70, Hsp40, Hop and p23 
leading to their inactivation. The loss of Hsp40 upon cell treatment with sclerotiorin could be 
the consequence of such covalent modifications. 
 
5.13.2. Bioactivity of xanthone derivatives isolated from Chaetomium aureum 
Xanthoradone D1 and D2 (14, 15) and xanthoradone E1 and E2 (16, 17) were subjected to 
cytotoxicity testing toward L5178Y (mouse lymphoma) cell line, protein kinases inhibition 
assays, antibacterial activity and Hsp 90 chaperone inhibition. All compounds were inactive. 
In contrast to literature, all xanthoradone derivatives were active against methicillin-resistant 
Staphylococcus aureus, produced by Penicillium radicum (Yamazaki et al., 2009). 
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5.13.3. Bioactivity of alkylresorcinol derivative isolated from Chaetomium aureum 
Chaetoresorcinol (18) was active against only Asp. Fumigatus, whereas it showed no 
antibacterial activities, which makes it selectively only against Asp. Fumigatus. 
Chaetoresorcinol was active against most of protein kinases, despite it inactivation against 
Hsp 90.  
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6. Conclusion 
 
Medicinal plants and endophytic fungi produce natural products with a large diversity of 
chemical structures, which might prove to be suitable for specific medicinal applications. 
Most of these secondary metabolites show biological activities in pharmaceutically relevant 
bioassay systems and thus represent potential lead structures, which could be optimized to 
yield effective therapeutic and bioactive agents. 
 
The Heat shock protein 90 plays a crucial role in maintaining oncogenic protein 
homoeostasis. Hsp90 inhibition offers great promise in the treatment of a wide variety of solid 
and haematological malignancies. Numerous natural Hsp90 inhibitors have been developed in 
recent years, some of which exhibit excellent antitumor activities and have entered clinical 
trials.  
 
The aim of this work was the isolation of secondary metabolites from the selected plant 
Thymelaea lythroides and its endophytic fungus Chaetomium aureum, followed by structure 
elucidation and examination of the antitumor activity of isolated compounds by screening 
their inhibitory activity on the Hsp90 machinery. 
 
The medicinal plant Thymelaea lythroides was selected from fifty five medicinal plants used 
as traditional medicine by the patients of the National Institute of Oncology in Morocco.  Five 
endophytic fungal strains (Alternaria sp., Chaetomium sp., Cladosporium sp. and Pleospora 
sp.), were isolated from Thymelaea lythroides. The fungal strain Chaetomium aureum was 
chosen for further investigation. It was grown in liquid Wickerham medium as well as on 
eleven solid media for a period of three to four weeks. The extracts obtained were then 
subjected to different chromatographic separation techniques in order to isolate the secondary 
metabolites. Structure elucidation of the isolated secondary metabolites was performed using 
state of the art techniques, including mass spectrometry (MS) and nuclear magnetic resonance 
(NMR) spectroscopy experiments.  
 
Finally, the isolated compounds were subjected to various bioassays to examine their 
antitumor activity by testing their ability to inhibit the chaperone Hsp90 machinery. Besides, 
the isolated compounds were also tested for their antimicrobial, antifungal and cytotoxic 
activities as well as inhibitory profiles towards selected protein kinases. 
  Conclusion 
  160 
 
6.1. Compounds isolated from the plant Thymelaea lythroides 
Eight secondary meltabolites were isolated from the medicinal plant Thymelaea lythroides 
including one depsipeptide (1; bassiatin), two coumarins (2; daphneone and 3; daphneolone), 
one dicoumarine (4; daphnoretin), two lignans (5; wikstromol and 6; δ-sesamin), one 
flavonoid glucoside (8; trans tiliroside), and one dicoumarine glucoside (7; rutarensine). 
 
Bassiatin (1) is an unusual plant secondary metabolite, which was previously reported 
exclusively from endophytic fungi. Thus, this is the first report of this compound from 
Thymelaea lythroides. 
 
Daphneone (2) showed strong cytotoxic activity when tested against L5178Y mouse 
lymphoma cell line. Only trans tiliroside (8) and rutarensine (7) inhibited several of the tested 
protein kinases. All the compounds isolated from Thymelaea lythroides were inactive against 
the Hsp90 chaperone machinery. 
 
6.2. Compounds isolated from the endophytic fungi Chaetomium aureum 
Six new compounds were obtained from this fungal strain, including a new alkylresorcinol 
derivative (18; chaetoresorcinol), four new xanthoradone derivatives (14; xanthoradone D1, 
15; xanthoradone D2, 16; xanthoradone E1 and 17; xanthoradone E2), and one pyrochromone 
derivative (13; SB 236050), together with four known azaphilone derivative (9; sclerotiorin, 
10; isochromophilone VII, 11; sclerotioramin and 12; isochromophilone VI).  
 
(+)-Sclerotiorin (9), (+)-isochromophilone VII (10), (+)-sclerotioramin (11) and 
isochromophilone VI (12) were not active upon testing their cytotoxic potential toward the 
L5178Y mouse lymphoma cell line. However, (+)-sclerotiorin (9) was active against all the 
tested protein kinases except MEK 1 wt, whereas its derivatives, isochromophilone VI (12) 
and sclerotioramin (11), inhibited only few of the tested enzymes. Furthermore, all 
compounds were tested in the Hsp 90 chaperone machinery inhibition assay. Only (+)-
sclerotiorin exhibited prominent activity with similar efficiency as the famous Hsp-90 
inhibitor 17-AAG (geldanamycin derivative). 
 
Chaetoresorcinol (18) showed selective moderated antifungal activity against Aspergillus 
fumigatus.  
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Table 6.1. Summary of the isolated compounds 
Compound name Structure Source Comment 
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HPLC   high performance liquid chromatography 
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µg    microgram 
µL   microliter 
µM   micromol 
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PR   progesterone receptor  
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t    triplet 
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Attachment 13. The 1H NMR spectrum of SB 236050 (13) 
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Attachment 14. The 1H NMR spectrum of xanthoradone D1 (14) 
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Attachment 14/15. The 1H NMR spectrum of xanthoradone D1 and D2 (14/15) 
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Attachment 16/17. The 1H NMR spectrum of xanthoradone E1 and E2 (16/17) 
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Attachment 18. The 1H NMR spectrum of chaetoresorcinol (18) 
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Attachment 19. The 1H NMR spectrum of (+)-deacetylsclerotiorin (19) 
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